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Apoptosis is a critically important mechanism that facilitates deletion of
unwanted or damaged cells in various circumstances including embryogenesis,
inflammation and tissue healing. However, apoptotic cells are an important
source of many autoantigens and the realisation that dendritic cells (DCs), the
main antigen presenting cell of the adaptive immune system, not only
internalise such dying cells but present antigen derived from them had
important implications for our understanding of autoimmunity, tumour
immunology and anti-viral responses.
The aim of this thesis was to explore the likely consequences of clearance of cells
dying by constitutive apoptosis by myeloid phagocytes, with particular
emphasis on the mechanism and outcome of DC clearance and the implications
for autoimmunity. Firstly it will show that DCs generated from murine bone
marrow demonstrate many characteristics attributed to DCs in vivo including
endocytosis and phagocytosis, and mature upon receipt of danger signals such
as endotoxin. However, internalisation of apoptotic cells does not augment DC
maturation but rather inhibits subsequent responses to LPS, rendering these
DCs less efficient than their neighbours at stimulating naive T cells. These
effects do not appear to be due to secretion of inhibitory cytokines such as TGFJ3
or IL10 and are not dependent on CD36 or (33/5 integrins, receptors thought to
be involved in DC internalisation of apoptotic cells. In addition apoptotic cells
inhibit LPS driven IL12 production by ex vivo DCs and in mice immunised with
apoptotic cells in vivo. Furthermore, macrophages, likely to be found in high
numbers in the inflammatory site also inhibit DCs and these inhibitory effects
could be further augmented by the presence of apoptotic cells. Taken together
these data demonstrate that internalisation of apoptotic cells by myeloid
phagocytes modulates the adaptive immune response and suggest that the
likely outcome of internalisation of cells dying by constituitive apoptosis will be
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"There is a big difference of course between natural death and accidental death, but
basically death will come sooner or later. Iffrom the beginning your attitude is, 'yes,
death is part ofour lives', then it may be easier to face.... The unfortunate event can be a




"Dulce et decorum est pro patria mori" Horace ii.13, circa 65-8BC
I have never been greatly interested in the minutiae of cell death, be it apoptotic
or necrotic. In all truth, as with life, all things come to an end and there is a
certain inevitability about mortality. What is more interesting is the outcome of
demise - is mourning inevitable or can we sometimes rejoice?
At a recent meeting someone asked of this work, 'why would our immune
systems do that?' In other words what is the purpose of the anti-inflammatory
response I have demonstrated here. This was interesting to me, coming from an
inflammation lab where we have the perhaps bizarre focus, not on how
inflammation is generated or maintained, but in how it is terminated. For this
reason, I have, from the outset, been interested more in why things don't
happen rather than why they do.
To answer this question I suppose we could start by considering the
consequences of cell death. Apoptotic and necrotic cells do not languish in vivo
but rather are cleared rapidly by any neighbouring cells, be they professional or
semi-professional phagocytes. Thus one inevitable consequence of cell death
appears to be phagocytosis. It has been suggested that this occurs for a reason
truly innate - as a source of cellular nutrition. Through this 'self-cannibalism'
multicellular organisms can recycle, regenerate and reuse precious nutrients
especially in times of stress or need, such as during development and tissue
remodelling.
Considering, therefore, that phagocytosis is as vital for recycling of fuel as for
protection against pathogens, is it not likely that pathways involved in death,
phagocytosis and response to infectious non-self would have evolved alongside
one another. In certain circumstances, might it not be better if phagocytosis of
dead cells continued without inciting a response, even when cell death was
11
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caused by, or associated with, pathogen, and that only occasionally, if things
were getting out of hand, would we require for the immune system to be
activated? Thus anti-inflammatory signals from apoptotic cell death may well
be dominant over conventional 'danger' signals.
An important point supporting this balance of power lies in the rarity of
autoimmune driven disease, especially considering what we now know of
apoptotic cells as a source of autoantigens. Although we could postulate that
disastrous self reactivity or 'horror autotoxicous' does not occur because of Tack
of appropriate danger signals', Tack of signal 2' or 'dose of antigen' these
explanations leave us (and our immune system) in a rather precarious place,
ready to be toppled by the first bout of flu or a developing mammary gland.
Instead would it not be wiser to evoke active inhibitory or regulatory networks?
And where else better for these to originate than with the apoptotic cell itself?
We now know that regulation exists at all levels of both the innate and adaptive
immune system including macrophages, NK cells and T cells. Perhaps a more
interesting question therefore, is how ancient are such regulatory networks? If,
as suggested, phagocytosis, pathogens and cell-death have co-evolved will we
find similar anti-inflammatory responses in our more primitive immunological
ancestors? Some of our delay in answering these questions is simply
experimental constraints - it requires us to devise novel ways of studying these
'negative' phenomena, redefine what we consider as 'immunity' to include
these regulatory spectra and, of particular importance, to fully encompass the








During normal tissue homeostasis, the rate of cell death is perfectly balanced by
the rate of production of new cells resulting in a constant cell number (Kerr et al.
1972). Apoptosis is a critically important mechanism that facilitates deletion of
unwanted or damaged cells in various circumstances including embryogenesis,
inflammation and tissue healing. However, apoptotic cells are an important
source of many autoantigens and the realisation that dendritic cells (DCs), the
main antigen presenting cell of the adaptive immune system, not only
internalise such dying cells but present antigen derived from them had
important implications for our understanding of autoimmunity, tumor
immunology and anti-viral responses.
The aim of this thesis was to explore the likely consequences of clearance of cells
dying by constitutive apoptosis by myeloid phagocytes. DCs have been shown
to play a vital role in linking the innate and adaptive immune response as well
as being important semiprofessional phagocytes. For these reasons I chose to





"The formation of tissue autotoxins would [therefore] constitute a danger threatening
the organism more frequently and much more severely than all exogenous injuries" Paid
Ehrlich
Autoimmunity occurs in 3-5% of the population and is characterised by
pathology caused by, or associated with, ones own immune system. In these
diseases the damage is often mediated either by self-reactive T cells or
autoantibodies directed towards antigenic components of self-proteins.
Autoimmune diseases are often associated with both genetic and environmental
predisposing factors including HLA associations, susceptibility genes that
control leukocyte reactivity and infectious triggers (Pickering et al. 2000a;
Lesage et al. 2001; Marrack et al. 2001; Ohashi 2002). Autoimmunity is probably
initiated by a single antigenic insult such as tissue destruction or infection, and,
through determinant spreading, comes to involve either different parts of the
same protein or other proteins within an organ. In many cases, such as multiple
sclerosis and diabetes, autoimmune diseases are organ specific the target being
determined by antigen expression, antigen presentation and vulnerability of the
target organ. However, occasionally autoimmunity is directed at components of
self that are expressed ubiquitously. In the archetypical systemic autoimmune
disease, systemic lupus erythematosus (SLE), the antigens fall into two distinct
types; either recently cleaved 'neoantigens,' such as those produced by
granzyme B activity, or intracellular components, often found within
multimolecular complexes such as dsDNA, ANA, chromatin and phospholipids
(Rosen et al. 1999; Napirei et al. 2000). Interestingly, both the activity of
granzyme B and the content of these multimolecular complexes is dependent on
a process of cell deletion found commonly within inflammatory or remodeling
tissue - 'apoptosis' (Casciola-Rosen et al. 1994; Rosen et al. 2001). The realisation
that dendritic cells (DCs), not only internalised cells dying by apoptosis, but also
present antigen derived from them (Bellone et al. 1997; Albert et al. 1998b) had
important implications for many areas of immunology especially autoimmunity.
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I chose therefore to study the fate of these dying cells and the DCs that engulf
them, focusing on the specific implications for self-tolerance and autoimmunity.
1.3 Apoptosis and immune regulation
1.3.1 What is apoptosis?
Apoptosis is characterised by stereotypical morphological and biochemical
changes including the activation of specific intracellular proteolytic enzymes
(caspases) that cleave myriad nuclear and cytoplasmic substrates (Thornberry
1997). Apoptosis may result from an insufficient supply of survival signals or
may be actively induced by various injurious stimuli such as hypoxia, reactive
oxygen species, complement attack, nitric oxide, cytokines such as tumour
necrosis factor-a (TNFa) or ligation of the Fas (CD95) cell surface death receptor
(Nagata 1996). Apoptosis elicits specific cell surface changes, such as the
exposure of phosphatidylserine (PS), normally found on the intracellular aspect
of the cell membrane, resulting in the swift uptake and degradation of apoptotic
cells either by local resident cells or infiltrating phagocytes (Savill et al. 1993;
Savill et al. 2000b). This process is very rapid such that apoptotic cells are
conspicuously absent in normal tissues. Furthermore, cell deletion by apoptosis
leading to clearance by 'professional' phagocytes such as macrophages is not
associated with proinflammatory mediator release (Meagher et al. 1992) but
rather causes release of anti-inflammatory agents such as transforming growth
factor (31 (TGF(31) (Voll et al. 1997a; Fadok et al. 1998a; Fadok et al. 2000). The
mechanisms whereby macrophages and 'semi-professional' phagocytes
(including retinal pigment epithelial cells (Finnemann et al. 1999) and mesangial
cells (Baker et al. 1994)) recognise and ingest apoptotic cells are complicated and
may involve numerous molecules (Savill et al. 2000a) including the vitronectin
receptor (av(33 integrin) (Savill et al. 1990; Savill et al. 1992; Rubartelli et al. 1997),
CD36 (Savill et al. 1992; Albert et al. 1998a; Fadok et al. 1998c) thrombospondin ,
the phosphatidylserine receptor (Fadok et al. 1992a; Fadok et al. 1992b; Fadok et
al. 2000), the first component of complement Clq (Taylor et al. 2000),
16
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complement receptors (Mevorach et al. 1998a), class A scavenger receptors (Piatt
et al. 1996), CD14 (Devitt et al. 1998), calreticulin (Ogden et al. 2001) amongst
others (Moynault et al. 1998; Oka et al. 1998; Imachi et al. 2000) (Fig 1.1).
1.3.2 The role of apoptosis in the maintenance of self tolerance and the
regulation of T cell populations
Self-tolerance requires the removal or deactivation of autoreactive T cells with
specificity to both central and peripheral antigens. Within the developing
thymus engagement of autoreactive T cells by self-antigen induces apoptosis
and deletion of these potentially injurious T cells. This process, referred to as
central tolerance, depends critically upon apoptosis and consequently, defects in
this 'programmed cell death' will facilitate the persistence of T cells capable of
recognising self and inducing autoimmunity (Nagata 1996).
However, the entire repertoire of self-antigens is not represented within the
thymus and therefore additional mechanisms are needed to maintain adequate
peripheral self-tolerance (Walker et al. 2002). Although this process is
incompletely understood apoptosis may also be involved. For example, it has
been recognised for some time that certain organs such as the eye (Griffith et al.
1995; Griffith et al. 1996) and the testes (Bellgrau et al. 1995) are
'immunologically privileged' sites, relatively protected from the adaptive
immune system. It is now apparent that this is at least partly due to the
expression of Fas ligand by resident tissue cells at these sites. This tissue 'self
defense' mechanism results in the induction of apoptosis in infiltrating Fas-
bearing lymphocytes following Fas ligation (Singer et al. 1994a; Singer et al.
1994b; Bu et al. 2001).
Apoptosis also plays a role in the regulation of T cell populations. Clonally
expanded populations of activated T cells that have served their functional
purpose are rapidly deleted by 'activation induced cell death' (AICD), a process























Figure 1.1: Apoptotic cells are recognised through a large
number of apoptotic cell surface ligands, bridging molecules




(Sytwu et al. 1996). Considering these three important roles for apoptosis in
control of self-tolerance, it is therefore very pertinent that mice with mutations
in the genes encoding either Fas or Fas ligand develop autoimmune disease
(Nagata 1998). Depending upon the genetic background, such mice exhibit
lymphadenopathy, splenomegaly, autoantibody formation, joint inflammation
and glomerulonephritis with features of SLE (Cohen et al. 1991). Interestingly,
early treatment of gld/gld mice, deficient in functional Fas ligand, with an
agonistic anti-Fas antibody protected mice from the subsequent development of
autoimmune disease by a mechanism which presumably involves Fas-
dependent deletion of autoreactive lymphocytes. Furthermore, treatment of
established autoimmune disease with the same agonistic anti-Fas antibody
resulted in a significant improvement in disease pathology (Nishimura et al.
1997).
A small number of human patients have been described with mutations in the
genes encoding either Fas or Fas ligand (Nagata 1998). These patients exhibit an
autoimmune lymphoproliferative syndrome (ALPS or Canale-Smith syndrome)
characterized by lymphadenopathy, splenomegaly and autoantibodies directed
at blood components such as erythrocytes and platelets (Fisher et al. 1995;
Martin et al. 1999). Affected individuals do not typically develop joint or renal
disease and therefore defects in the Fas death receptor or its ligand do not
appear vital to the pathology in these organs but can contribute to autoimmune
disease. Taken together these observations support an important role for
apoptosis in the deletion and removal of autoreactive cells.
1.4 Dendritic cells
"It is easy to be fascinated by dendritic cells, not only because of their pivotal role in the




1.4.1 DCs as innate and adaptive immune players
DCs are highly specialized antigen presenting cells and phagocytes, with
important roles both in the innate and adaptive immune response (Banchereau
et al. 1998; Liu, Y. J. et al. 2001b; Mellman et al. 2001). As innate immune players
they efficiently internalise antigen and share many phagocytic and scavenger
receptors with macrophages (Austyn 1996; Rubartelli et al. 1997). They are
found well positioned, at portals of entry of pathogens such as the Peyers
patches of the gut and in the skin, to perform their sentinel tasks. Besides a
variety of endocytic receptors specialized for pathogen internalisation (e.g. the
mannose receptor) they also have many pattern recognition receptors, including
numerous members of the family of Toll-like receptors (Aderem et al. 2000;
Kaisho et al. 2000), allowing them to recognize and respond directly to pathogen
associated molecular patterns (PAMPS) (Reis e Sousa 2001), such as
lipopolysaccaride (LPS), lipetechoic acid, dsRNA, CpG DNA or flagellin (Horng
et al. 2001). In response to pathogens DCs secrete a variety of factors involved
in early response effector functions (Huang, L. Y. et al. 2001; Rescigno et al.
2001) including IL12, type 1 and 2 IFNs and TNFa (Hochrein et al. 2001). These
cytokines act to arm the effector cells of the innate response, such as NK cells,
NK T cells and macrophages, against viral and bacterial pathogens as well as
priming the adaptive immune response (Reis e Sousa et al. 1997). DCs can also
be indirectly activated by environmental cues such as IL1 and TNFa, secreted
by infected keratinocytes and epidermal T cells acting on bystander Langerhans
cells (Yokota et al. 1996; Reis e Sousa 2001), and matrix components, such as
hyaluronan (Termeer et al. 2002), and heparin sulfate (Kodaira et al. 2000).
Furthermore, certain necrotic cells (Gallucci et al. 1999; Sauter et al. 2000),
possibly via production of heat shock proteins (HSP) (Janetzki et al. 1998; Basu
et al. 2000; Srivastava 2002b; Srivastava 2002a) or induction of proteolytic
cascades, also provide suitable maturation stimuli for DCs.
The role of the DCs in adaptive immunity is even more subtle - qualitative and
quantitative differences in their initial response contribute to determine the type
20
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of the adaptive response that is initiated (Moser et al. 2000). For example,
production of cytokines such as IL12, IL18 or IL10 can drive Thl, Th2 or Treg
responses (Moser et al. 2000; Pulendran et al. 2001). This complexity may be
added to further by different responses from different DC subsets (Shortman
2000; Liu, Y. J. 2001; Liu, Y. J. et al. 2001b) - CD8a+DCs produce large amounts
of IL12 and prime Thl responses and IFNy production from interacting T cells;
plasmacytoid DCs prime Th2 response and via production of type IIFN induce
anti-viral immunity. This combination of responses and the functional
consequences that ensue allow DCs not only to sense pathogen but also to
activate the appropriate arm of the adaptive immune response, acting to bridge
the innate and adaptive immune systems.
1.4.2 Immature vs. mature DCs and T cell interactions
It was proposed by Janeway that pathogens would be required to activate
antigen-presenting cells, upregulating costimulatory molecules and T cell
stimulatory function, for the immune system to be activated. Furthermore, he
predicted the existence of pathogen associated molecular patterns (PAMPS) and
a recognition system that would perform this function (Janeway, C. A., Jr. 1989b;
Janeway, C. A., Jr. 1992). Matzinger further expanded this theory by suggesting
that these 'danger' signals might be derived from endogenous products
(Matzinger 1994). In support of this, DCs fulfill many of these requirements and
appear to exist in at least two distinct activation states, immature and mature
(Figl.2) (Banchereau et al. 2000), controlled by exposure to 'danger' signals, be
they exogenous or endogenous. Although this model probably oversimplifies
the situation in vivo, it is useful to discuss for clarity.
In their immature state DCs are specialized for antigen capture, a task they
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Figure 1.2: DCs exist in two distinct states, immature and mature
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internalize such large volumes of antigen that they possess specific aquaporins
for fluid egress (de Baey et al. 2000). Macropinocytosis and phagocytosis are
more specific than endocytosis and require actin-cytoskeletal rearrangement,
initiated after cell surface receptor ligation, for antigen internalization (Austyn
1996; Garrett et al. 2000; West et al. 2000). These mechanisms of antigen capture
will be discussed in greater detail in chapters 3 and 6.
DC maturation is associated with movement of class IIMHC from the lysosomal
compartments to the cell surface, via class II rich vesicles (Mellman et al. 2001).
In the mature DC the MHC molecules are expressed with increased stability
(increasing from <10 to 100 hours) (Cella et al. 1997; Pierre et al. 1997; Inaba et
al. 2000) and are found associated with increased levels of expression of
costimulatory molecules on the cell surface (Caux et al. 1994; Inaba et al. 1994;
Turley et al. 2000). Membrane rearrangement and up regulation of T cell
adhesion molecules (including CD54 and DC-SIGN) also facilitate initial DC: T
cell interactions and formation of the 'immunological synapse'. In addition DCs
alter their chemokine receptor profiles, downregulating CCR5 and 6 and
upregulating CCR7, allowing them to traffic to draining lymph nodes (Dieu et
al. 1998; Yanagihara et al. 1998). Although initially thought that maturation and
migration were linked it has been suggested that this is in fact not the case and
that not all parts of the maturation programme need to be completed before DCs
can exit the tissue (Randolph 2002). Finally, DCs produce a variety of cytokines
(Langenkamp et al. 2000), able to modulate T cell responses, including IL12
(which is an absolute requirement for Thl priming) (Magram et al. 1996). Thus
DCs are unique in being able to provide all elements for T cell activation: 'signal
1' is provided by an abundance of MHC and stable MHC-peptide complexes,
'signal 2' as they express high levels of costimulatory molecules and 'signal 3' as
they secrete the potent T cell activating cytokine, IL12 (Janeway, C. 1989a).
Furthermore, the migratory properties of DCs allow both spatial and temporal
compartmentalisation of DC functions; immature DCs acting in the periphery to
capture antigen and mature DCs, having migrated to draining lymph nodes are
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stimulated by T cells which provide signals, via ligation of CD40 (Cella et al.
1996; Schulz et al. 2000), inducing terminal maturation and differentiation.
1.4.3 Antigen processing and cross-priming
Antigens captured are targeted to specific lysosomal and endosomal
compartments within the immature DC (Inaba et al. 2000; Turley et al. 2000).
One such compartment is the late endosome in which large amounts of class II
MHC is stored and it is within these specialised compartments that degraded
peptides are loaded onto MHC II molecules (Figl.3). In further support of
Janeway's prediction, presentation of internalised antigen is not inevitable but
instead requires an orchestrated maturation programme, initiated by TLR
ligation, proinflammatory cytokines or CD40 (Cella et al. 1996; Schulz et al.
2000), before transportation of these MHC-peptide complexes to the cell surface
occurs.
Bevan initially described cross-priming in the 1970s (Bevan 1976b; Bevan 1976a)
when he observed that donor minor histocompatability antigens were found
presented on recipient MHC. From this observation it was apparent that a
recipient cell must internalise and present donor cell-associated antigens
(Carbone et al. 1990). Unlike Class II MHC presentation of exogenous antigens,
how class I is loaded with extra-cellular peptides remains poorly understood
(Kurts et al. 1996) ((Norbury et al. 1997) and it is this latter phenomenon that is
now usually called 'cross-priming' and appears unique to DCs (Heath et al.
2001a; Heath et al. 2001b).
Two distinct pathway of class I antigen presentation (cytosolic and endosomal)
have been identified (Figl.3). DCs are also unusual in that they sequester
antigen in their lysosomal compartment whilst macrophages 'degrade' them.
These antigens may well be able to 'leak' into the cytosol of the DC via a DC













is the case with infections by certain pathogens (Finelli et al. 1999). Here they
are then available for class I loading via the conventional endogenous pathway
and as such is TAP dependent (Huang, A. Y. et al. 1996; Norbury et al. 1997).
Alternatively, class I restricted peptides may be presented independently of
TAP (Bachmann et al. 1995; Schirmbeck et al. 1995) or be specifically chaperoned
to the ER for loading (Srivastava 2002a), loaded directly at the DC cell surface
where HLA-DM and class I may co-localise or presented from exosomes
(Zitvogel et al. 1998; Thery et al. 1999; Wolfers et al. 2001) or extracted
membrane from the cell of origin (Harshyne et al. 2001). In addition, apoptotic
(Bellone et al. 1997; Albert et al. 1998a; Albert et al. 1998b) and necrotic cells (Lu,
Z. et al. 2000) appear to be a highly efficient means of delivering exogenous
peptides to both class I and class II MHC (Inaba et al. 1998) in vitro and are
likely to be an important source of cellular antigens for cross-priming in vivo.
However, cross-presentation is not a characteristic of all DC subsets and the
identity of the cells responsible in vivo has remained elusive. It is only recently,
nearly a quarter of a century after his original description, that Bevan has
identified the CD8a+DC as a likely candidate (den Haan et al. 2000; Pooley et al.
2001).
1.4.4 DC subsets
Different functions of DCs can be explained not only by different maturation
and activation states but also by separate developmental lineages with distinct
functional attributes (Shortman et al. 2002). A detailed analysis of human DC
subsets is beyond the scope of this thesis but bears many similarities to the
murine subsets that have been described. To date, excluding plasmacytoid DCs
(O'Keeffe et al. 2002a; O'Keeffe et al. 2002b), five murine DC subsets have been
identified, characterised by cell surface markers and functional phenotypes
(Anjuere et al. 1999; Vremec et al. 2000; Hochrein et al. 2001) with complex (and
often contradictory) models of developmental origins (Liu, Y. J. 2001). Two
important distinctions have been made by the expression of CD8a, the presence
of which was initially thought to represent a specific DC lineage of lymphoid
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origin. Although this division now appears to be an oversimplification CD8a+
DCs are still often referred to as lymphoid DCs and contribute about 25% of the
DCs found within the spleen. These lymphoid DCs appear to have many
important functional specializations such as in vivo IL12 production (Reis e
Sousa et al. 1997) and biasing of Thl response. In contrast, CD8a- (or 'myeloid')
DCs make much less IL12 and preferentially drive Th2 responses (Maldonado-
Lopez et al. 1999). Interestingly, CD8a+ DCs also appear to induce accelerated
activation induced T cell death, which is not a feature of CD8a-DC: T cell
interactions (Suss et al. 1996). Furthermore, CD8a+ DCs have been found to
preferentially phagocytose apoptotic cells in vivo (Iyoda et al. 2002; Liu, K. et al.
2002; Schulz et al. 2002b) potentially explaining the efficiency with which they
cross-present cellular derived antigens when compared to CD8a- DCs, which
require an additional stimulus such as LPS to perform this task.
1.4.5 DCs and tolerance
Although exactly how peripheral tolerance is initiated and maintained is not
fully understood it is likely that DCs are intimately involved - their ability to
sample their surroundings, interact with naive T cells and modulate the
outcome of such interactions supports this suggestion (Steinman et al. 2000;
Shortman et al. 2001). Certain DC populations such as the lymphoid DC may
have distinct characteristics and contribute specifically to peripheral tolerance
by anergising or deleting interacting T cells (Suss et al. 1996). Hence, the
possibility that CD8a+DCs might cross-prime not only foreign or transplant
antigens but also self-antigens is particularly pertinent as they may have the
potential to delete a variety of self-reactive T cells. In support of this, deletion of
interacting CD8 T cells appears to be the outcome of constitutive cross-priming
in vivo (Kurts et al. 1997b; Adler et al. 1998; Morgan et al. 1999).
Another proposition is that it is not the DC subtype but its activation state that
determines the induction of tolerance or immunity. For instance, immature DCs
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which fail to express costimulatory molecules or IL12, carrying self-antigen (see
later) may generate and maintain regulatory T cell subsets (Dhodapkar, M. V. et
al. 2001). In a linear model of DC activation that has been recently proposed,
early activated DCs might be specialized for production of IL12 and generation
of Thl response whilst later 'exhausted' DCs prime Th2 responses (Langenkamp
et al. 2000). Finally DCs might be specifically modified by their tissue micro-
environment, such as lung (Akbari et al. 2001) or gut (Iwasaki et al. 1999) DCs
exposed to TGF[3 or IL10 (Fiorentino et al. 1991; Steinbrink et al. 1997), providing
particular cues and driving specific types of regulatory T cell responses.
1.5 Clearance of apoptotic cells and autoimmunity
1.5.1 Apoptotic cells express potential autoantigens near their cell surface
The origin of the autoantibodies typically present in the sera of patients with
autoimmune conditions such as SLE (often directed towards ubiquitous
intracellular antigens such as DNA, ribonucleoproteins and nucleosomes) has
been perplexing as these autoantigens are normally 'invisible' to the immune
system because of their localisation within the cell. However, seminal work by
Casciola-Rosen et al indicated that keratinocytes undergoing apoptosis
displayed potential autoantigens near their cell surface where they are available
for interaction with immunologically competent cells (Casciola-Rosen et al. 1994;
Rosen et al. 1999) (Fig 1.4). These potential autoantigens on apoptotic cells are
likely to have undergone proteolysis by caspases and other proteases resulting
in the production of immunogenic 'altered self' motifs (Napirei et al. 2000).
Indeed, cleavage of intracellular substrates by the enzyme granzyme B can
result in unique modification of potential intracellular autoantigens increasing
their immunogenicity and raise the possibility that cytotoxic lymphocyte-
mediated death of target cells (mediated by granzyme B) may play a specific
28
Figure 1.4: Apoptotic cells contain autoantigens. Apoptotic
keratinocyte demonstrating co localisation of Ro (green) and DNA
(red) to the surface of apoptotic cells and apoptotic blebs. From
Casciola-Rosen et al (1994).
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role in the development of autoimmunity (Rosen et al. 1999). It seems likely that
the intracellular components such as dsDNA and chromatin will be found
alongside neoantigens and 'altered self' motifs in macromolecular complexes on
the surface of dying cells and may act as specific antigenic stimuli for generation
and maintenance of self reactive B and T cells.
Despite the surface of apoptotic cells expressing potential autoantigens, it is
obvious that the majority of the population does not develop autoimmune
pathology and therefore apoptosis itself is insufficient to induce autoimmune
disease. It is believed that, in normal circumstances, apoptotic cells are rapidly
ingested and degraded by phagocytes. Indeed, in vivo studies of both renal
development and glomerulonephritis indicate that the vast majority of apoptotic
cells evident in tissue sections actually lie within other cells (Baker et al. 1994).
This suggests that autoimmunity may be more likely to arise if there is a defect
in the clearance of apoptotic cells and accumulating evidence suggests that this
is indeed the case.
1.5.2 Evidence for an association of autoimmunity with defective apoptotic
cell clearance
Experiments involving the injection of normal mice with irradiated syngeneic
apoptotic thymocytes resulted in the transient development of antinuclear
autoantibodies and anticardiolipin and anti-ssDNA antibodies, albeit at
relatively low levels (Mevorach et al. 1998b). Furthermore, these mice also
exhibited mild glomerular immunoglobulin deposition. These data indicate that
exposure to large numbers of apoptotic cells, which may exceed the phagocytic
capacity of the reticuloendothelial system, is able to elicit an autoantibody
response.
As indicated previously, multiple macrophage cell surface receptors and
bridging molecules may be involved in the recognition and ingestion of
apoptotic cells. However, the involvement of Clq, the first component of the
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classical complement pathway, is of particular interest since Clq deficiency is
strongly associated with the development of SLE (Pickering et al. 2000b;
Walport 2000). It is therefore extremely important that mice targeted for the
deletion of the Clq gene spontaneously develop both autoantibodies and
glomerulonephritis (Fig 1.5). Indeed, the glomerular inflammation in the Clq-/-
mice is characterised by an impressive accumulation of apoptotic cells within
glomeruli implicating defective clearance of apoptotic cells as an important
aetiological factor in the development of disease (Botto et al. 1998). In addition,
as in human disease, the genetic background of the Clq knockout mice plays an
important role in modulating disease susceptibility and phenotype (Mitchell et
al. 2002). A pathogenic role for defective apoptotic cell clearance in the
development of autoimmunity may also explain why exposure to UV light or
intercurrent infections are associated with increased disease activity since they
would be predicted to increase the burden of apoptotic keratinocytes or
leucocytes requiring phagocytic clearance. Lastly, it is pertinent that monocyte-
derived macrophages isolated from patients with SLE exhibit reduced ingestion
of apoptotic cells in a quantifiable in vitro assay of phagocytosis suggesting that
a defect in apoptotic cell clearance may be relevant to the pathogenesis of SLE.
The receptor tyrosine kinase Mer has been shown to bind Gas6 homologue
proteins bound to the phophatidylserine exposed on apoptotic cells. Similar to
the Clq-/-, the Merkd/Merkd mice, bearing a tail deletion mutation in this
receptor, also exhibit a defect in macrophage clearance of apoptotic cells and
develop autoantibodies (Scott et al. 2001). Furthermore, examination of the
Tyro-Axl-Mer triple knockout, in which all members of the receptor tyrosine
kinase family are mutated, demonstrate not only autoantibodies but also
develop a constellation of autoimmune pathologies including nephritis and
arthritis (Lu, Q. et al. 2001).
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Figure 1.5: Defective apoptotic cell clearance is associated with
autoimmunity. Glomerulus from C1q-/- mouse showing crescentic




1.5.3 Evidence for mechanisms increasing safe clearance of apoptotic
cells and preventing autoimmunity
Biological systems have evolved to ensure that apoptotic cells do not normally
undergo secondary necrosis that would be predicted to increase the likelihood
of autoimmune responses (Mevorach 2000). For example, C reactive protein
(CRP), a teleologically ancient acute phase reactant protein, can bind to the
apoptotic cell surface. Bound CRP stimulates activation of the classical pathway
of complement resulting in opsonisation of the cell with complement
components that can augment apoptotic cell clearance (Gershov et al. 2000) and
also assists the maintenance of cell viability by inhibiting the activation of the
cytolytic C5b-9 terminal membrane attack complex. In addition, the pentraxin
PTX3, an acute phase protein generated locally within inflamed tissues, inhibits
uptake of apoptotic cells by dendritic cells preventing presentation of apoptotic
cell-derived antigen to T cells (Rovere et al. 2000). Lastly, the acute phase
protein serum amyloid P component (SAP) binds chromatin on apoptotic cell
surfaces as well as binding, solubilizing and regulating the degradation of free
chromatin that results from cell breakdown. The importance of this chromatin
scavenging system is underscored by the phenotype of mice targeted for the
deletion of the SAP gene which exhibit antinuclear autoantibodies and
glomerulonephritis (Bickerstaff et al. 1999).
1.5.4 Presentation of antigens derived from apoptotic cells
Unlike macrophages, dendritic cells are unique in their ability to stimulate
primary immune responses. Immature dendritic cells exist in the periphery and
constantly sample their antigenic milieu. In order to become fully functional
antigen presenting cells they must mature and migrate to draining lymph nodes
where they can interact with naive T cells. Recent data indicate that dendritic
cells not only ingest apoptotic cells but also are capable of presenting apoptotic
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cell-derived antigen to cross-prime both CD4 and CD8 T cells if they receive
appropriate activation signals (Bellone et al. 1997; Albert et al. 1998a; Albert et
al. 1998b; Inaba et al. 1998). Since apoptotic cells are a source of potential
autoantigens it is conceivable that dendritic cells internalising them might
induce a primary autoimmune response. However apoptotic cells do not induce
DC maturation and they would require receipt of concurrent 'danger' signals.
Indeed, it has been suggested that a high load of apoptotic cellular material,
perhaps due to secondary necrosis following failed clearance, may predispose to
the development of autoimmune responses by increasing the potential for
dendritic cells to phagocytose apoptotic cell material and subsequently present
autoantigens (Kurts et al. 1998; Rovere et al. 1998; Ronchetti et al. 1999).
However, autoimmunity is the exception rather than the rule and presentation
of such apoptotic-derived self-antigens is likely to be tightly controlled. Hence,
the ability of DCs containing apoptotic cells to respond to 'danger' signals is
important and may be vital in modulating the outcome of cross-presentation of
self-antigens derived from these dying cells, determining whether self-tolerance
or autoimmunity ensues.
1.6 Conclusion
Apoptosis and the clearance of apoptotic cells are essential for normal tissue
homeostasis, embryogenesis and tissue remodeling. Apoptotic deletion of
potentially autoreactive T cells is involved in the maintenance of self-tolerance.
However, apoptotic cells are an important and preferential source of many
potential autoantigens and defective apoptotic cell clearance may facilitate the
inappropriate presentation of these antigens by dendritic cells, thereby initiating
autoimmune responses. In this thesis I will explore the likely outcome of DC
interactions with cells dying by normal constitutive apoptosis. I will
demonstrate that in normal circumstances regulatory effects, generated after
phagocytosis of the apoptotic cells, in fact modulate DCs in ways which are
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likely to contribute to prevention of autoimmunity and that presentation of







BALB/c mice were used for all experiments unless otherwise stated. Animals
were purchased from B&K Universal (Hull, U.K.) and were used from 8 weeks
of age. DO11.10 transgenic mice were breed in house at the University of
Edinburgh animal facility and screened by tail bleed an FACS of peripheral
blood lymphocytes. CD36 -/- were a kind gift of R. Silverstein and were breed in
house at the University of Edinburgh animal facility and screened by tail tip
PCR. (33, /35 an (33/5-/- animals were a kind gift of K. Hodivala-Dilke and were
breed and screen at the Institute for Cancer Research (Potters Bar) by tasil tip
PCR and Southern. IL10-/- mice were purchased from Jackson Laboratory along
with wild-type controls and used from 8-10 weeks of age.
2.2 Cell generation and cell culture
2.2.1 Bone marrow derived dendritic cells
Murine cells were cultured in RPMI1640 supplemented with 2mM L-glutamine,
lOOU/ml penicillin, lOOug/ml streptomycin, and 10% heat inactivated foetal
bovine serum unless otherwise stated. DC complete medium also contained 10-
15% conditioned supernatant from a stably transfected B cell line (kind gift of
Prof D Gray, Edinburgh) expressing recombinant GMCSF resulting in a final
concentration of GMCSF of 20-30 ng/ml (Zal et al. 1994). This hybridoma also
produces IL-10 at a final concentration of approximately 2ng/ml but no TNFa
or IL12. All culture reagents were obtained from Gibco unless otherwise stated.
DCs were cultured as described previously (Lutz et al. 1999). Briefly, femurs
from BALB/c mice were removed, dipped in 70% ethanol for 10 seconds and
then placed in DC complete medium. Bone marrow was flushed from femurs
and 10 ml of a single cell suspension of bone marrow cells at 2 x 105 / ml plated
in non-tissue culture grade petri dishes. On day 3 a further 10 ml of fresh
medium was added to the cultures. On day 6 half of the media was removed,
and the cells pelleted, resuspended in fresh media and added back to the petri
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dishes. On day 7 non-adherent cells were removed, leaving strongly adherent
macrophages on the plate. These harvested cells were pelleted, re-suspended at
2 x 105 cells / ml and replated before use. On day 7 these were a heterogeneous
population, 65-80% of the cells having surface phenotype and morphologyof
immature DCs with granulocytes being the main contaminant. Maturation was
initiated on day 7 with 0.1-lpg/ml of LPS (Sigma: E. Coli serotype 026:B6) or
0.02 % w/v Staphlococcus Aureus (Cowan strain) (SAC, Calbiochem) and cells
assessed on day 8 (see Chap 3 for detailed analysis).
2.2.2 Bone marrow derived macrophage
Bone marrow was isolated as described for DCs. To generate macrophages cells
were cultured in DMEM supplemented with 2mM L-glutamine, lOOU/ml
penicillin, lOOug/ml streptomycin and 10% heat inactivated foetal bovine serum
and 10% conditioned supernatant from L929 cells, a source of murine MCSF.
Cells were plated at 4x10s cells per well of a 24 well plate. On day 2 cells were
washed and media changed. Macrophages were used for most experiments at
day 6-7 of culture.
2.2.3 Isolation of human neutrophils
Neutrophils were extracted from peripheral blood of healthy volunteers as
described previously (Savill et al. 1992). Briefly, blood was drawn into citrated
50ml Falcon tubes and spun at 350G for 20 minutes. Plasma was removed and
to the remaining fraction was added 6ml of 6% dextran and tubes topped up
with warmed normal saline before gently being inverted and allowed to
sediment for 20 minutes. During this time a Percoll gradient was prepared.
100% Percoll was made up to 90% by addition of 4ml of lOxPBS to 36ml 100%
Percoll. Using this 90% Percoll gradients were made from fractions containing
79%, 68% and 55% Percoll by addition of lx PBS without Ca2+/Mg2+. The 2.5ml
of the 68% fraction was overlayed onto 2.5ml of the 79% fraction in a 15ml
38
CHAPTER 2: Methods
Falcon tube. The leucocyte enriched fraction was harvested from the top layer
after the dextran sedimentation of the blood and pelleted at 350G for 6 minutes
and resuspended in 2.5ml of 55% Percoll. This layer was overlayed onto the
other two layers and the gradient spun at 720G for 20min (acceleration 9,
deceleration 12, Sigma centrifuge). Peripheral blood mononuclear cells
(lymphocytes and monocytes) were harvested from the top interface and
peripheral blood neutrophils from the bottom interface. Cells were washed
twice in PBS without Ca2+/Mg2before use. This yielded highly pure human
neutrophils (>90 %). Autologous serum was made by clotting 10ml of plasma in
glass tubes by addition of 200pl of 1M CaCl2 at 37°C. Platelet poor plasma (PPP)
was prepared by centrifugation of plasma at 3000rpm for 20 minutes.
2.2.4 Generation of apoptotic/late apoptotic and necrotic cells
Human neutrophils were allowed to undergo constitutive apoptosis by aging
overnight in Iscove's medium (IMDM) supplemented with lOOU/ml penicillin
and lOOug/ml streptomycin and 10% autologous serum. After this period of
time the cells were 40-80% apoptotic by cytospin morphology. This method of
generating apoptotic bodies was preferred as there was no significant necrosis
(<1%) by trypan blue exclusion, confirmed by annexin-PI staining and flow
cytometry (Fig 2.1). Apoptotic murine thymocytes were also generated for use
in some experiments by treating single cell suspensions of thymocytes with
dexamethasone for 4-6 hours. This method yielded apoptotic cells but these
preparations often contained contaminating post-apoptotic cells and other non-
apoptotic thymic cells. For most experiments cells were stained using a green
cell tracker dye (CMFDA) (Molecular probes) prior to overnight culture. To
stain, neutrophils were suspended at high density (20x106 cells/ml) in serum-
free IMDM and lOpl of 2mg/ml CMFDA added (to stain a maximum 120xl06
cells) for 15 minutes at 37C. Cells were then diluted out to 4xl06 cells/ml in
IMDM with autologous serum.
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Late apoptotic/apoptotic separation was performed on 24 hour aged
neutrophils by density gradient centrifugation. To protect fragile late apoptotic
cells, all procedures were performed at 4°C. Aged neutrophils were
resuspended in plasma and overlayed onto a Percoll gradient made up of 31%
Percoll (Percoll 620/d + 1380/xl PPP), 42% Percoll (Percoll 840^1 + 1160/rl PPP)
and 51% Percoll (Percoll 1020/xl + 980/xl PPP) in a 15ml Falcon tube. Gradients
were spun at 550G for 20min at 4°C and cells harvested from the interfaces as
follows:
Plasma/31% Percoll interface = pure late apoptotic cells
31%/42% Percoll interface = mixed late apoptotic and apoptotic cells
42%/51% Percoll interface= pure apoptotic cells
Necrotic cells were generated by heat treatment of live (primary necrotic) and
apoptotic cell (secondary necrotic) at 100°C for 3 min.
Necrotic, apoptotic and late apoptotic cells were phenotyped using annexin-V
and PI (Fig2.1)
2.2.5 Splenic DCs
DCs were isolated from spleen according to a modified protocol kindly
provided by C Reis e Sousa (Reis e Sousa et al. 1997). Spleens were collected in
RPMI and kept on ice before use. A single cell splenocyte preparation was
obtained by digesting spleens using Liberase (Boehringer-Mannheim) at 1.67
WunschU/ml and DNAse (Boehringer-Mannheim) 0.2mg/ml in RPMI by
injecting 5ml/spleen along length of the organ held over a 15 ml Falcon tube.
The remaining spleen was dropped into the solution and left at 37°C for 30
minutes. Digested spleens were filtered through a cell strainer by rubbing the
spleen onto the filter with the plunger from a 1ml syringe. Filtered cells were
collected into 50 ml Falcon by washing with PBS/2mM EDTA. For most
experiments the spleen suspension was further purified from debris by
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Fig 2.1 Surface phenotype of dying cells. Annexin-V/PI staining
of 16 hour aged human neutrophils containing both live and




resuspending in 2x5 mis aliquots and spun through 5ml of Lympholyte-M
(Cedarlane labs) at 1250G for 20 minutes according to manufacturers
instructions, and cells isolated from the interface.
Cells were washed twice in PBS/2mM EDTA and resuspended in MACS buffer
(lOOpl/spleen) left on ice for 2 min. CDllc-MACs beads were diluted 1:10 and
100 jiil of diluted CDllc-MACS beads add 100 pi to each spleen to a final volume
of 200ul. Cells were incubated in the fridge for 10 minutes, washed x2 in MACS
buffer and resuspended in MACS buffer (in 0.5ml/spleen). Cells were passed
through a 40pm strainer before adding to a positive selection column to yield 3-
4X106DCs/spleen.
2.2.6 T cell isolation
CD4 T cells were isolated from spleens of DO11.10 transgenic mice. In brief,
spleens were made into a single cell suspension by passing through a 53pm
filter in PBS and debris and red cells removed by density gradient
sedimentation through Lympholyte-M (Cedarlane Laboratories) according to
manufacturer's instructions. Cells were then isolated using L3T4 (CD4)
microbeads and MACS purification system (Miltenyi Biotec).
2.2.7 Hybridoma culture
L929 mouse fibrosarcoma line were cultured in Gibco DMEM/F12
supplemented with 10% FCS and lOOU/ml penicillin, lOOug/ml streptomycin.
Cells were passaged 1/10 2-3 x week. To harvest M-CSF containing
supernatant, cells were grown to a confluent monolayer, media harvested and
cleared by centrifugation.
GM-CSF was generated from a hybridoma (kind gift of Prof D. Gray).
Hybridoma cells were cultured in Gibco IMDM supplemented with lOOU/ml
penicillin, lOOug/ml streptomycin, 2mM L-glutamine, 2Mercaptoethanol and
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5% heat inactivated FCS. Selection antibioticG418 (Gibco-BRL 10131-019) was
added at lmg/ml and cells maintained between 7.5-40xl04cells/ml by
passaging 2-3 times per week 1:3 or 1:5. Cells were washed 3 times in media
without G418 and resuspended in media without G418 at a medium density (i.e.
30-40xl04 cells/ml) in 20 ml. Cells were grown in a 162 cm2 flask to harvest
supernatant. Media was harvested whilst still pink but cells thick and dense
(0.75-lxl06cells/ml) and cleared by centrifugation before storing at -80°C.
2.3 Microscopy
All images were examined using an inverted microscope (Zeiss), and images
captured using Open Lab software and CoolSnap digital camera unless
otherwise stated.
2.3.1 Cytospins and Giemsa staining
70-100pl of cell suspension were spun at 400rpm for fresh cells or 300rpm for
aged cells for 3 minutes onto glass slides. Slides were allowed to air dry, and
then fixed in methanol 1 minute before staining. For Giemsa staining slides
were stained in Diff-Quik 1 for 1minute, Diff-Quik 2 for 1 minute and washed
with distilled water before mounting. For fluorescent microscopy cells were pre-
stained before cyto-spinning and mounting in DPX under glass coverslips.
2.3.2 Plate based fluorescence
For fluorescent microscopy DCs were grown on chamber well slides (Lab-Tek),
allowed to interact with red fluorescent apoptotic cells then fixed with 4%
paraformaldehyde. Slides were stained in PBS with 0.5% BSA and 0.2% sodium





DCs that had been cocultured with apoptotic cells were pelleted and fixed with
25% glutaraldeyde (EM grade I) in 0.1 M sodium cacodylate buffer for at least 1
hour at room temperature. Fixative was removed with 1 wash of 0.1M sodium
cacodylate buffer and the pellet imbedded in a resin plug. The plug was then
processed with osmium tetroxide, lead citrate, araldite embedding and ultra
thin sections (60nm) cut. Samples were analysed on a Philips CM150 TEM.
2.4 Flow cytometry
Cells were harvested, washed and resuspended in flow buffer. Non-specific
antibody binding was blocked by preincubating cells with normal mouse serum
for 10 minutes on ice. Cells were then pelleted at 300G for 2 minutes,
resuspended in flow buffer and stained for 30 minutes on ice, in the dark.
Antibodies were used at varying concentrations established by titration from 1
in 80 to 1 in 400. Some antibodies were not primary conjugated and hence a
second step staining was required. Cells were then washed and resuspended in
200pl of FACS wash and analysed using FACSCalibur and FlowTo® software.
The following antibodies were used (all from Pharmingen unless otherwise
stated): FITC-I-Ad/I-Ed, PE-CD40, PE-CD86, PE-CD54, PE-CDllc, APC-CDllc,
FITC-F4/80 (Serotec), unconjugated sialoadhesin (Serotec), unconjugated CD36
(Calbiochem), FITC-anti rat secondary (Serotec), FITC- anti mouse IgA
(Pharmingen). All samples were compared to appropriate isotype controls. The
geometric mean fluorescence of cells positive to isotype control was used in
analysis (see Chap 3 for detailed analysis).
2.5 Phagocytosis/endocytosis assays
2.5.1 Flow cytometry based assays
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Fluorescently labelled apoptotic cells were co-cultured with Day 7 DCs at a ratio
of 2-5:1, apoptotic cells:DC. Most assays were performed in 96 well U-bottomed
plates. Interaction of DCs with apoptotic cells was assessed by removing cells
after 2 hours and staining with APC-CDllc for FACS analysis. All FACS
analyses were carried out on a FACSCalibur flow cytometer (Becton-Dickinson).
Gates defining phagocytosis were established by comparing cells co-cultured in
the absence of fluorescent apoptotic cells (or, in some experiments, DCs co-
incubated with apoptotic cells at 4°C) with DCs that had interacted with
apoptotic cells at 37°C. Maximum interaction was seen at ratios of >5:1 apoptotic
cells: DCs but the large numbers of uningested apoptotic cells reduced the
efficiency of cell-sorting and so ratios of 2:1 were used in most experiments.
Endocytosis assays were performed in a similar manner but the interaction was
stopped by quenching with ice cold PBS and cells washed once with FACS
buffer.
2.5.2 Cell sorting
To separate ac+ and ac- cells DCs were cultured with green fluorescent
apoptotic cells for 2 hours at a ratio of 2:1. Cells were then activated using LPS
and allowed to mature overnight (16 hours). DCs were next harvested and
resuspended at 3-5xl06/ml in RPMI with 10% FCS in sterile Falcon FACS tubes
and sorted into ac+ and ac'DCs by the presence of forward and side scatter and
coincident green fluorescence using a FACS vantage fluorescent cell sorter.
2.6 Cytokine assays
2.6.1 ELISA
ELISAs were performed according to manufacturer instructions (R&D). In brief,
capture antibody was diluted in PBS and used to coat 96 well microtitre plates
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by adding lOOpl per well and incubating overnight. Each well was washed 3
times with ELISA wash buffer and then blocked using ELISA block solution for
1 hour. Plates were washed, loaded with lOOpl of culture supernatant (or in the
case of serum samples, diluted 1:100 in reagent diluent) and incubated for 2
hours. Plates were washed again and 100ml of detection antibody added for a
further hour. Plates were washed and lOOpl of streptavidin-HRP added for 20
min, washed and lOOpl substrate solution added for a further 20 minutes before
the interaction was stopped. Plates were read on an ELISA plate reader.
2.6.2 Intracellular cytokine staining
For intracellular cytokine staining, cells were co-cultured with apoptotic cells for
4 hours and stimulated with LPS for 5 hours in the presence of GolgiPlug
(Pharmingen) lpg/ml according to manufacturer's instructions. Cells were
harvested and stained for cell surface markers as described above. Cells were
then fixed using 4% paraformaldehyde and permeabilised with 2% saponin in
PBS with 0.5% BSA and 0.2% sodium azide and 10% mouse serum whilst
staining with APC-TNFa, IL10 and IL12p40/p70 (Pharmingen). Specificity of
staining was confirmed by either preincubating with excess unlabelled antibody
(IL12p40) or by addition of excess cytokine (TNF). All samples were compared
to irrelevant isotype control and unstimulated cells.
2.7 T cell assays
2.7.1 Phenotyping DO11.10
8-week-old TCR transgenic mice were tail-bled lOOpl in 500pl Alservers'
solution in 1.5ml eppendorf tubes, topped up with PBS and kept on ice. Diluted
blood was spun through 2.5ml of Lympholyte-M at 1250G for 20 minutes in
FACS tubes. Lymphocytes were harvested form the interface. Peripheral blood
mononuclear cells were stained for CD4 (Pharmingen) and KJ126 (Scottish
Antibody Production Unit), a clonotypic antibody specific for the v(38.2 T cell
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receptor expressed as a transgene on DO11.10 T cells, to quantify percentage
transgenic positive T cells. Both heterozygotes and homozygotes were used for
experiments.
2.7.2 T cell stimulation
CD4 T cells were isolated from spleens of DO11.10 transgenic mice by Miltenyi
MACS purification as described previously. Day 7 DCs were co-cultured with
apoptotic cells for 4 hours, stimulated with LPS overnight and then were pulsed
with 5pg/ml OVA peptide (OVA 323.339) (Albachem Laboratories, Edinburgh
University) for 2 hour. They were then washed thoroughly and cells sorted into
DCs containing apoptotic cells and those not, using a FACSVantage cell sorter
(Becton-Dickinson). Contaminating apoptotic cells could be excluded from the
sort by their smaller size and bright fluorescence. 3 x 105 OVA-TCR transgenic T
cells were co-cultured in 24 well tissue culture dishes with varying doses of DCs
for 5 days in a final volume of 2 ml. Proliferation was assessed by removing
triplicate lOOpl samples pulsed with 1 pCi / well of [3H]- thymidine (Sigma) for
16 hours. Cells were harvested and thymidine incorporation measured using a
scintillation counter. Interactions were performed in duplicate. For T cell
restimulation T cells were washed, and resuspended in fresh media on day 5 of
stimulation and allowed to 'rest' before being stimulated with PMA/ionomycin
for 24 hours on day 7.
2.8 Miscellaneous
2.8.1 In vivo experiments.
Balb/C mice were used at 10 weeks. Apoptotic cells were washed twice with
PBS and resuspended at 80xl06 cells/ per ml and kept on ice. Mice were
injected with iv endotoxin, 80 pg/mouse in lOOpl of PBS. In addition 8x106
apoptotic cells were also injected either mixed with the LPS or subcutaneously.
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After 4 hours the mice were sacrificed and bled by cardiac puncture. Serum
samples were allowed to clot at 37°C for 1 hour, spun at 1500rpm and serum
stored at -20°C until analysed by ELISA.
2.8.2 Annexin/PI staining
Apoptosis was assessed by cytospin morphology and annexin-V FITC and PI
staining. For assessment of PS exposure cells were stained for 15 minutes on ice
with annexin-V FITC in a Ca2+/Mg2+rich buffer. PI was used to assess
membrane permeability by adding to FACS tubes at O.lpg/ml for 120s prior to
analysis.
2.8.3 Cell adhesion
Polylysine treated chamber well slides were either left uncoated or coated with
matrix as follows: laminin, fibronectin and vitronectin was diluted to 10pg/ml,
in 0.1M NaHCO3 , pH8, and 200pl added to each well. Wells were coated by
rocking at room temperature for 3 hours before matrix was removed and the
chamber wells used. Cell adhesion was performed by prestaining DCs using
CMFDA as described for neutrophils and allowed to adhere to matrix coated
plates for 1 hour at 37°C in the absence of serum prior to aspiration of excess
media and addition of PBS. Cells were observed by fluorescent microscopy.
2.9 Statistical analysis
All data represents means +/- standard deviations unless otherwise stated.
Data was analysed on Microsoft Excel using ANOVA statistical analysis.
Differences were considered significant if p<0.05 and represented as or highly
significant if p<0.01 and represented by




PBS: 137mM NaCl, 2.7 mM KC1, 8.1 mM Na2HP04/1.5 mM KH2P04/ pH7.2-7.4
MACS buffer: PBS, EDTA(2mM), 0.5% BSA (TC grade), no azide
FACS wash: PBS without Ca2+/Mg2+, 0.2% BSA, 0.1% NaN3
ELISA block solution: 1% BSA, 5% sucrose in PBS with 0.05% NaN3
Reagent diluent: 1% BSA in PBS (0.2 pm filtered)
ELISA wash buffer: PBS/Tween (0.05% Tween 20 in PBS)
Sodium citrate: 0.1M Na Citrate, pH5
TMB: lOpg dissolved in 1ml DMSO
Substrate solution: sodium citrate, 2pl of 30% H20210ml, 75pl
tetramthlybenzidine (TMB)/ per 10ml
Stop solution: 51ml dH20 plus 3ml 2 N H2S04
Alservers solution: 20g glucose, 0.55g citric acid, 8g trisodium citrate dehydrate,
4.2g NaCl made up to 11 with mH20, pH6.1
Annexin buffer: Hanks balanced salt solution plus added 2mMCa2+
Liberase: 250mg (1000 WunschU) bottle of CI lyophilised enzyme blend made
up in 15ml sterile LPS free H20 left on ice 30 min then filtered through a low-
protein binding 0.22pm polysulphone membrane (eg Millipore Millex-GP




Bovine serum albumin Fraction V #A9418
Sodium azide #S 8032
Citric acid #C7129


















Phosphate buffered saline tablets (Dulbecco's) #BR0014G
Pansorbin ® cells (lyophilised) Calbiochem
Dil-OxLDL Intracel #RP173
Dil-AcLDL Intracel #RP078
TGFbSR R&D # 41-R2
IL10 SR R&D # 474-MR
GRGDSP (Gly-Arg-Gly-Asp-Ser-Prol) Calbiochem #03-34-0035
GRADSP (Gly-Arg-Ala-Asp-Ser-Prol) Calbiochem #03-34-0052
GRGDTP (Gly-Arg-Gly-Asp-Thr-Prol) Calbiochem #03-34-0055
Fibronectin (murine) Gibco-BRL #12173-01
Diff-Quik I and II Dade Behring #130834/5
DPX mountant BDH #36029 4H
Laminin (natural mouse) Gibco-BRL #23017-15
Liberase Boehringer-Mannheim #1-814-435
DNAsel Boehringer-Mannheim #1-284-932




2.10.3 Tissue culture reagents
Gibco-BRL:
RPMI1640 #31870-025
DMEM (F12) # 21331-012




EDTA Molecular Biology Grade # E7889
Bovine serum albumin 30% # 8327
Tissue culture plastics
Costar:
U-bottomed 96 well plates #3799
12 well plates #3513




Falcon bacterial grade 10cm dishes #351029
0.5pm tissue culture inserts B.D Labware
Chamber well slides #154526
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3.1 Introduction
Dendritic cells have been described as the sentinels of the adaptive immune
response. In an immature state in the periphery they capture antigen by
macropinocytosis, receptor mediated and non-receptor mediated endocytosis
and phagocytosis. Although DCs were known to be highly phagocytic they
were only recently shown to be capable of internalising apoptotic cells and at
the outset of this work few descriptions of this existed - two describing DC
phagocytosis of apoptotic cells in a human system (Rubartelli et al. 1997; Albert
et al. 1998a) and another in a murine DC cell line (Rovere et al. 1998). Thus, the
first objective was to reproducibly generate murine bone marrow derived DCs
and confirm their ability to internalise antigens including apoptotic cells. In
addition it was necessary to establish a reliable system for evaluation of
phagocyte : apoptotic cells interactions.
The data presented in this chapter demonstrates that murine bone marrow
could be reliably differentiated into cells with cell surface, morphological and
phenotypic characterisitics of DCs (Inaba et al. 1992a; Inaba et al. 1992b; Winzler
et al. 1997; Lutz et al. 1999). In their immature state, these cells could capture
antigen by endocytosis and phagocytosis and internalised antigen could be
visualised by microscopy and reliably quantified by flowcytometry. This latter
technique will allow, in future chapters, study of quantitative differences in cell
surface expression of costimulatory molecules and cytokine production by
individual DCs that had (ac+DCS) or hadn't (ac-DCs) phagocytosed apoptotic
cells.
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3.2 Results
3.2.1 Microscopy of DC and macrophage.
DCs and macrophages demonstrate strikingly different characteristics in
culture. Macrophages grown in tissue culture plastic were strongly adherent
laying down large amounts of extracellular matrix and growing, over 7 days, to
a confluent monolayer (Fig 3.1). Removal of such cells was difficult requiring
forceable washing and ice cold EDTA. In contrast DCs were only loosely
adherent to plastic, growing mostly in grape like clusters. Phase contrast of such
cells revealed irregular veiled protrusions and dendrites, characteristics from
which the names 'veiled cell' and 'dendritic cell' were derived (Fig 3.1).
Cytospins of macrophages and DCs also demonstrate morphological
differences; macrophages were heterogeneous with a vacuolated cytoplasm (Fig
3.2) whilst DCs were extremely heterogeneous. Unfortunately, the fine veils
and dendrites are difficult to preserve on cytospin morphology but can be seen
on some cells (Fig 3.2).
3.2.2 Surface phenotype of DC vs macrophages
Although many of the surface characteristics of macrophages and immature
DCs are similar, DCs can be readily distinguished from macrophages by the
their ability to upregulate costimulatory molecules and class II MHC, which are
rapidly mobilised from intracellular stores to the cell surface upon activation
and maturation. Thus, to establish the phenotype of our murine bone marrow
DCs, immature DCs, LPS matured DC and macrophages were compared for cell
surface expression of a variety of myeloid markers (Fig 3.3). On day 7 immature
murine DCs cultured according to the method of Lutz (Lutz et al. 1999) were 60-
80% pure DCs as assessed by high expression of the relatively DC specific
marker, CDllc although this is also expressed at lower levels on other myeloid
cells. The contaminating cells at day 7 of culture were predominantly
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Figure 3.1: Phase contrast microscopy of macrophages and
DCs. DCs (A) are heterogeneous, non adherent cells with multiple
fine veils and dendrites observable in culture. Macrophages (B)
demonstrate a strongly adherent monolayer population of
homogeneous cells. Lower magnification (C ) of DC cultures





Figure 3.2: Cytospins of DCs and macrophages.
Macrophages(A) are more homogeneous with a vacuolated
cytoplasm. In contrast, DCs (B) are heterogeneous and in a
resting state have a more homogeneous cytoplasm. Morphology
of the fine dendrites (arrow) and veils (arrowhead) is poorly
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Figure 3.3: Surface phenotype of Macrophages and DCs.
Cultures of macrophages (7 days) or DCs (7 days) were
harvested, stained for cell surface markers and analysed by FACS.
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granulocytes (Fig 3.4), the percentage of which decreased over time with DC
cultures being >90% pure by day 10. At day 7 these murine DCs were
aheterogeneous population expressing varying levels of class II MHC and
costimulatory molecules. In addition they expressed low levels of the
macrophage marker F4/80, no CD14 and no sialoadhesin (both
macrophage/monocyte specific) (Fig 3.3) (Fraser et al. 1994; Gordon 1999).
3.2.3 DC maturation
To determine whether these DCs were functional and responsive to maturation
stimuli the ability of LPS and SAC to upregulate DC maturation markers was
assessed (Winzler et al. 1997). Murine DC cultures were extremely
heterogeneous for expression of a variety of costimulatory molecules.
Costimulatory molecule CD86, was expressed at varying levels in resting
cultures with most cells being low (or negative) although a few CD86 high cells
could be found. The proportion of CD86 high DCs increased spontaneously
during the culture period from day 7 to 10 and was also upregulated markedly
upon stimulation with both LPS (increasing from 31 to 56%) and SAC
(increasing from 31 to 71%) (Fig 3.5). CD86 expression in the whole population
when expressed as geometric mean fluorescence intensity (GMFI) was found to
be a reliable and objective marker of DC maturation in the bone marrow derived
cells changing from low to high upon stimulation corresponding to
aproximately 2.5 fold increase in CD86 GMFI when stimulated with LPS and 6
fold increase when stimulated with SAC (Fig 3.5) and was used for data analysis
in most experiments. GMFI appeared to correlate well with percentage of DCs
that were CD86 high and was used rather than mean fluorescence to prevent
high expression of CD86 on some cells skewing results. Thus, using this marker,
appropriate conditions required for DC stimulation were determined; maximal
stimulation was achieved with smooth mutant E.Coli LPS at 0.5-lpg/ml (slight
batch variations did exist) (Fig 3.6 and 3.7) and SAC at 0.02% vol (Fig 3.7) and
doses in these ranges were used for all subsequent experiments. LPS has been
reported to cause death of DCs but did not affect the viability and cell recovery
58
Figure 3.4: Identification of granulocytes as main
contaminants in DC cultures. DC cultures at day 7 were
stained for Gr-1 and analysed by FACS. Approximately 20 % of the
cells were GR-1 positive, indicating granulocytes or cells of
granulocyte lineage. The filled histogram represents cells stained







Figure 3.5: Response of DCs to maturation by bacterial
products. DC cultures (day 7) were stimulated with LPS or SAC
for 24 hours, harvested, stained for CD86 and analysed by FACS.
Unlabelled cells and cells stained with isotype controls are in the
first log order of fluorescence. CD86 GMFI and percentage CD86
high and low cells are shown.
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CD86 CD40
Figure 3.6: Dose response of DCs to maturation by LPS. DC
cultures (day 7) were stimulated with LPS for 24 hours, harvested,
stained for cell surface markers and analysed by FACS. Data are
expressed as mean GMFI +/- s.d. representatitive of at least 3
independent cultures.
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Figure 3.7: Dose response of DCs to maturation by microbial
products. DC cultures (day 7) were stimulated with LPS or SAC
for 24 hours, harvested, stained for cell surface markers and
analysed by FACS. Data are expressed as mean GMFI +/- s.d.
from 2 independent cultures.
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over the 24 hours of culture. In some cultures a powerful stimulus to DC
maturation is cluster disruption (Pierre et al. 1997). Interestingly, in our murine
system, DC transfer on day 7 away from adherent contaminating macrophages
by gentle washing, did not provoke extensive phenotypic changes or DC
maturation after 24 hours unless additional stimuli were applied (Fig 3.8). Other
costimulatory molecules were also assessed (Fig 3.9). Resting DCs expressed
almost no CD40 but could be induced to upregulate it upon stimulation with
LPS resulting in homogeneous expression of CD40 in most cells. CD80 was
expressed in most resting DCs and was also upregulated upon stimulation in a
manner similar to CD86 generating a mixed population of CD80 high and low
cells. CD54 and MHCII also demonstrated staining patterns and response to
LPS similar to CD86 with populations of both high and low expression in
resting cultures and an increase in the percentage high cells upon stimulation.
3.2.4 Phagocytosis by murine bone marrow DCs
Initially fluorescent microscopy was used to confirm internalisation of apoptotic
cells by dendritic cells. DCs were counterstained either with CDllc-PE and
challenged with green fluorescent labelled apoptotic cells or stained fluorescent
green with MHCII-FITC or green cell tracker dye (CMFDA) and cocultured with
red fluorescent apoptotic cells. In both these situations DCs could be seen to
efficiently internalise apoptotic cells/bodies (Fig 3.10).
It was then necessary to establish a flow cytometric-based phagocytosis assay to
reliably study DC phagocytosis/endocytosis of fluorescent substrates. In most
experiments DCs were gated either as CDllc positive cells or counterstained
with fluorescent cell tracker dyes (Fig 3.11). The assays were performed in U-
bottomed plates to maximise DC: dead cell contact with varying DC: apoptotic
cell ratios. In a typical experiment (Fig 3.12), with apoptotic cell : DC ratios of
4:1, approximately 30 % of the DCs would internalise apoptotic cells, although
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Figure 3.8: Maturation of DCs following transfer. DC cultures
(day 7) were transferred to fresh culture plates without additional
stimuli, or stimulated with LPS or SAC. 24 hours after transfer and
stimulation, DCs were harvested and stained for cell surface
markers and analysed by FACS. Figures show CD86 and MHC II
staining on CD11c + cells. Marked gates show the upper limit of
isotype antibody staining.
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Isotype control LPS 0 pg/ml
LPS 0.1 ng/ml
LPS 0.5 jig/ml
Figure 3.9: Maturation of DCs by LPS treatment. DC cultures
(day 7) were stimulated with LPS. After 24 hours DCs were
harvested, stained for cell surface markers and analysed by FACS.
Figures show surface molecule staining on all cells.
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Figure 3.10: Phagocytosis by immature DCs (1). DC cultures
(day 7) were incubated for 2 hours with apoptotic neutrophils
labelled with green (A) or red (B) fluorescent tracker dyes,
counterstained with CD11c-PE (A) or MHCII-FITC (B) and
visualised by fluorescence microscopy under x 100 (oil) objective.
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FL1-H: PHAGOCYTOSIS
Figure 3.11: Apoptotic cell phagocytosis by DCs (1):
Detection by FACS. DC cultures (day 7) were unstimulated or
incubated with apoptotic neutrophils labelled with green fluorescent
tracker dye, for 2 hours, counterstained with CD11c-APC and
analysed by FACS. DCs can be clearly gated as CD11c positive
and sub-divided into ac phagocytosing and non-phagocytosing
cells. Numbers on FACs plots are percentage of cells in each
quadrant region.
67
0 20mM 0% 10%
EDTA (mM) Serum (%)
Figure 3.12: Apoptotic cell phagocytosis by DCs (2): Inhibition
by temperature and EDTA and augmention by serum. DC
cultures (day 7) were incubated for 2 hours with fluorescent green
apoptotic neutrophils and phagocytosis measured by FACS.
Phagocytosis was carried out at 4 °C or 37 °C (A), in the presence
or absence of EDTA (B) or the presence or absence of serum (C).
In B and C graphs are of mean +/- s.d. from triplicate wells
representative of 3 independent experiments. ** represents
significant difference from control (p < 0.01, ANOVA).
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was performed in the presence of EDTA (Fig 3.12) phagocytosis was perturbed
demonstrating that it did indeed detect specific DC:apoptotic cell interactions.
To determine binding rather than internalisation the assay was also performed
on ice and demonstrated only low levels of binding of DCs to apoptotic cells
(typically 4-8% of DCs binding apoptotic cells) (Fig 3.12). Furthermore,
performing the assay in the presence or absence of serum allowed
determination of the contribution of serum components (Fig 3.12), which
approximately doubled the proportion of DCs ingesting apoptotic cells. A dose
response of apoptotic cells demonstrated that the efficiency of DC
internalisation of apoptotic cells increased with increasing number of dying cells
(Fig 3.13) but never reached the level of efficiency demonstrated for
internalisation of control particles such as latex beads. This assay was also used
to determine the kinetics of the interaction; phagocytosis increased with time,
peaking at 2 hours (Fig 3.13) after which there was a slight loss of fluorescence
within the ac+DCs perhaps due to redistribution/'digestion' of internalised dye.
Despite this loss of fluorescence, the cell-tracker dye could still be detected
within the phagocyte up to 24 hours after the interaction both by microscopy
and flowcytometry and hence it was possible to use this assay to follow the fate
of DCs that had internalised apoptotic cells (ac+DCs) at a single cell level over
this period of time.
To confirm that this assay was detecting internalised apoptotic cell or apoptotic
cellular fragments, ac+DCs and ac-DCs were sorted by flow cytometry. ac+DCs
contained either whole apoptotic cells, apoptotic bodies or apoptotic cell
derived fluorescence whilst ac-DCs had no evidence of ac associated
fluorescence (Fig 3.14). It was unlikely that ac associated fluorescence was
derived merely from internalisation of debris or free dye as deliberate cell lysis
(by multiple freeze thaw or hypotonic treatment) destroyed ac associated
fluorescence which could not then be detected in the fluorescent assay. Thus it
was likely that any apoptotic cell-associated fluorescence represented
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Figure 3.13: Apoptotic cell phagocytosis by DCs (3):
Dependence on DC/ ac ratio and time. DC cultures (day 7) were
incubated with fluorescent green apoptotic neutrophils and
phagocytosis measured by FACS. A: Phagocytosis was carried
out for 2 hours with a constant number of DCs (0.2x106 cells in 0.2
ml) and increasing numbers of apoptotic cells (0.1-3.2x106). B:
Phagocytosis by 0.2x106 cells DCs with 0.4x106 cells apoptotic
cells was stopped after 60 - 240 minutes by placing on ice. 0 time
controls are from DCs and apoptotic cells mixed on ice. Data are
expressed as mean +/- s.d. from triplicate wells, representative of
3 independent experiments.
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Figure 3.14: Apoptotic cell phagocytosis by DCs (4):
Confirmation of FACS assay. DC cultures (day 7) were
incubated with fluorescent green apoptotic neutrophils for 24
hours, and sorted. DCs were identified by size, and separated into
DCs with (A) and without (B) associated green fluorescence.
Pictures are of cytospins of sorted cells visualised by fluorescence
microscopy (x 100 (oil) objective). Panels in B are exposed for the
same time as (A), and contain DCs when visualised by bright field
microscopy (not shown)
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3.2.5 Morphology after phagocytosis
DCs are heterogeneous cells in vivo and in vitro. It was noted that after
phagocytosis, DCs became larger and more granular. Cytospin preparations of
DCs after coculture with apoptotic cells demonstrated certain interesting
characteristics; DCs developed cytoplasmic protrusions and intracellular
inclusions and an asymmetric nucleus (Fig 3.15). EM examination confirmed
internalisation of apoptotic cells, found typically within tight phagosomes (Fig
3.16).
3.2.6 Endocytosis and phagocytosis of control particles by immature DCs
DCs also internalise antigen by both receptor mediated and non-receptor
mediated endocytosis and phagocytosis (Austyn 1996). Firstly I wished to
demonstrate the phagocytic capacity of immature DCs and addition of 2pm
fluorescent latex beads to DC cultures demonstrated that they phagocytosed
these inert particles with high efficiency (>80%). Internalisation of oxidised lipid
represents an interesting example of receptor-mediated endocytosis as it shares
with apoptotic cells a common recptor, CD36 (Febbraio et al. 2001). Although
the exact component of the apoptotic cell that is recognised by CD36 is
unknown, it is likely that it recognises altered lipid components in the cell wall
of dying cells. It is controversial whether murine CD36 binds oxidised lipid but
it was considered an ideal control to study the effect of receptor-mediated
endocytosis on DCs. Using labelled substrates it was demontrated that
immature day 7 DCs can effectively internalise FITC-dextran (Fig 3.17) and lipid
(Fig 3.18), both of which could be visualised by fluorescent microscopy (Fig
3.19). Interestingly, although all immature DCs internalised oxidised lipid, a
subpopulation performed this task with much higher efficiency (Fig 3.18).
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A
Figure 3.15: Apoptotic cell phagocytosis by DCs (5):
Morphology of phagocytosing cells. Cytospins were prepared
from unstimulated DCs (A) or DCs incubated with apoptotic cells
(B), and viewed under x 100 (oil) objective. A: unstimulated DCS
show finer dendrites and a homogenous cytoplasm. B: DCs co-
cultured with apoptotic cells are larger and demonstrate a distinct
morphology with blunt pseudopodia (arrow), granular inclusions
(arrowhead)and an asymmetric nucleus. Note contaminating live
murine granulocytes in these cultures (pmn). AC=apoptotic cell
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Figure 3.16: Apoptotic cell phagocytosis by DCs :
Confirmation by transmission electron microscopy (TEM).
DCs incubated with apoptotic cells were fixed and prepared for
TEM. An apoptotic body can be clearly seen inside the cytoplasm










Figure 3.17: Endocytosis by immature DCS (1): dextran. DCs
(day 7) were incubated with 1 mg/ml 4 kDa or 70 kDa FITC-
dextran. After 0-120 minutes cells were quenched and
endocytosis measured by incorporation of FITC into DCs, using
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Figure 3.18: Endocytosis by immature DCS (2): LDL. DCs (day
7) were incubated with 10 pig/ml li-labelled acetylated or oxidised
LDL. After 0-120 minutes cells were fixed and endocytosis
measured by incorporation of Dl into DCs, using FACS.
Histograms are red fluorescence associated with DCS, gated by
size. Note a biphasic peak of oxLDL positive cells suggesting
either degeneration of oxLDL or heterogenicity of receptor
expression .
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Figure 3.19: Endocytosis by
immature DCS (3): Dextran and
LDL. DCs (day 7) were
incubated with 1 mg/ml FITC-
dextran (A) or 10 |ig/ml Dl-
labelled oxidised LDL (B). After
240 minutes cells were fixed and
examined by microscopy. Dl-
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Furthermore, by pulsing DCs with apoptotic cells and FITC-dextran it was
apparent that that the requirements for phagocytosis of apoptotic cells were
more stringent than endocytosis and that only 25% of DCs able to endocytose
actually internalised apoptotic cells (Fig 3.20). It has been shown previously
that DCs that have internalised dextran are able to export it into the cytosol via
an endosomal-cytosolic pore able to transport substances less than 40kD. The
cell tracker dye used for these experiments becomes covalently linked to
intracellular proteins and hence allowed us to track the fate of internalised
apoptotic cell-associated proteins. Interestingly, in these experiments, using
different sizes of dextran it could be demonstrated that dextran of 4kD 'leaked'
from the endosomal compartment into the cytoplasm as described previously
(Rodriguez et al. 1999b). However, no such movement was demonstrable for
apoptotic cell associated fluorescence or 70kD dextran, which remained mostly
co-localised in endosomal compartments at 6 hours (Fig 3.21).
3.3 Discussion
Here I demonstrate that murine bone marrow DCs, like human monocyte
derived DCs, demonstrate many of the characteristics attributed to DCs in vivo.
Firstly, these cells express the cell surface markers and morphological
characteristics of DCs. In addition, their maturation in response to stimulus by
bacterial products could readily be demonstrated as assessed by upregulation of
costimulatory molecule and class II MHC expression.
These murine bone marrow DCs were able to internalise antigen by endocytosis
and whole cells by phagocytosis as demonstrated in our fluorescent
phagocytosis assay. In confirmation of this, apoptotic cells or control endocytic
particles were visualised within DCs by fluorescent microscopy. The
requirements for apoptotic cell phagocytosis were presumably somewhat





Figure 3.20: Comparison of endocytosis and phagocytosis by
DCs. DCs (day 7) were co-challenged with both FITC-dextran and
fluorescent red apoptotic cells for 2 hours and analysed by FACS.
DCs were gated by size and green and red fluorescence
measured. Histograms show both control DCS (red lines) and
DCs incubated with fluorescent dextran/ acs (blue lines). Numbers
show percentage of cells that are more fluorescent than control
cells. Although the majority (98%) of immature DCs internalised
dextran only a small percentage (26%) phagocytosed apoptotic
cells.
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A: 70kD FITC-Dextran, 1hour
B: 70kD FITC-Dextran, 6hours
C: 4kD FITC-Dextran, 1hour
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Figure 3.21: The fate of the internalised material. DCs pulsed
with 70kD (A and B) and 4kD (C and D) FITC-dextran and red
fluorescent apoptotic cells were examined 1 hour (A and C) and 6
hours (B and D) after the interaction to track the fate of the
internalised material. Panels show green (dextran), red (apoptotic
cells ) and green/ red overlayed images. Apoptotic cell associated
fluorescence co-localised with 70kD dextran at 1 and 6 hours
whilst by 6 hours 4kD dextran had 'leaked' from the endosomal
pathway into the cytosol.
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cells when co-challenged. This implied that DC phagocytosis of apoptotic cells
required not only an immature DC but additional machinery, such as cell
surface receptors or actin polymerisation, to confer phagocytic capacity. The
exact nature of that machinery will be investigated later in this thesis.
In addition, the morphology of DCs challenged with apoptotic cells was subtly
changed; DCs increased in size, demonstrating granular cytoplasmic inclusions
and an asymmetric nucleus along with blunt cytoplasmic protrusions. These
changes mirror many of the changes described in the OX41-/CD4- rat DCs (Liu,
L. et al. 1998), recently found to contain apoptotic inclusions in vivo (Huang, F.
P. et al. 2000). We postulate that the phenotypic differences between these and
their CD4+/OX41+ counterparts may not represent a distinct subset of DCs but
rather the consequences of internalisation of apoptotic cells and can be modelled
in vitro by challenging DCs with apoptotic cells in culture.
The phagocytosis of apoptotic cells has been shown to be a preferential source of
antigen for cross-priming (Bellone et al. 1997; Albert et al. 1998b; Inaba et al.
1998). The exact mechanism by which apoptotic derived antigen accesses the
class I pathway is not fully understood, but one postulated mechanism is via a
DC specific endosomal pore which allows Teak' of endosomal proteins into the
cytosol where they can access the endogenous pathway for antigen presentation
(Rodriguez et al. 1999b). In contrast to 4kD dextran, which 'leaks' into the
cytoplasmic compartment, ac associated fluorescence is found co-localised with
70kD dextran. Thus ac-associated proteins appear to remain within the
endosomal compartment and, although we must interpret these initial
observations with caution, it is possible that apoptotic cell derived antigen
utilise another route to access the endogenous pathway. Instead I favour the
possibility that apoptotic-derived antigen is processed and loaded onto MHC in
the endosomal compartment or chaperoned into the ER by calreticulin or heat
shock proteins (HSP), implicated along with CD91 in apoptotic cell phagocytosis
in macrophages (Basu et al. 2001; Ogden et al. 2001; Srivastava 2002a).
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4.1 Introduction
As was shown in the previous chapter, immature DCs (akin to those that exist in
the periphery) capture and process exogenous antigen. Upon receipt of
maturation stimuli DCs migrate to draining lymph nodes, a process associated
with phenotypic changes, including down regulation of their antigen capturing
machinery, upregulation of MHC and costimulatory molecules and production
of IL-12, becoming fully functional antigen presenting cells. This maturation
process is affected by a variety of endogenous or exogenous factors and can be
modeled in vitro by stimulation with LPS and other microbial products.
Ingestion of bacteria (and other pathogens) signalling via a variety of Toll-like
receptors or certain necrotic cells (immortalised/tumour cells) is capable of
inducing DC maturation (Sauter et al. 2000). The exact components of necrotic
cells able to activate DCs are not fully defined but one possibility is production
of heat shock proteins (Basu et al. 2000; Srivastava 2002b) and other mediators
also capable of inducing DC maturation by Toll-like receptors. In contrast,
ingestion of apoptotic cells fails to activate DCs, appearing to be an
immunologically null event (Gallucci et al. 1999; Sauter et al. 2000). However,
apoptotic cell ingesting DCs have been shown, after concurrent maturation with
the strong external stimulus of monocyte-conditioned media, to mature and
present antigen derived from the ingested apoptotic cells to T cells (Albert et al.
1998b).
A growing body of evidence implicates DCs that ingest dying cells in
influencing self-tolerance. One role of DCs is to constantly sample peripheral
self-antigens and present them in a 'tolerogenic' way to the adaptive immune
system (Kurts et al. 1997b; Hawiger et al. 2001). Another is the clearly
demonstrated ability of DCs to cross-present cell-derived antigen, including
those originating from apoptotic cells, to induce a T cell response (Albert et al.
1998b). Thus a dichotomy exists in the role of DCs which may be either 'friend
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or foe' in maintaining tolerance. The ability of a DC to deliver 'signal two',
either as costimulation or IL-12, singly or in combination, appears key in
determining subsequent immune responses and is likely to be tightly controlled.
Interestingly the ingestion of apoptotic cells by macrophages generates an active
anti-inflammatory response through the production of TGF-pl and other anti¬
inflammatory molecules (Voll et al. 1997b; Fadok et al. 1998b; Fadok et al. 2000),
and down regulates subsequent release of pro-inflammatory cytokines. Because
of the close lineage relationship of macrophages and myeloid DCs, we chose to
investigate whether apoptotic cell ingestion by DCs might not only fail to
activate DCs but might actively inhibit their maturation with particular regard
to costimulatory molecule expression and IL12 production.
This chapter demonstrates that immature murine bone marrow-derived DCs
ingesting apoptotic cells become functionally distinct. We confirm that apoptotic
cells do not mature DCs but demonstrate that endotoxin-induced production of
IL12, but not TNFa is selectively diminished in DCs that have ingested
apoptotic cells. In addition, endotoxin driven upregulation of the co-stimulatory
molecule CD86 is inhibited in those DCs that had phagocytosed apoptotic cells,
but not in neighbouring DCs. The functional consequences of these changes are
demonstrated as these DCs have a reduced capacity to stimulate T cell
proliferation. Furthermore, many of these anti-inflammatory effects can be seen
after DCs internalize cells that have been rendered 'necrotic' by heat, a process
associated with externalization of phosphatidlyserine and loss of membrane
integrity demonstrating that 'necrotic' cell death is heterogeneous and can result
in non-phlogistic clearance and induction of an immunosuppressive response.
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4.2 Results
4.2.1 Ingestion of apoptotic cells specifically inhibits the ability of DCs to
upregulate CD86
To ascertain whether ingestion of apoptotic cells alters DC phenotype, cell
surface expression of activation markers was studied by flow cytometry after
phagocytosis. Although phagocytic DCs expressed slightly lower levels of
CD86 as would be expected in cultures with some spontaneous maturation, no
significant difference in cell surface expression of costimulatory molecules was
seen between immature DCs that had ingested apoptotic cells (ac+DCs)and
those that had not (acDCs) immediately (2 hours) (Fig4.1) after phagocytosis
confirming that ingestion of apoptotic cells did not activate DCs. Similarly, 24
hours after ingestion unstimulated ac+ and ac" DCs also had comparable levels
of CD40, CD86 and CD54 (Fig4.2). However, after 24 hous of DC maturation
with LPS a marked difference in surface expression of CD86 was detected
between ac+DCs and ac" DCs (Fig4.2). Immature DCs were predominantly
CD86'° with a small population of CD86hl cells. Upon maturation driven by LPS
the proportion of CD86hl cells increased in a dose dependent manner. However,
fewer ac+ DCs became CD86hl compared to ac" DCs; in a typical experiment at
0.1 pg/ml LPS only 13.2% of ac+DCs became CD86hl vs 42% ac'DCs, and this
difference was maintained at the highest LPS dose of 0.5pg/ml, with only 24%
of ac+ DCs becoming CD86hl compared with 46% of ac'DCs (Fig 4.2). Mature DCs
were heterogeneous for CD54 with distinct populations of CD54'0 and CD54hl
cells, becoming most apparent at the highest dose of LPS (0.5pg/ml). Despite
the general increase in fluorescent intensity of the ac+ DCs after phagocytosis it
is apparent that the percentage of CD54hl cells was lower in ac+ than ac"
populations (Fig 4.2). CD40 expression was unaffected by apoptotic cells, with
maturation in response to 0.5pg/ml generating a single CD40+ population (Fig
4.2) and no statistically significant difference was seen in MHCII or CD80
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Figure 4.1:Cell surface phenotype of phagocytic vs
nonphagocytic DCs. DCs were incubated with fluorescent apoptotic
cells for 2 hours, and then stained for cell surface markers and
analysed by FACS. Phagocytosing (red lines) and non-
phagocytosing (blue lines) cells were identified by incorporation of
green fluorescence from apoptotic cells. Both populations have
similar levels of cell surface molecules, although phagocytosing DCs
express slightly lower levels of CD86 and higher levels of F4/80
suggesting a slightly more immature phenotype
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Figure 4.2:Cell surface phenotype of phagocytic vs
nonphagocytic DCs after LPS maturation. DCs were incubated
with fluorescent apoptotic cells for 2 hours, matured with LPS for 24
hours, stained for cell surface markers and analysed by FACS.
Phagocytosing (filled histogram) and non-phagocytosing (open
histogram) cells were identified by incorporation of green
fluorescence from apoptotic cells. DCs containing apoptotic cells are
less efficient at upregulating CD86 and to a lesser extent CD54 upon
stimulation with LPS. In contrast no statistically significant difference
was apparent in CD40 expression.
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general unresponsiveness to LPS but appeared to affect a subset of
costimulatory molecules.
Failure to upregulate CD86 expression in ac+DCs could reflect preferential
ingestion of apoptotic cells by a subpopulation of DCs destined not to become
CD86hl in response to maturation stimuli. However, when the mean CD86
fluorescence for the whole DC population was compared between DCs matured
in the presence or absence of apoptotic cells (Fig 4.3 and 4.4), the presence of
apoptotic cells resulted in a significantly lower CD86 fluorescence for the whole
DC population compared to control. No such difference would have been
detectable had the capacity to ingest apoptotic cells merely marked a
subpopulation of DCs destined not to upregulate CD86 in response to LPS.
This, and the observation that no significant difference in costimulatory
molecule expression was detected between the ac+DCs and ac'DC population
immediately after ingestion (Fig4.1) support the fact that phagocytosis had not
preferentially occurred in a subpopulation destined to be CD86'°. Also, this
inhibitory effect was not merely a result of particle ingestion as immature DCs,
when cocultured with latex beads and oxidised lipid, showed remarkably high
levels (>85%) of phagocytosis and endocytosis respectively and exhibited no
defect in LPS-driven upregulation of CD86 expression, exhibiting instead
apparently enhanced expression (Fig 4.4.c). Taken together these data support
the hypothesis that apoptotic cell ingestion alters DCs subsequent response to
maturation stimuli.
4.2.2 Ingestion of apoptotic cells modulates proinflammatory cytokine
secretion by DCs.
Cytokines produced by DCs are especially important in determining subsequent
T cell responses. We therefore examined the effect of ingestion of apoptotic cells
on cytokine production by DCs by combining the fluorescent phagocytosis
assay and intracellular cytokine staining of cells, allowing us to study
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Figure 4.3: Effect of phagocytosis on DC upregulation of CD86
(1). DCs were incubated with apoptotic cells, and subsequently not
stimulated (A) or matured with LPS (B) or SAC (C). Surface CD86
expression on DCs was determined by FACs. Apoptotic cells were
excluded from analysis by size and bright green fluorescence. CD86































Figure 4.4: Effect of phagocytosis on DC upregulation of CD86
(2). A,B: DCs were incubated with apoptotic cells, and subsequently
matured with SAC (A) or LPS (B). Surface CD86 expression on DCs
was determined by FACs and is plotted as mean GMFI (relative to
control unstimulated DCs) +/- sd. for 3 measurements from one
culture. Similar results were seen in 3 (SAC) or 5 (LPS) experiments.
*, p< 0.05 (by ANOVA).. Apoptotic cells were excluded from analysis
by size and bright green fluorescence. C: DCs were also incubated
with latex beads or oxLDL, and CD86 expression measured. The
mean fluorescence of duplicate cultures is shown, with similar results
seen in 2 independent experiments.
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production of cytokines by individual DCs. Autocrine response to TNFa
produced after LPS stimulation is an important factor in terminal maturation
and activation of DCs as well as recruitment and activation of neighbouring
effector cells. Interestingly, virtually all of the DCs containing apoptotic cells
expressed TNFa after stimulation with LPS for 5 hours, demonstrating their
functional viability and continuing responsiveness to LPS stimulation (Fig 4.5).
A small population of the ac" DCs failed to produce TNFa and probably
represented a population of fully matured or 'exhausted' DCs (Fig 4.5). IL-12 is
produced predominantly by DCs and orchestrates both the innate and adaptive
immune response. DCs express a functional IL-12 receptor, ligation of which by
bioactive IL-12p70 augments LPS maturation. In contrast to TNFa, ac+ DCs
failed to express IL12, even when stimulated with 0.5pg/ml of LPS (Fig 4.6). The
inhibition of IL12 was further confirmed by ELISA of the supernatants and
demonstrated a significant decrease in IL12 production by DCs co-cultured with
apoptotic cells prior to LPS stimulation (Fig4.7). Interestingly, when DCs were
stimulated by whole Staph, aureus apoptotic cells only appeared to inhibit IL12
produced at early time points (Fig4.8). This observation may reflect the ability
of Staph, aureus to ligate a different TLR (TLR2) or the use of whole bacteria
which might provide a more complex maturation stimulus.
4.2.3 Ingestion of apoptotic cells generates DCs with diminished capacity
to sustain antigen dependent naive T cell proliferation and primes T cells
for deletion.
To determine whether these cytokine and surface CD86 differences reflected a
distinct functional phenotype of DCs, we chose to examine the capacity of ac"
DCs and ac+ DCs to sustain antigen dependent naive T cell proliferation, a
process critically dependent on IL12 production and expression of costimulatory





Figure 4.5: TNF-a expression by DCs following apoptotic cell
phagocytosis. DCs were incubated with fluorescent apoptotic cells
and stimulated with LPS. Intracellular TNF-a was measured after 4
hours by FACS analysis gated on CD11c+ cells. DCs that have
ingested apoptotic cells can be distinguished on the basis of green
fluorescence. Quadrant markers are set on DCs stained with isotype
control antibodies (TNF-a ) or DCs without apoptotic cells
(phagocytosis). Figures give the percentage of cells in each
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Figure 4.6: IL12 expression by DCs following apoptotic cell
phagocytosis. DCs were incubated with fluorescent apoptotic cells
and stimulated with LPS. Intracellular IL12p40/p70 was measured
after 4 hours by FACS analysis gated on CD11c+ cells. DCs that
have ingested apoptotic cells can be distinguished on the basis of
green fluorescence. Quadrant markers are set on DCs stained with
isotype control antibodies (IL12) or DCs without apoptotic cells
(phagocytosis). Figures give the percentage of cells in each







Figure 4.7: IL12 production by DCs following apoptotic cell
phagocytosis and LPS stimulation. DCs were incubated with
apoptotic cells and stimulated with LPS. Culture supernatants were
harvested at 1 to 48 hours and levels of IL12 measured by ELISA.
Data are presented as mean +/- s.d. of triplicate measurements for 6
hour supernatants (A) or the full time course (B). LPS stimulated


























Figure 4.8: IL12 production by DCs following apoptotic cell
phagocytosis and SAC stimulation. DCs were incubated with
apoptotic cells and stimulated with SAC. Culture supernatants were
harvested at 1 to 48 hours and levels of IL12 measured by ELISA.
Data are presented as mean +/- s.d. of triplicate measurements for 1
hour supernatants (A) or the full time course (B). SAC stimulated
IL12 production was only inhibited at 1-6 hours. Similar results were
seen in 2 experiments.
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allowed us directly to compare T cell proliferation in response to mature ac
DCs vs ac" DCs, pulsed in both cases with OVA323.339 peptide after LPS
maturation. Interestingly ac+ DCs retained the ability to sustain naive T cell
proliferation but were only approximately 30% as effective as stimulators when
compared to ac" DCs or DCs matured without apoptotic cells when cultured at
a ratio of 10:1 T cells : DCs (Fig 4.9).
Both IL12 and costimulatory molecule expression are known to be important not
only in the amount of T cell stimulation delivered but also in determining the
outcome of the interaction. Thus the supernatants were examined to determine
if either ac+ or ac" DCs preferentially drove Thl or Th2 cytokine production.
Interestingly, both ac+and ac" DCs stimulated IFNy production by T cells
(Fig4.10) and only negligible amounts of IL4. Furthermore, PMA/ionomycin
restimulation of T cells after a week in culture showed no increase in Th2
cytokine production when examined by intracellular cytokine staining with
both ac+and ac'DCs producing T cells that secrete IFNy. However, upon
PMA/ionomycin restimulation, ac+DC primed T cells initially proliferated and
then underwent accelerated activation induced cell death such that, after 24
hours of stimulation, more than 75% of the T cells were apoptotic compared to
only 25% of ac" or control DC primed T cells (Fig4.11).
4.2.4 'Necrotic' cells
Cells dying by apoptosis are rapidly cleared and hence secondarily necrotic
cells, which have lost membrane integrity after undergoing apoptosis and begun
to Teak' intracellular contents, are uncommon in vivo unless apoptotic cell
clearance is impaired. It is postulated that clearance of such secondary necrotic
cells may be associated with autoimmunity. This process of secondary necrosis
can be recapitulated in vitro by ageing neutrophils for longer periods, a process
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Figure 4.9: Antigen-driven T cell stimulation by DCs following
apoptotic cell phagocytosis. Mature DCs were pulsed with OVA232.
339 peptide, sorted into ac- and ac+ cells and incubated with T cells
from D011.10 mice. DCs that had not been incubated with apoptotic
cells were included as a control. T cell proliferation was measured by
[3H]-thymidine incorporation. A: Proliferation in response to different
T cell: DC ratios, measured after 3 days. B: Time course of T cell/
DC interaction demonstrates inhibition at all time points. Background
proliferation in the absence of OVA peptide was < 2000 cpm in all
experiments. The mean +/- s.d. from triplicate measurements in one
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Figure 4.10: IFN-y production by ac+ and ac- DC
stimulated T cells. Mature DCs were pulsed with OVA232_33g
peptide, sorted into ac- and ac+ cells and incubated with T
cells from D011.10 mice. Supernatants from T cell cultures
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Figure 4.11: ac+ DCs prime T cells for death upon restimulation
(A). T cells from D011.10 mice were incubated with immature and
mature DCs that were sorted into ac- and ac+ cells and pulsed with
OVA232_339 peptide. T cells were then restimulated with PMA and
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Figure 4.11: ac+ DCs prime T cells for death upon restimulation
(B, C). T cells from D011.10 mice were incubated with immature and
mature DCs that were sorted into ac- and ac+ cells and pulsed with
OVA232-339 peptide. T cells were then restimulated with PMA and
ionomycin. B: Photographs of restimulated cells. C: Percentage of
cells gated as 'live' by forward/ side scatter that are Annexin V
positive, hence apoptotic.
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(Ren et al. 2001). These cells demonstrate an intermediate level of permeability
to PI and are annexin positive when compared to cells rendered necrotic by heat
treatment. Previous experiments in our lab have demonstrated that
macrophage clearance of such late-apoptotic cells is in fact non-phlogistic (Ren
et al. 2001). To determine whether inhibition of DC activation was only a feature
of early apoptosis we cultured DCs with heat-treated 'necrotic' cells
(representative of the terminal stage of cell death). DCs efficiently internalized
these 'necrotic' cells a process surprisingly associated with inhibition of IL12
(Fig 4.12) as seen with apoptotic cells (Fig 4.13). Furthermore, by intracellular
staining, these 'necrotic cells' also appeared to inhibit TNFa production to some
degree (Fig 4.14).
4.3 Discussion
The data presented demonstrate that DC ingestion of apoptotic cells, but not
control particles, results in down regulation of LPS driven IL12 production and
CD86 expression. Furthermore this correlated with impaired antigen dependent
T cell activation in vitro and also appeared to prime T cells for deletion on
subsequent stimulation. Interestingly, these effects were restricted to those DCs
that had ingested apoptotic cells and were also seen after internalization of our
in vitro generated 'necrotic' cells implicating ligation of specific phagocytic
receptors, recognising 'altered self' motifs present on the cell surface of dead
cells, in this process.
Apoptotic cells are poorly immunogenic and, unless they overload normal
clearance mechanism or are associated with danger signals, rarely incite an
immune response. Furthermore, UV irradiation, characterized by widespread
apoptosis, is associated with generalised immunological hyporesponsiveness





































Figure 4.12: Effects of different 'dying' cells on IL12 expression
by DCs. DCs were incubated with fluoresecntly labelled untreated
(live), apoptotic and heat treated cells and stimulated with LPS. IL12
expression was measured by intracellular cytokine staining, analysed
by FACS and is plotted against phagocytosis. Both primary heat
treated live cells and secondarily necrotic (heat treated apoptotic
cells) are efficiently internalised "by DCs and inhibit the production of
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Figure 4.13: Effects of different 'dying' cells on IL12 production
by DCs. DCs were incubated with untreated (live), apoptotic and heat
treated cells and stimulated with LPS. Cell culture supernatants were
harvested and levels of IL12 measured by ELISA. Apoptotic and heat
treated apoptotic cells (secondarily necrotic) primary cells inhibit LPS
driven IL12 production to a greater extent than heat treated live
(primarily necrotic) cells.
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Figure 4.14: Effects of different 'dying' cells on TNF-a
expression by DCs. DCs were incubated with fluoresecntly labelled
untreated (live), apoptotic and heat treated cells and stimulated with
LPS. TNF-a expression was measured by intracellular cytokine
staining, analysed by FACS and is plotted against phagocytosis. -
104
CHAPTER 4: Inhibitory effects of apoptotic cells on dendritic cells
apoptotic cells on the adaptive immune system. In two interesting recent
reports, apoptotic cells have been shown to be capable of promoting
transplantation tolerance (Bittencourt et al. 2001) and protecting from
autoimmunity (Hugues et al. 2002). Although the exact mechanisms of
immunosuppression in these systems were not fully understood, a bone marrow
derived cell, likely to be the DC, has been implicated. Exactly how this occurs is
controversial but an increasingly accepted view is that the immature DC, with
low levels of costimulatory molecule expression, would fail to deliver 'signal
two' and induce anergy or deletion of an interacting T cell. In support of this,
repeated immunisation with immature DCs does appear to induce Treg/Trl
cells (Dhodapkar, M. V. et al. 2001). In contrast, mature DCs, which are able to
secrete a potent stimulatory cytokine, IL12, and express high levels of
costimulatory molecule expression, induce strong adaptive immunity.
Interestingly, the observation that ac+ DCs appear to prime T cells for deletion
upon restimulation is supported by other studies; for instance, in vivo cross-
priming to cellular antigen has been shown to result in deletion of antigen
specific CD8 T cells (Kurts et al. 1997a; Kurts et al. 1997b) and, in a similar
human in vitro model, deletion of influenza specific CD8+ T cells also occurred
unless CD40 ligation was provided to the DC (Albert et al. 2001). Thus,
although the mechanism of deletion in these class I restricted systems is not
clear, it is possible that such ac+DCs prime not only CD8 but also CD4 T cells for
deletion. One possible contributing factor might be the failure of ac+ DCs to
produce IL12 whilst continuing to produce TNFa. IL12 has been shown to have
a myriad of functions including modulating Thl vs Th2 switching, activation of
NK cells and production of IFN-y. Furthermore, autocrine effects of IL12 have
been shown to augment DC responses to exogenous stimuli, underscoring the
importance of this cytokine in DC effector functions and the subsequent
adaptive immune response (Adorini et al. 1996; Lamont et al. 1996). In addition,
cytotoxic activity of DCs has been attributed to various members of the TNF
superfamily (Liu, S. et al. 2001a; Vidalain et al. 2001; Yu et al. 2002), including
TNFa and TRAIL, the former being secreted by ac+DCs.
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Of note, my experiments with necrotic cells yield data that contrast with some
reported studies. Necrotic cells have been shown to have some
proinflammatroy effects, promoting maturation of DCs perhaps through
associated danger signals such as heat shock proteins or proteases (Basu et al.
2000). The process by which I rendered cells 'necrotic' may not represent
necrosis found in vivo well and the associated 'danger signals' released from
intracellular contents may have been destroyed during heat treatment.
Furthermore, Sauter et al's rigorous examination of the potential of a variety of
necrotic cells to promote maturation of DCs demonstrated that it was a feature
only of certain immortalized or malignant cells and was not demonstrated by
primary cells such as those used in these studies (Sauter et al. 2000). In addition,
Fadok et al have demonstrated that the presence of PS bearing/apoptotic
membrane fragments, as found in our 'necrotic' cells (Fig 2.1) was able to
provide an inhibitory signal which, in their macrophage system, was dominant
over any danger signals from necrotic cells (Fadok et al. 2001). Flence, the anti¬
inflammatory signal from the dying cell membrane may be overriding
proinflammatory mediators in our system. Finally, in C. elegans, clearance of
necrotic and apoptotic cells occurs by a shared phagocytic pathway (Chung et
al. 2000) and may therefore stimulate similar inhibitory responses. It is possible
that a phlogistic response to necrotic cells requires additional cues from the
micro-environment such as activation of proteolytic cascades or tissue derived
'danger signals' that would not be apparent in vitro.
In conclusion, it is essential for DCs to mature before they can activate naive T
cells and these data and two recent studies confirm that ingestion of apoptotic
cells alone did not provide sufficient maturation stimulus. Therefore, DCs
ingesting apoptotic cells must be exposed to additional stimuli such as heat
shock proteins, monocyte-conditioned medium or viral products before they
become capable of stimulating T cells. Many of these agents will be present in
inflamed sites alongside apoptotic cells in vivo, and the potential for DCs both to
acquire apoptotic cell derived self-antigens and receive maturation signals is
high. However autoimmunity is uncommon and the response of the DC is
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likely to be tightly regulated. This data would suggest that ingestion of
apoptotic cells is not immunologically null but is capable of regulating DC
maturation, providing a counterbalance for inflammatory stimuli. A failure to
see these inhibitory effects of apoptotic cells in other studies may reflect the
percentage of DCs ingesting apoptotic cells, the strength of the maturation
stimulus used, the mechanism of cell death or an inherent difference in response
of DCs to constituitive vs. induced apoptosis. In the next chapters, we will
attempt to investigate possible mechanisms by which such inhibitory effects are
exerted on DCs and defining whether apoptotic cells act directly to alter DCs
effector functions in vivo or whether interactions with other cells of the
monocyte lineage is required.
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Chapter 5: Inhibitoryeffects of
apoptotic cells onDCS both ex vivo
and in vivo
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5.1 Introduction
I was interested in whether my observations of DC inhibition by apoptotic cells
would be restricted to in vitro bone marrow derived DCs or whether similar
inhibitory effects might be seen in ex vivo or in vivo DC. In this chapter we will
demonstrate that the effects of apoptotic cells are able to modulate ex vivo
isolated DCs and also in vivo IL12 production.
5.2 Results
5.2.1 Isolation of ex vivo DCs
Dendritic cells exist at low frequency in tissue but are widely distributed in
secondary lymphoid tissue such as the spleen and lymph nodes. The spleen
contains three of the five DC subsets recognised in the mouse (Liu, Y. J. 2001;
Shortman et al. 2002). An important DC subset, the CD8a+CDllc+DC
constitutes approximately 25% of DCs within the spleen and have been shown
to be the principal source of IL12 production in vivo and are responsible for
cross-presentation of cell derived antigens. Using a protocol modified from C
Reis e Sousa (Schulz et al. 2002a) it was possible to obtain highly enriched DC
preparations (Fig5.1) containing all of the CDllc+ subsets described in the
spleen (i.e. CD4+/CD8a+, CD4+/CD8a- and CD4-/CD8a- DCs) (Shortman et
al. 2002). These DCs were viable and relatively unactivated upon isolation,
matured spontaneously in overnight culture (Fig5. 1) and retained the capacity
to respond to LPS stimulation (Fig 5.1).
5.2.2 Ex vivo DCs contain apoptotic cells
To assess the morphology of our ex vivo DCs we performed cytospins which
demonstrate the characteristics of DCs (Fig5.2). Interestingly, some of the



























1 10 100 1000 10000 1 10 100 100010000 1 10 100 100010000
MHCII ►
Figure 5.1: Cell surface phenotype of ex vivo isolated DCs.
DCs were harvested from mouse spleen and purified by positive
sorting for CD11c+ cells. DCs were stained for surface molecule
expression after purification or cultured for a further 24 hours with
or without LPS (1 pg/ml), and stained. DCs show some
spontaneous maturation in culture (demonstrated by increases in







Figure 5.2: Cytospins of ex vivo isolated DCs. CD11c+
spleen DCs were cytospun, stained (Dif-Quik) and photographed
under x 100 (oil) objective. DCs demonstrate fine cytoplasmic
protrusions (arrow). Some DCs had blunt pseudopodia and
contained prominent granular inclusions reminiscent of apoptotic
bodies (arrowhead).
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characteristic of apoptotic cells and apoptotic cells could also be seen contained
in the phagolysosome of the DCs (Fig5.2).
5.2.3 Ex vivo DCs express scavenger receptor and phagocytose
The immediate ex vivo identification of DCs that appeared to contain newly
phagocytosed apoptotic cells implied that these splenic DCs may retained their
phagocytic capacity. Furthermore, I identified that these DCs expressed CD36,
(Fig5. 3) which was found preferentially on CD8a+DCs, further suggesting that
they would internalise apoptotic cells. Thus, to test the ability of these DCs to
phagocytose apoptotic cells DCs were challenged with fluorescent apoptotic
murine thymocytes or neutrophils, which were efficiently internalised (Fig5. 4).
Interestingly at high apoptotic cell: DC ratios (40:1) CD8a-DCs also internalised
apoptotic cells.
5.2.4 Ex vivo DCs are inhibited by apoptotic cells.
Bone marrow derived DCs share many characteristic with macrophages and the
ability of apoptotic cells to inhibit cultured DCs in previous experiments might
simply represent an in vitro artefact. Thus I chose to test the ability of freshly
isolated splenic DCs to be inhibited by apoptotic cells. Culturing these DCs
with apoptotic cells also inhibited LPS driven upregulation of CD86 (Fig5.5) in a
similar manner to the murine bone marrow cultures, confirming that this
characteristic was probably conserved between many DC types. Furthermore,
IL12 production from whole splenocytes in response to LPS was also inhibited
in a manner very similar to the bone marrow derived cells (Fig 5.6). Cell sorting
of splenocytes into CDllc+ and CDllc- fractions confirmed previous reports
that DCs are responsible for all IL12 produced and demonstrated that they were
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Figure 5.3: CD36 expression on ex vivo DCs. Mouse spleen
cells were stained for CD11c, CD36 and CD8a. Figure shows
that CD8a + cells express high levels of CD36. FACS analysis
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Figure 5.4: Phagocytosis of apoptotic cells by ex vivo DCs.
Mouse spleen cells were incubated with fluorescently labelled
apoptotic human neutrophils (at ratios of 10:1 and 40:1 apoptotic
cells: CD11 c+ DCs) for 4 hours, and stained for CD11 c and
CD8a. Phagocytosis was assessed by incorporation of apoptotic
cell associated fluorescence into CD11 c+ CD8a + or CD11 c+
CD8a" cells (DCs). Results are expressed as mean percentage

















Figure 5.5: Maturation of ex vivo DCs following apoptotic
cell uptake. Mouse spleen cells were incubated with apoptotic
human neutrophils for 2 hours, stimulated with LPS for 24 hours
and maturation assessed by surface expression of costimulatory
molecule CD86. DCs were gated by CD11c expression and
CD86 GMFI measured by FACS. Data are presented as mean
GMFI +/- s.d. from three replicate cultures.
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Figure 5.6: IL12 production by splenocyte cultures following
apoptotic cell uptake. Mouse spleen cells were incubated with
apoptotic human neutrophils for 2 hours, stimulated with LPS for
24 hours, culture supernatants harvested and IL12 measured by
ELISA. Data are presented as mean IL12 production/2.5 x 104
















































Figure 5.7: IL12 production by purified ex vivo DCs
following apoptotic cell uptake. Ex vivo DCs were purified
from mouse spleen cells by postive sorting for CD11c + cells.
CD11 c + and CD11 c " cells were incubated with apoptotic human
neutrophils for 2 hours, stimulated with LPS for 24 hours, culture
supernatants harvested and IL12 measured by ELISA. Data are
presented as mean IL12 production/ 2.5 x 104 DCs (CD11 c +
cells) +/- s.d. from three replicate cultures.
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5.2.5 Immunisation of small loads of apoptotic cells in vivo is sufficient to
establish systemic suppression of DC cytokine production
To test the in vivo effect of apoptotic cell load, mice were immunised either
subcutaneously or intravenously with apoptotic cells. These mice were then
challenged with endotoxin (80|ug/mouse) and systemic production of IL12
assessed at 4 hours, previously shown to be when the peak of DC production of
this cytokine occurs. Interestingly, despite using only 8x106 apoptotic cells, in
both situations (intravenous and subcutaneous immunisations) a significant
inhibition of systemic IL12 (Fig 5.8) occurred, implying that the inhibitory effects
of apoptotic cells were spread to bystander leucocytes that were unlikely to
have opportunities to interact directly with them. It is possible that some of
these systemic effects were mediated by inhibitory cytokines produced by
macrophages as well as direct effects on DCs. Notably, although this is not the
ideal time point to study TNFa production in response to LPS (the peak being at
less than one hour), it did not appear to be modified by apoptotic cells (Fig 5.8).
5.3 Discussion
In this section the ability of apoptotic cells to inhibit freshly isolated murine DCs
has been examined. Isolated splenic DCs efficiently internalised apoptotic cells
and, as with murine bone marrow derived DCs, apoptotic cells inhibited DC
maturation and IL12 production. Furthermore, apoptotic cell administration in
vivo inhibited systemic IL12 production. Interestingly, as with my bone marrow
derived system, human apoptotic cells were able to inhibit murine DCs
implying recognition of a common characteristic of apoptotic cells that is
conserved across species barriers.
Early systemic IL12 release in response to intravenous endotoxin challenge in
vivo has been shown derive primarily from CD8a+ dendritic cells (Reis e Sousa





























Figure 5.8: Serum cytokine production in mice following
injection of apoptotic cells and LPS. Mice were injected with
LPS (80pg/mouse intravenously) and apoptotic human
neutrophils (8 x 106 cells intravenously or subcutaneously). After
4 hours mice were bled under terminal euthanasia serum levels
of IL12 and TNF-a measured by ELISA. Co-injection of apoptotic
cells reduced serum IL12 levels. Data are presented as mean
+/- s.e.m. from 3 to 5 mice. *, ** data are significantly different
from mice injected with LPS alone (*p < 0.05, p <0.01**,
ANOVA).
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the effects of apoptotic cells on DC function in vivo. However, LPS is not a
potent stimulus for IL12p70 but rather produces IL12p40 without induction of
the IL12p35 subunit and it was for this reason that it was necessary to study
IL12p40 modulation. However, IL12p40 has been shown to be able to form
homodimers suggested to block the signalling of the biologically active IL12p70
heterodimeric complexes (Trinchieri 2003). It is possible therefore to envisage
that the reduction of IL12p40 might paradoxically increase signalling of IL12p70
and it would be necessary to measure total IL12p70 or a functional readout of its
production (such as T cell priming) to ascertain the exact biological effect of
apoptotic cell administration. It would be interesting therefore to extend these
studies to other stimuli which produce strong I112p70 signals as well as
investigating modulation of adaptive responses and T cell priming.
The observations that CD8a+ DCs express CD36, efficiently internalise apoptotic
cells (as demonstrated by our in vitro data and by recent publications (Belz et al.
2002b; Iyoda et al. 2002; Schulz et al. 2002a) ) and that apoptotic cells modulate
the response of this DC subset to LPS raise tantalising possibilities as how this
may occur in vivo. In my system no IL10 was detected nor were TNFa levels
modulated at the time point analysed. Although we cannot exclude modulation
of cytokines (especially those produced by macrophages) at an earlier time point
than we tested, these data suggest that apoptotic cells may well have direct
effects on DCs. However, it would seem likely that the inhibitory effects of
apoptotic cells act may also through systemic inhibitory cytokines secreted by
macrophages/monocytes or 'switch off' of macrophage proinflammatory
mediator release and will be an interesting area of future study (see Chap7).
Conditions inducing large amounts of apoptosis in vivo, such as certain
infections and UV irradiation, appear to be associated with immunosuppressive
effects both locally and systemically (Yoshida et al. 1998). In support of this,
three interesting reports have demonstrated the ability of apoptotic cells to
induce tolerance. In a murine model of bone marrow transplantation, co-
immunisation of apoptotic cells along with the bone marrow permitted
120
CHAPTER 5: Effects of apoptotic cells on ex vivo/in vivo DCs
engraftment across MHC barriers (Bittencourt et al. 2001). In addition, another
elegant model demonstrated that induction of limited apoptosis in the pancreas
of NOD mice protected against autoimmune diabetes by inducing tissue specific
tolerance (Hugues et al. 2002) supporting previous results demonstrating a role
for limited cell death in inducing tolerance in a model of cross-presentation.
Finally, elegant studies by Liu et al have demonstrated that immunisation of
mice with small loads of dying cells can indeed induce antigen specific deletion
of T cell clones (Liu, K. et al. 2002). These data support a powerful
immunoregulatory effect of apoptosis and our data would further suggest that it
is mediated, at least in part, by the effects of apoptotic cells on DC activation.
We have shown that ex vivo CD8a+DCs preferentially express CD36, an
important receptor involved in recognition and internalisation of apoptotic cells
and that they efficiently phagocytose dying cells. We postulated that CD8a+DC
clear small numbers of apoptotic cells during normal cellular homeostasis in
vivo and that this might increase during high rates of apoptosis or upon
immunisation with dying cells. Indeed, CD8a+DCs did internalise apoptotic
cells in vitro and examination of the functional sequela of such clearance
demonstrated that apoptotic cells could inhibit IL12 production by both ex vivo
DCs and when injected in vivo. Although it is difficult to determine whether
this 'modulated' activation may contribute to the functional phenotype of
CD8a+DCs in vivo the corollary is true; bone marrow derived DCs can be
induced to cause T cells to undergo rapid AICD, a characteristic unique to
CD8a+DCs, if they contain apoptotic cells (see Chapter 4).
121
CHAPTER 6: Examination of inhibitory mechanism of apoptotic cells on dendritic
cells
Chapter 6: Examination of inhibitory
mechanism ofapoptotic cells on
dendritic cells
122
CHAPTER 6: Examination of inhibitory mechanism of apoptotic cells on dendritic
cells
6.1 Introduction
Bone marrow-derived DCs and macrophages both arise from myeloid
precursors and have many characteristics in common whilst maintaining
important differences in responses and effector functions. Macrophages and
DCs share a variety of receptors including Toll-like receptors, Fc receptors and
scavenger receptors but respond to ligand engagement very differently,
modulating effector functions distinct to each cell type (Austyn 1996; Martinez-
Pomares et al. 1996). For example, macrophages, specialised in killing and
disposal of internalised pathogens, respond to many pathogens with an
oxidative burst; in contrast DCs respond to the same stimuli by upregulation of
costimulatory molecule expression, important in their prime function as antigen
presenting cells. The previous data support evidence showing that DCs bind
and ingest apoptotic cells but modulate cytokines differently from macrophages
in response to this stimulus (Fadok et al. 1998b; Urban et al. 2001; Stuart et al.
2002). Nevertheless, in both cell types the response is predominantly anti¬
inflammatory/immunosuppressive and may be linked to common receptor and
signalling pathways with differences between these two phagocytic cells being
determined by cell type specific 'hard-wiring' to effector functions.
Previous reports emphasise that this phenotypic change of macrophages
ingesting apoptotic cells is 'spread' to surrounding cells, through paracrine
action of anti-inflammatory cytokine release triggered by the ingestion of
apoptotic cells (Voll et al. 1997a; Fadok et al. 1998b). This is in contrast to the
response of DCs ingesting apoptotic cells, which, in this current study, did not
affect the ability of neighbouring DCs that had not ingested apoptotic cells to
mature or stimulate T cells. This would implicate a direct and cell specific effect
of apoptotic cell ingestion on DC expression of CD86 and cytokine production,
rather than a paracrine effect of secreted anti-inflammatory cytokines. In this
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chapter I have investigated these two possible mechanisms of inhibition (i.e.
secreted anti-inflammatory cytokines and direct receptor ligation) that could be
responsible for the inhibitory effects of apoptotic cells.
6.2 Section 1: Anti-inflammatory cytokines
Studies have concentrated on two major anti-inflammatory cytokines, TGF-P
and IL10.
TGF-P
TGF-Pl is a pleiotropic anti-inflammatory cytokine with diverse effects on cell
survival, differentiation and proliferation (Shull et al. 1992; Kulkarni et al. 1993;
Massague et al. 2000). Systemic and local effects of TGF-P differ; infusion of
high levels of systemic TGF-p causes significant immunosuppression whilst
local infusion is associated with fibrosis and hypercellularity. TGF-P beta has
been shown to alter macrophage phenotype inducing them to adopt an
'alternative' phenotype producing less nitric oxide and driving Th2 responses
(Mills et al. 2000) whilst in DCs, it inhibits myeloid DC maturation (Geissmann
et al. 1999) and yet is essential for generation/maintenance of Langerhans cells
in the periphery which are conspicuously absent from the dermis of TGF-f5-/-
mice (Borkowski et al. 1996) Many cells produce TGF-P, including fibroblast and
regulatory T cells, and in tissue, macrophages are an important source of this
key cytokine. However, in an interesting recent report (Chen et al. 2001),
apoptotic T cells have been shown to produce both active and latent TGF-P
localized to intracellular membrane compartments including the mitochondria
suggesting that they may actively contribute to TGF-P accumulation in inflamed
and remodelling sites as well as in lymphoid tissue. TGF-P exists in a latent form
which requires activation before it can signal via a heterodimeric receptor
complex composed of type I and type II receptors (Massague 1998). Of
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relevance, TGF-P activation can be augmented by TSP, the vitronectin receptor
and macrophages themselves (Murphy-Ullrich et al. 1992; Schultz-Cherry et al.
1993). Furthermore, ingestion of apoptotic cells stimulates macrophages to
adopt an anti-inflammatory phenotype, inhibiting LPS-induced release of TNFa
and upregulating release of TGF-(3l and other anti-inflammatory mediators
(Fadok et al. 1998a; Fadok et al. 2000). Neutralisation of TGF-P in the
macrophage system almost completely restores the LPS response of apoptotic-
cell treated macrophages, implicating this cytokine in the anti-inflammatory
effect.
IL10
IL10 is a key anti-inflammatory cytokine with an essential role in development
and maintenance of regulatory T cells (Asseman et al. 1999). The important role
of IL10 in the control of inflammation is highlighted by the phenotype of IL10-/-
mice which spontaneously develop an inflammatory colitis (Flara et al. 2001).
IL10 inhibits DC maturation and activation and, under certain circumstances
DCs themselves can produce IL10 which acting in an autocrine and paracrine
manner, is capable of inhibiting DC maturation (Fiorentino et al. 1991). It is
likely that lack of these effects on DCs along with an associated failure to
produce regulatory T cells, contribute to the autoimmune phenotype that
develops spontaneously in mice deficient in this cytokine. In human systems,
DCs (Urban et al. 2001) and monocytes (Voll et al. 1997a; Byrne et al. 2002)
cocultured with apoptotic cells release IL10 suggesting a possible role for this
cytokine in the anti-inflammatory response in this murine system.
6.2.1 Results
Role of TGF-P1
TGF-pl was found in our DC :apoptotic cell culture supernatants although
levels of serum contamination made determining its origin difficult. However,
when soluble TGF-P receptor was added to neutralise any active TGF-P
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released, DCs' response to LPS was still inhibited after ingesting apoptotic cells
(Fig 6.1). In contrast, soluble TGF-(3 receptor reversed the ability of apoptotic
cells to inhibit TNFa production by macrophages in a parallel system
confirming that the reagent neutralised TGF-(3. Together, these data suggest
that paracrine TGF-P does not contribute significantly to the suppressive effects
of apoptotic cells on DCs.
Role of IL10
To investigate if changes in IL10 production by DCs ingesting apoptotic cells
might contribute to the different phenotypes, intracellular IL10 production and
release into the supernatant were studied. IL10 was detectable in DC culture
supernatants but was unaffected by interaction with apoptotic cells or the
addition of LPS (Fig 6.2). Intracellular IL10 was difficult to detect reliably over
background staining and no differences in levels of IL10 staining between ac+
and ac" DCs were detectable (Fig 6.2). Furthermore, blockade of functional IL10
by soluble IL10 receptor did not differentially affect co-stimulatory molecule
expression in the two DC subpopulations (Fig 6.2).
To further study the role of IL10, bone marrow derived DCs were generated
from IL10-/- and WT controls. IL10 inhibits DC maturation without affecting the
phagocytic capacity of DCs and in support of these observations IL10-/- DCs
showed neither a difference in the resting phenotype nor a defect in their
capacity to phagocytose apoptotic cells (Fig 6.3). On stimulation with LPS IL10-/-
DCs showed an increased response, expressing higher levels of CD86 and
producing more IL12, consistent with reports of autocrine IL10 inhibiting DC
maturation (Fig 6.3). Flowever, apoptotic cell ingestion was able to inhibit both
CD86 expression (Fig 6.3) and percentage IL12+ve cells (Fig 6.3) in the IL10-/-
DCs showing that, in our murine system, IL10 did not contribute to the anti¬













































Figure 6.1: Effect of TGF|3 neutralisation on DC/ apoptotic cell
cocultures. (A) Mouse bone marrow derived DCs were
cocultured with apoptotic cells and stimulated with 0.5 ^g/ml LPS
in the presence or absence of neutralising TGFpSR (0.5 ng/ml).
Maturation was assessed by CD86 expression and is expressed
as mean GMFI relative to unstimulated cells, +/- s.d. of triplicate
measurements. Apoptotic cells continued to inhibit DC maturation
despite inhibition of TGF-p signalling. (B) Mouse bone marrow
derived macrophages were incubated with apoptotic cells and/ or
LPS and culture supernatant TNF-a levels measured after 24
hours. TGFpSR inhibited the effect of apoptotic cells on TNF-a
production confirming a role for TGF-pi in macrophage


























Figure 6.2: Role of IL10 in apoptotic ceil modulation of DCs.
A: Mouse bone marrow derived DCs were incubated with apoptotic
cells, stimulated with LPS for 24 hours and IL10 measured in culture
supernatants. Data are expressed as mean +/- s.d. for triplicate
measurements. Also shown is IL10 levels in culture medium. B:
DCs were incubated with fluorescent apoptotic cells, stimulated with
LPS and stained for intracellular IL10 after 4 hours. DCs were gated
from apoptotic cells by size, and are plotted as phagocytosis
(apoptotic cell associated fluorescence) against IL10. Quadrant
markers are set on isotype stained/ unstimulated DCs. C: DCs were
incubated with apoptotic cells and stimulated with LPS in the
presence or absence of IL10 soluble receptor (IL10SR used at
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Figure 6.3: Apoptotic ceil phagocytosis and response by IL10 ~A
DCs. Bone marrow derived DCs were prepared from IL10 ~A and
control mice, incubated with apoptotic human neutrophils and
stimulated with LPS. A: Phagocytosis of fluorescent apoptotic cells
was measured after 4 hours (2:1 ac: DC ratio) by FACS, and is
expressed as mean percentage phagocytic DCs (CD11c+ cells)+/-
s.d. for triplicate samples.B, C: DC maturity was assessed after 24






















































% CD86 high % CD86 high
ac+DCs 6.41 5.84
ac" DCs 11.5 8.01
ac+DCs 8.28 5.48
ac" DCs 16.3 9.45
ac+DCs 13.5 8.12
ac" DCs 24.2 15.9
Figure 6.3: Apoptotic cell phagocytosis and response by IL10 "A
DCs. Bone marrow derived DCs were prepared from IL10 "A and
control mice, incubated with apoptotic human neutrophils and
stimulated with LPS. D: Representative histograms of expression of
CD86 in ac+ and ac- DCs in WT and IL10-/- DCs. E: Table showing
percentage CD86 high in ac+ and ac-DCs.
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6.2.2 Discussion
The initial observations that only those DCs that had phagocytosed were
inhibited, whilst bystander DCs remained unaffected suggested that a soluble
mediator was unlikely to be responsible for these inhibitory effects. However,
data published during the course of this work, demonstrated release of IL10 by
human DCs upon culture with apoptotic cells (Urban et al. 2001) suggesting a
possible role for this cytokine. Our initial strategy of neutralisation of two
candidate cytokines, TGF-(3 and IL10, failed to reverse inhibitory effects and
further mitigated against a role for secreted factors in the anti-inflammatory
actions. Interestingly, neutralisation of IL10 was reported to be unable to reverse
apoptotic cell inhibition of DC maturation by Urban in the human DCs. We then
elected to perform definitive experiments using DCs generated from IL10-/-
bone marrow. These DCs phagocytosed normally and were also inhibited by
apoptotic cell ingestion eliminating the possibility that production of this
cytokine was responsible for the inhibitory phenomenon.
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6.3 Section 2: Phagocytic receptor ligation
The preferential inhibition of IL-12 is a common consequence of ligation of a
large number of receptors on macrophages including Fc and complement
receptors (Mosser et al. 1999) and receptors used by viruses such as measles
(Fugier-Vivier et al. 1997; Sutterwala et al. 1999) and vaccinia (Engelmayer et al.
1999). In contrast, only specific ligands will induce production of IL10 or down
regulation of TNFa demonstrating both conserved and divergent signalling
pathways and responses linked to phagocytosis (Sutterwala et al. 1998; Mosser
et al. 1999; Gerber et al. 2001a; Gerber et al. 2001b; Grazia Cappiello et al. 2001).
Therefore, in macrophages, the receptor used determines the type of response
generated; for instance IL10 production along with inhibition of IL12 appears to
be a feature of FcyRl ligation but not complement receptor mediated
phagocytosis. Similarly, ligation of both the vitronectin receptor (Voll et al, 1997
; Freire-de-Lima et al, 2000) and PsR (Fadok et al. 2000) induce production of
TGF-P from macrophages. It has been suggested that receptor ligation may act
alone or in synergy with autocrine inhibitory cytokine production to cause the
inhibitory effects after phagocytosis by macrophages (Mosser et al. 1999) and
this may also be the case after internalisation of apoptotic cells. Furthermore, it
is possible that the different outcome of macrophage and DC phagocytosis of
dying cells may be determined by the distinct recognition mechanisms
employed for their clearance.
CD36
CD36 is a heavily glycosylated integral type II membrane protein with multiple
ligands including apoptotic cells, thrombospondin (Silverstein et al. 1992), long
chain fatty acid, modified lipids, malaria parasitized erythrocytes, sickled
erythrocytes and rod outer segments in the eye (Fig 6.4) (Febbraio et al. 2001).
CD36 is found localised in lipid rich caveoli where it is thought to have multiple
functions including signalling, regulation of caveolin function and uptake of
















Figure 6.4: Putative DC receptors for apoptotic ceils. A: CD36
CD36 is a multiligand receptor able to bind malaria parasitized
erythrocytes, ox LDL and thrombospondin. Cartoon shows the
proposed membrane organisation of CD36, with identified ligand
binding sites marked with primary sequence position (amino acid,
aa). B: av integrins avp3 and av|35 are implicated in apoptotic cell
recognition and may act in conjunction with associated proteins such
as CD47.
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discussion of all its functions is beyond the scope of this thesis it is important to
emphasise its role in lipid handling and the aetiology of atherogenesis (Febbraio
et al. 2001).
CD36 is involved in apoptotic cell uptake by both macrophages (Savill et al.
1992; Fadok et al. 1998c) and DCs (Albert et al. 1998a) as well as other non¬
professional phagocytes such as retinal pigment epithelial cells removing rod
outer segments in the eye (Finnemann et al. 2001). In many cell types CD36 is
thought to co-operate with integrins av|35 and av(33 (VnR) to mediate apoptotic
cell engulfment. Furthermore, the discovery that a Drosophila homologue of
CD36 (croquemort) was important for clearance of dying cells in the fly, has
demonstrated a teleologically conserved function for this molecule and
underscored its importance (Franc et al. 1996; Franc et al. 1999). Antibody
blockade studies in human dendritic cell systems have implicated CD36 in
phagocytosis of apoptotic cells. The exact domains of CD36 that bind apoptotic
cells are thought to be distinct from binding sites for oxLDL (which binds aa
120-155) and TSP-1 (aa 93-120) but antibody studies have demonstrated that
they share their binding domain with malaria parasitized erythrocytes (Fig 6.4).
However, it is controversial whether CD36 on macrophage and RPE (Ryeom et
al. 1996) (and by inference DC) binds directly to the apoptotic cell and it has
recently been demonstrated that ligation of CD36 increases internalisation even
when it is unable to bind directly to the target cell suggesting that it has a
signalling role as well as a role as a receptor (Finnemann and Silverstein. 2001).
Interestingly, some of the inhibitory effects of apoptotic cells can be
recapitulated in human DCs by antibody ligation or by malaria-parasitized
erythrocytes (Urban et al. 2001). In their human system, Urban demonstrated
selective inhibition of IL12 production and no modulation of TNFa following
antibody ligation of CD36 and LPS stimulation of DCs, similar to the results
demonstrated in our murine system. Mutations in human CD36 are found
commonly in certain areas of Africa and are associated with different
susceptibility to cerebral malaria (Aitman et al. 2000) supporting a possible role
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for CD36 in modulating the immune response in this infection (Urban et al.
1999). Taken together, these observations suggest that the malaria-parasitized
red cells and apoptotic-cells may bind a common site in CD36, which in turn,
may be important for consequent anti-inflammatory signalling. We therefore
took advantage of mice rendered deficient in this receptor to study the role in
both phagocytosis and response of DCs to apoptotic cells.
avP3/5 (vitronectin receptor)
Integrins are cell surface receptors composed of an a and (3 subunit, which
heterodimerize and through combinatorial variation create up to 20 receptors
with varying specificities. They are important in cell binding to matrix, celkcell
interactions and migration. Non-inflammatory macrophages use av(33 integrin
(Fig 6.4) for internalisation of apoptotic cells and, although recent work has
demonstrated the presence of avP5 on these cells, it does not appear to be active
for phagocytosis unless PKC activation by PMA has occurred (Finnemann et al.
1997). In contrast retinal pigment epithelial cells do not use avP3 but express
and utilise avP5 for phagocytosis, which is unaffected by activation with PMA.
Human DC phagocytosis of apoptotic cells is thought to proceed after ligation of
avP5 integrin which is linked to an unidentified tyrosine kinase shown to
recruit pl30cas, Crkll and DOCK180 resulting in Racl activation and actin
polymerisation (Albert et al. 2000; West et al. 2000; Giles et al. 2001). Although
avP5 has been implicated in DC phagocytosis of apoptotic cells in human
systems (Albert et al. 1998a) other groups have suggested that DCs may also use
P3 integrins (Rubartelli et al. 1997) and it remains unresolved whether DCs may
in fact be capable of utilising both integrins interchangeably depending on PKC
activation. For these reasons, DCs generated from mice null for both P3 and P5
integrins were used to study their role in the anti-inflammatory response.
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DCs were generated from wild type mice and mice rendered deficient in CD36
that had been screened by PCR to confirm the absence of CD36. First I wished
to determine if our WT DCs expressed a functional CD36 receptor at the cell
surface but at the time of these experiments an anti-murine CD36 antibody was
not available. However, CD36 is considered the principal macrophage receptor
for OxLDL and we chose to examine this function in our WT and CD36-/- DCs
as a surrogate for CD36 receptor expression . WT DCs ingest OxLDL, but in
contrast to ingestion of acetylated LDL (thought to be predominantly SRA
mediated), DCs exhibit either high or low capacity for OxLDL uptake possibly
representing varying levels of maturity in these murine cultures. Interestingly,
DCs from CD36 -/- mice internalised lipid with similar efficiency to their WT
controls probably representing utilisation of additional scavenger receptors (Fig
6.5) able to mediate uptake. However, OxLDL can induce apoptosis a
phenomenon that has been shown to be dependent on CD36 ligation. CD36-/-
DCs were resistant to apoptosis when cultured in OxLDL supplemented media
for 4 days (Fig 6.5) whilst WT DCs died in OxLDL rich media. These data
demonstrate that CD3 6-/-DCs do indeed lack a functional receptor and
confirmed previous reports from human monocyte systems, that CD36 is
required for OxLDL mediated cell death (Wintergerst et al. 2000).
The role of this receptor in binding and internalisation of apoptotic cells by DC
was also assessed. At 4°C DC binding to apoptotic cells was partially serum
dependant, approximately doubling in the presence of serum components in the
WT DCs (Fig 6.6). Interestingly, CD36-/- and WT DCs bound apoptotic cells
equally in the absence of serum but the CD36-/- DCs were defective in apoptotic
cell binding in the presence of serum (Fig 6.6) compared to WT controls. Thus
CD36 binding of apoptotic cells requires a serum component and accounts for
approximately 50% of serum dependent binding of DCs to apoptotic cells.








Figure 6.5: CD36 is required for oxidised LDL induced
apoptosis of DCs. Bone marrow derived DCs were prepared from
CD36 and control strain matched (C57BI/6) mice, incubated with
fluorescent acetylated or oxidised LDL(10ng/ml) for 4 days, and
viewed by phase contrasts and fluorescent microscopy (x 40
objective). Images show untreated DCs (phase contrast) and lipid
treated cells (phase contrast/ fluorescence composites). OxLDL but





























Figure 6.6: CD36 is not required for phagocytosis of apoptotic
cells by DCs. Bone marrow derived DCs were prepared from CD36
and control strain matched (C57BI/6) mice, incubated with
fluorescent apoptotic cells and phagocytosis measured by FACS.
A: DCs were incubated with apoptotic cells with or without serum
on ice to prevent phagocytosis and measure tight binding to DCs.
B: DCs and apoptotic cells incubated together at 37° C for 1 hour to
measure phagocytosis. C: time course of apoptotic cell
phagocytosis. All data are presented as mean percentage
phagocytic/ interacting cells +/- s.d. for triplicate measurements.
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compared to WT DCs (Fig 6.6). Thus, at higher temperatures permissive for
cytoskeletal rearrangement DCs probably recruit additional binding molecules
for utilisation in the phagocytic process demonstrating possible 'redundancy' of
apoptotic cell recognition.
Finally, upon subsequent challenge with LPS, ac+DCs from both CD36-/- and
WT mice demonstrated lower CD86 expression (Fig 6.7) and decreased numbers
of IL12+cells (Fig 6.7). Interestingly, CD36-/- DCs responded to LPS more
vigorously than WT controls suggesting that CD36 may indeed provide an
inhibitory signal. Although the identity of the ligand is unknown it does not
appear to be exogenously added apoptotic cells and I would suggest lipid or
TSP contained in serum as possible candidates. Thus, although in human
systems ligation of CD36 by antibody may be sufficient to inhibit DC
maturation, it does not appear to be necessary for the inhibitory effects of
apoptotic cells on mouse DCs.
Role of (33/5 integrins
The vitronectin receptors have been implicated in phagocytosis of apoptotic
cells by both macrophages and DCs. I first wanted to establish if our bone
marrow derived DCs demonstrated a requirement for integrins to internalise
apoptotic cells. Few antibodies are available for murine integrins and we chose
instead to use peptides GRGDSP, GRGDTP (specificly inhibits binding to
collagen, fibronectin and vitronectin) and the irrelevant control peptide,
GRADSP to study the role of integrin-dependent internalisation. DGapoptotic
cell interactions were not affected by the presence of these peptides (Fig 6.8) at
0.5mg/ml although EDTA (used as a positive control) significantly decreased
DC phagocytosis confirming previous reports for a dependency on cations for
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Figure 6.7: CD36 is not required for DC response to apoptotic
cells. A: Bone marrow derived DCs were prepared from CD36"/_
and control strain matched (C57BI/6) mice, incubated with
fluorescent apoptotic cells and stimulated with LPS. Cell surface
expression of CD86 was analysed by FACS, DCs identified by size
and CD11c expression. Data show CD86 expression on DCs
separated into those that had ingested apoptotic cells (ac+) from
bystander DCs (ac-) by incorporation of apoptotic cell associated
fluorescence.
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Figure 6.7: CD36 is not required for DC response to apoptotic
ceils. B: DCs from CD36 and control mice were incubated with
apoptotic cells and stimulated with LPS. IL12 producing DCs were
detected by intracellular staining, and analysed by FACS (DCs
identified by size and CD11 c expression). Data show percentage of
IL12 producing DCs in cultures with or without apoptotic cells and
are expressed as mean percentage +/- s.d. for triplicate
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Figure 6.8: Phagocytosis of apoptotic cells by DCs is not
blocked by inhibitors of integrin-ligand binding. Mouse bone
marrow derived DCs were incubated with fluorescent apoptotic cells
in the presence of EDTA (20 mM) or peptide inhibitors of integrin-
ligand binding (0.5mg/ml) for 1 hour, and phagocytosis measured by
FACS. Profiles are apoptotic cell fluorescence associated with DCs
(CD11 c+ cells). Numbers show percentage phagocytic cells.
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However, these results were at odds with published data on DC phagocytosis
using antibody blockade, the results of which heavily implicate integrin (35 and
(33 in phagocytosis. We chose therefore to take advantage of mice generated
with double targeted deletions for both (33 and (35 integrins (Reynolds et al.
2002). (35/3-/- DCs developed normally in culture and appeared to have similar
surface phenotype to their WT equivalent. Firstly, we established that DCs
generated from our cultures had a functional vitronectin receptor. As
antibodies to murine P5 are not available we chose to study an integrin
dependant function; binding and spreading on vitronectin coated plates was
marked in WT DCs whilst (35/3-/- DCs failed to spread on this matrix indicating
an absence of a functional receptor (Fig 6.9). WT and (35/3-/- deficient DCs
bound equally to control polylysine plates (data not shown). To assess other
integrins, DCs were also plated onto laminin (which binds al(3l, a2pi, c6pi,
o6P, a7pl, c£pl and a 6P4) and fibronectin (which binds av and pi integrin
families). Interestingly, slight morphological differences in binding to
fibronectin between WT and (35/3-/- were seen whilst neither WT nor (35/3-/- DCs
bound laminin (Fig 6.9). Thus our WT bone marrow derived DCs, unlike our
(35/3-/- DCs, express functional vitronectin receptors allowing them to adhere
and spread on the appropriate matrix.
DCs from these mice were then used to determine the role of these integrins in
both phagocytosis and inhibitory signalling to apoptotic cells. The (35/3-/- did
not appear to demonstrate a defect in apoptotic cell binding at 4°C as compared
to WT DCs nor was there a deficiency in their phagocytosis at 37°C (Fig 6.10).
Furthermore, the ablility of apoptotic cells to inhibit DC maturation (Fig 6.11)
was retained in the (35/3-/- DCs mitigating against an absolute requirement for









Figure 6.9: Role of p3 and p5 integrins in DC attachment and
spreading on matrix. Mouse bone marrow derived DCs from wild
type or integrin p3_/~ |35 _/" mice were labelled with cell tracker dye
(CMFDA), cultured on coverslips coated with matrix components for
1 hour, and visualised by fluorescent microscopy. Pictures show
representative fields of cells viewed with x 40 objective. Control
cells clearly spread more when plated on vitronectin.
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Figure 6.10: Role of p3 and p5 integrins in apoptotic cell
binding and phagocytosis by DCs. Mouse bone marrow derived
DCs from wild type or integrin p3"A (35 ''' mice were incubated with
fluorescent apoptotic cells for I hour on ice (A) or 37 °C (B) and
binding/ phagocytosis measured by FACS. Data are presented as
mean percentage phagocytic DCs +/- sd for triplicate samples The
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Figure 6.11: Role of {33 and {35 integrins in response of DCs to
apoptotic cells. Mouse bone marrow derived DCs from wild type
or integrin |33"A |35 A mice were incubated with apoptotic cells
(shaded bars) and stimulated with LPS. Maturation was measured
by intracellular IL12 or surface CD86 staining. Data are presented
as mean percentage positive DCs or mean CD86 GMFI +/- sd for
triplicate samples The same results were seen in cultures from at
least three knockout and control mice.
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6.3.2 Discussion
In this section I have considered the role of two candidate phagocytic recptors
invovlved in ac:DC interactions, CD36 and (33/5 integrins (Rubartelli et al.
1997). Experiments using CD36-/- DCs confirm previous reports that DCs utilise
this molecule to bind apoptotic cells. Interestingly in this murine system binding
required a serum component suggesting that murine CD36 does not bind
directly to apoptotic cells but via a bridging molecule (likely to be
thrombospondin). In contrast, human CD36 has an additional binding site
mapped by antibody blockade studies, and shared with malaria-infected
erythrocytes, that binds apoptotic cells directly. It is possible that this latter site
in murine CD36 binds neither malaria infected erythrocytes or apoptotic cells
with high affinity explaining discrepancies found in the role of CD36 in human
and mouse studies of both malaria and apoptotic cell clearance. The observation
that DCs deficient in CD36 phagocytose normally would suggest redundancy in
the scavenger receptor family or compensatory upregulation of alternative
receptors. Interestingly, the resistance of CD36-/-DCs to OxLDL mediated
apoptosis indicates that this particular response shows no redundancy and
cannot be compensated for by other receptors.
Our data examining binding to matrix components support published data
demonstrating expression of VnR in immature DCs (Albert et al. 1998a). In
addition, it suggests that DCs do not express or utilise (31 integrins (as they are
relatively poor at binding to laminin) and that fibronectin binding is likely to
use av integrin family members. The differences in fibronectin binding were
subtle but may represent either VnR dependent binding or differences in other
integrin functions (such av) modified by the absence of (35/3 signalling. The
existence of such integrin 'cross-talk' (Blystone et al. 1999; Boettiger et al. 2001)
and data from transfection experiments, demonstrating that av expression is
stabilised by (35/3 (Albert et al. 2001), suggests that defects in the [35/3-/- DCs
may be due in part to dysfunction in other integrins.
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The observation that DC internalisation of apoptotic cells was not blocked by
RGDS peptides is in agreement with Rubartellis original study where only Vn-
RGD, the natural peptide ligand for VnR, was able to block DC phagocytosis
whilst both RGDS and Vn-RGD blocked macrophage internalisation (Rubartelli
et al. 1997). The conclusion drawn from these original experiments was that
macrophages utilised the TSP binding site of av(l3 (blocked by RGDS) whilst
DCs did not and, in support of this, resting DCs do not to express TSP. An
alternative explanation is that DCs utilise an alternative VnR to macrophages,
such as av(35 as suggested by Albert et al, and that this is blocked by only by
Vn-RGD. Establishing the relative use of av(33 and av(35 in macrophage and DC
adhesion will be interesting area of future study and work is currently
underway examining single (33 and (35 deficient phagocytes and using Vn-RGD
in this murine system and will be particularly important in light of new
evidence that DCs express lactadherin (Thery et al. 1999; Thery et al. 2002)
shown to bridge av(33 to the apoptotic cell in a macrophage system (Hanayama
et al. 2002).
However, our data showing no role for P3/5 in binding and phagocytosis in the
knockout DCs is rather at odds with evidence derived from antibody blockade
experiments. Various possibilities exist explaining this 1) (33/5 integrins are
simply not involved in apoptotic cell recognition 2) that under the conditions of
our binding assay (ie 4°C) defects are not apparent, particularly likely as
integrin binding has been shown to require temperatures of greater than 18°C
(Finnemann et al. 1997), 3) that redundancy also exists - ie that av is able to
partner other P integrins, such as P6, to perform these phagocytic tasks or 4) that
integrin antibody ligation mediates its effects not by directly blocking the
integrin binding site but by signalling to other receptors (including other
integrins) and modulate the efficiency with which they bind to apoptotic cells.
Interestingly, similar contradictory results have been shown in the role of p3/5
integrins and angiogenesis; antibody blockade experiments directed at P
integrins were able to inhibit angiogenesis in murine tumour models whilst
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studies using these same j33/5-/- mice have shown, if anything, an increase in
new vessel formation (Reynolds et al. 2002). Although there is no definite
explanation for this apparent paradox, the ability of soluble integrin antibodies
to 'transdominantly inhibit' functions of other integrins has been postulated and
may also explain this discrepancy. Further studies will be required to determine
these possibilities. However, it does appear that apoptotic cell clearance is not
limited by recognition by these molecules and is more likely determined by
rates of actin polymerisation and cytoskeletal rearrangement, controlled as part
of the DC maturation programme.
During the course of this work two papers have been published exploring the
role of CD36 and (33/5 integrins in cross-presentation by splenic CD8a+DC
(Belz et al. 2002b; Schulz et al. 2002a). Using the same CD36-/- and (33/5-/- mice
these investigators demonstrate that these receptors are not required for
internalisation or cross-presentation of osmotically loaded cell associated
antigen, suggesting that neither of these receptors are required for phagocytosis
or processing of dying cells. These observations are in keeping with our data
demonstrating that neither of these receptors are required for the inhibitory
response in bone marrow derived DCs. However, CD36 has been identified
exclusively on the CD8a+DC subset (Belz et al. 2002b; Iyoda et al. 2002; Schulz
et al. 2002a) which preferentially phagocytose apoptotic cells, thus raising
interesting questions concerning the role of this receptor in this DC subset.
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6.4 Section 3: Role of G-protein coupled signalling molecules.
G protein coupled signalling pathways (Braun et al. 2001) modulate DC
cytokine secretion; treatment with pertussis toxin, inhibiting Gai (and so block
Gai inhibition of adenylate cyclase activity), increases cAMP levels and
paradoxically causes spontaneous release of IL12 (He et al. 2000) whilst cholera
toxin (activating Gas directly) inhibits concurrent LPS stimulation (Braun et al.
1999). Apoptotic cell internalisation is modulated by cAMP (Rossi et al. 1998)
suggesting a link between apoptotic cell clearance and such a G protein coupled
pathway. We have attempted to explore possible roles of such signalling by
studying cholera toxin and pertussis toxin effects on apoptotic cell inhibition of
DCs.
6.4.1 Results
To confirm a role of G protein receptors in control of cytokine production by
LPS treated DCs, DCs were treated with toxins known to modulate G proteins.
Our results were consistent with published data; pertussis toxin caused
spontaneous release of IL12 and slightly (although not significantly) increased
release in response to LPS (Fig 6.12) and cholera toxin inhibited LPS dependent
release of IL12 production (Fig 6.12). Treatment of DCs with these inhibitors
prior to apoptotic cell/LPS challenge did not affect the ability of apoptotic cells
to inhibit DCs (Fig 6.12). These results mitigate against a role for cholera or
pertussis sensitive signalling pathways in these events.
6.4.2 Discussion
G protein coupled signalling pathways (Braun et al. 2001) modulate DC
cytokine secretion and I confirm that treatment with pertussis toxin causes


























Figure 6.12: Role of G protein signalling in antiinflammatory
effects of apoptotic cells. DCs were incubated with apoptotic cells
and stimulated with LPS, in the presence or absence of pertussis
toxin (0.5ng/ml) or cholera toxin (0.5p.g/ml). DC Maturation was
measured by production of IL12 in culture supernatants. DCs
cocultured with apoptotic cells (shaded bars) produce less IL12 than
control DCs (solid blue bar). CT (red bar) inhibits IL12 production in
response to LPS and does not effect apoptotic cell inhibition of DCs
(red shaded bar). PT causes a small increase in IL12 production in
resting DCs and slightly augments LPs responsiveness (turquoise
bars) but does not reverse the ability of apoptotic cells to inhibit
DCs.
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concurrent LPS stimulation (Braun et al. 1999). These observations explain, in
part, the ability of cholera to act as a mucosal adjuvant, allowing DC activation
but driving immune deviation (Gagliardi et al. 2000) and the ability of Pertussis
Toxin to drive Thl responses and promote autoimmunity in animal models.
Resting DCs are thought to be under continuous tonic inhibition mediated by a
pertusis sensitive signalling pathway, likely to use cAMP as a second
messanger. cAMP has been shown recently to have potent regulatory effects on
DC maturation and activation. Interestingly, vitronectin receptors are thought
to, when associated with CD47 (integrin assocoiated protein), form an 'ad hoc'
seven transmembrane receptor likely to signal by G proteins (Green et al. 1999;
Demeure et al. 2000). Thus, the possibility that the vitronectin receptors were
acting in concert with CD47 during apoptotic cell phagocytosis to form such 'ad
hoc' seven transmembrane receptors mediating the inhibitory response was of
interest. However the ability of apoptotic cells to still inhibit both cholera and
pertussis treated DCs mitigates against a link between response to apoptotic
cells and G protein coupled pathway. However this analysis has not been
comprehensive and I believe this area warrants a more detailed analysis of
intracellular cAMP signalling in macrophages and DCs after phagocytosis of
apoptotic cells.
An additional possibility is that the inhibitory signalling is mediated by CD47
(integrin associated protein) independent of phagocytosis and phagocytic
receptors. There is considerable evidence in the literature that this may indeed
be the case. TSP, a ligand for CD47, and CD47 antibody ligation have been
shown to result in similar patterns of cytokine modulation in DCs, preferentially
inhibiting IL12 production (Armant et al. 1999). Also, the malaria infected
erythrocytes used to define the role of CD36 by Urban et al (Urban et al. 1999),
also bind TSP and may possibly also ligate CD47 on DCs. It is possible that both
malaria infected erythrocytes and apoptotic cells complex TSP on their surface
and that TSP has numerous important functions. Firstly, it bridges the
phagocytic receptors CD36 and/or ocv[33/5 to an unidentified ligand on the
apoptotic cell; secondly, it initiates integrin cross-talk upregulating integrin
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function and their recruitment to the 'phagocytic synapse' and finally, by
ligating CD47 initiates the inhibitory effects of both apoptotic cells and malaria
infected erythrocytes.
6.5 Summary
In summary, since in both CD36-/- and (35/3-/- DCs apoptotic cells are able to
inhibit maturation, it suggests an alternative mechanism independent of these
receptors. The fact that phagocytosis can still proceed normally implies that
alternative receptors are used and that these too may be capable of signalling
the inhibitory phenomenon. Alternatively, the inhibitory phenomenon may be
linked to common signalling molecules recruited independently to the
phagocytic synapse (such as CD47) or originate distal to receptor ligation from
processes (such as pl30cas/CRKII/DOCK180/Rac/Cdc42) involved in actin-
cytoskeleton rearrangement required for phagocytosis. Determining the
mechanism by which apoptotic cells inhibit both macrophages and DCs will be
important work in the future.
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7.1 Introduction
The migratory capacity of DCs is vital for their function. Importantly, DCs are
able to 'interpret' the microenvironment in which they first encounter antigen
and, by the phenotype they adopt on migration to lymphoid tissue,
communicate information concerning the state of the periphery to T cells. Thus,
despite a spatial separation of naive T cells from peripheral tissue, DCs
constantly deliver contextual information that helps initiate an appropriate
adaptive immune response. Hence, identification of tissue cues able to modulate
DCs is of increasing interest. These include endogenous 'danger signals' such as
hyaluronan, a matrix component found in inflammatory tissue (Termeer et al.
2002) and necrotic cells (Gallucci et al. 1999; Sauter et al. 2000). In contrast,
recently identified tissue factors may be able to deliver 'safety' signals; TSP
(Demeure et al. 2000) (which binds CD47 ), CRP (Gershov et al. 2000) (and other
pentraxins) and tissue derived cytokines such as TGF-(3 (Letterio et al. 1998;
Gershov et al. 2000) and IL10 (Fiorentino et al. 1991), can all modulate DC
activation, inhibiting IL12 production and initiation of immune responses. Of
particular interest is the identification of leukocyte derived factors which
modulate bystander DCs; monocyte (Reddy et al. 1997) and T cell (Kato et al.
2001) derived conditioned media contain a variety of components including
CD40L, IL1, IL6 and TNFa which mature DCs and factors derived from infected
keratinocytes are able to stimulate bystander uninfected Langerhans cells. Thus
we should not consider DC functions, including clearance of apoptotic cells, in
isolation but rather alongside other leucocytes or in the context of tissue in
which it occurs.
Previous chapters have focused on DC interactions with apoptotic cells and
demonstrate that only DCs that phagocytose are inhibited with bystander cells
remaining unaffected. However, it is becoming apparent that there may be
systemic immunosuppressive effects of apoptotic cells (Yoshida et al. 1998).
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Therefore it seems likely that cells other than DCs initiate this systemic
imunosuppression, generating signals affecting all immune cells. Macrophages
share the tissue micro-environment with DCs and because of the high efficiency
with which they phagocytose apoptotic cells, their relative numbers and their
capacity to secrete factors able to act systemically, they are likely to make a
significant contribution to the outcome of apoptotic cell clearance in vivo.
Interestingly, the presence of contaminating macrophages in in vitro cultures
appears to retard DC maturation (via secretion of factors including TGF-(3)
(Yamaguchi et al. 1997) and also inhibits cross-presentation, implicating
macrophages in indirectly downregulating adaptive responses driven by DCs
(Albert et al. 1998b).
This chapter will investigate the interactions of DCs with macrophages in vitro,
with particular emphasis on the effects that macrophages internalising apoptotic
cells have on bystander DC maturation.
7.2 Results
7.2.1 Immature DCs can compete with macrophages to phagocytose
apoptotic cells in vitro
In previous studies, failure of cross-presentation of apoptotic cells in the
presence of macrophages has been attributed, at least in part, to antigen
sequestration. However, it has been observed that immature DCs are highly
phagocytic with up to 50% of immature murine DCs able to internalise
apoptotic cells in vitro. Thus, to test the ability of macrophages to prevent DCs
from internalising apoptotic cells we established a co-culture system. Green
fluorescent-labelled immature DCs were transferred onto a monolayer of
murine bone marrow macrophages at ratio of 1:1. To these cultures were added
red fluorescent apoptotic human neutrophils and phagocytosis observed after




















Figure 7.1: Phagocytosis in DC: macrophage co cultures.
Fluorescent green mouse bone marrow derived DCs (green) were
cultured with unlabelled macrophages and increasing numbers of red
fluorescent apoptotic cells. A: DCs can be seen to internalise red
apoptotic cells (arrowheads) despite a monolayer of macrophages. Note
apoptotic cells can also be seen inside macrophages (arrows). B:
Phagocytosis of apoptotic cells by DCs was quantified by FACS
analysis. Figures show mean percentage phagocytic DCs +/- s.d. for
triplicate measurements and representative of three similar experments.
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macrophages at a ratio of 1 DC: 2 macrophages inhibition of phagocytosis
remained constant at approximately 50% despite varying the phagocyte:
apoptotic cell ratio from 3:1 to 1:3 (Fig 7.1). Hence macrophages and immature
DCs appear to compete for antigen and the fate of the antigen will depend on
the relative numbers of apoptotic cells, macrophages and DCs. Curiously, even
after 24 hours of culture, DCs could still be seen to be internalising apoptotic
cells, a process that had ceased when DCs were cultured without macrophages
(data not shown). Thus macrophages did not completely sequester apoptotic
cells away from DCs but rather appeared to prolong their phagocytic lifespan,
militating against sequestration of antigen being the sole contributing factor to
failure of cross presentation in vitro when they contaminate cultures.
7.2.2 Macrophages inhibit T cell proliferation which is in part due to a net
inhibitory effect on dendritic cells
Macrophages added to a DC: T cell co-culture inhibited T cell proliferation as
assessed by thymidine incorporation (Fig 7.2) confirming previous reports that
macrophages can inhibit T cell proliferation (Mills 1991). One model suggests
that macrophages act directly on T cells to suppress T cell proliferation.
However, I hypothesised that macrophages might suppress DC maturation. To
investigate this I chose to culture DCs either alone or with macrophages and
assessed DC activation induced by LPS by studying CD86 expression or IL12
production.
Upon treatment with LPS DCs mature and produce large amounts of IL12.
Macrophages have been shown to modulate DC activation especially when
cultured with immature proliferating bone marrow DCs (Yamaguchi et al. 1997).
In confirmation of this co-culturing day 6 DCs with macrophages decreased the
release of IL12 in response to LPS (Fig 7.3) suggesting that macrophages could
inhibit DCs. Interestingly, this inhibition appeared to be mediated by a contact
dependent mechanism, and was not seen when DCs and macrophages were
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Figure 7.2: Macrophages inhibit T cell proliferation. DCs were,
pulsed with OVA peptide and cultured with CD4+ T cells from OVA TCR
transgenic ( D011.10 )mice in the absence of macrophages (black bars),
or in the presence of macrophages (white bars) +/- stimulation by LPS
(0.5|ag/ml). Macrophages and DCs were separated by a transwell
membrane. T cell proliferation was measured by thymidine incorporation
(+/-s.d of triplicate cultures).
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Figure 7.3: Macrophage inhibition of DCs requires cell surface
contact. DCs were cultured with macrophages directly (A) or separated
by a transwell (B), matured with LPS and levels of IL12 in culture
supernatant measured by ELISA. Figures show mean cytokine levels
+/- s.d. for triplicate measurements
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separated across a semi-permeable transwell membrane (Fig 7.3) suggesting a
role for a membrane receptor or a membrane bound cytokine such as TGF(3,
known to be trapped and activated on the surface of macrophages (Murphy-
Ullrich et al. 1992).
7.2.3 Apoptotic cell primed macrophages can inhibit dendritic cells in a
contact independent manner
Macrophages internalising apoptotic cells have been shown to downregulate
proinflammatory cytokine production and upregulate production of important
anti-inflammatory mediators including TGF-(3 (Fadok et al. 1998a; Fadok et al.
1998b). We therefore hypothesised that internalisation of apoptotic cells by
macrophages might alter their ability to modulate bystander DCs either by
decreasing production of proinflammatory cytokines or causing release of anti¬
inflammatory mediators. To test the ability of apoptotic cells to modulate
macrophages and subsequent DC activation we first allowed macrophages to
interact with apoptotic cells for 2 hours, washed off non internalised dead cells
and allowed the macrophages to condition their medium for 24 hours. To this
conditioned media (which we termed acMo) DCs were added separated from
macrophages by a media permeable transwell membrane. DCs, when bathed in
this acMo, were inhibited in a contact independent manner, an effect not seen in
the control macrophage conditioned media (Fig 7.4). In addition this acMo was
less effective than MoCM at inducing CD86 expression on DCs in supernatant
transfer experiments (Fig 7.5). This suggested that the acMo either contained
less proinflammatory cytokine or produced increased amounts of additional
anti-inflammatory mediators. However, neutralisation of TGF-(3 in acMo in LPS
stimulated cultures did not restore the ability of acMo to stimulate CD86
expression suggesting that this was not the active agent (Fig 7.5). This
observation suggests that acMo was less stimulatory than MoCM because the
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Figure 7.4: Conditioned medium from macrophages treated with
apoptotic cells inhibits IL12 production by DCs. Mouse bone
marrow derived macrophages were unstimulated or incubated with
apoptotic cells, with or without LPS (0.1 ^g/ml) and culture supernatant
harvested after 24 hours. These conditioned supernatants were added
to immature DC cultures. IL12 production by DCs was measured by
ELISA after a further 24 hours culture. Figures show mean cytokine
































Figure 7.5: Conditioned medium from macrophages treated with
apoptotic cells inhibits CD86 expression on DCs. Mouse bone
marrow derived macrophages were unstimulated or incubated with
apoptotic cells and / or LPS (0.1 ng/ml) and culture supernatant
harvested after 24 hours. These conditioned supernatants were added
to immature DC cultures, with or without TGF-p soluble receptor
(TGFpSR). CD86 surface expression on DCs was measured by FACS
after a further 24 hours culture. Figures show mean GMFI +/- s.d. for
triplicate measurements. acMo appears to inhibit CD86 expression on
resting DCs. Furthermore MoCM but not acMo from LPS stimulated
macrophages can induce weak upregulation of CD86 expression.
Neutralisation of TGF|3 does not reverse this difference.
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To further assess if macrophages ability to directly stimulate DCs was
modulated by phagocytosis we chose to study the effects of secreted factors
from macrophages stimulated with LPS. To prevent direct effects of LPS DCs,
DCs from C3H/HeJ mice were used. These mice have a functional mutation in
TLR4 rendering them resistant to LPS (Hoshino et al. 1999; Qureshi et al. 1999).
Stimulation of these DCs with media conditioned from LPS stimulated
macrophages caused release of small amounts of IL12 (Fig 7.6) and weak
upregulation of CD86, demonstrating that macrophage conditioned media did
indeed contain factors that could indirectly activate bystander DCs. To increase
IL12 production the cultures were also stimulated with IFNy/LPS. Pre-
treatment of macrophages with apoptotic cells in these IFNy/LPS cultures also
reduced IL12 production (Fig 7.6). Taken together these data suggest that failure
of production of proinflammatory DC maturing cytokines by macrophages that
have internalised apoptotic cells is a key factor and that this along with tonic
inhibition by contact dependent mechanism contribute to the inhibitory effect of
macrophages that have internalised apoptotic cells.
7.3 Discussion
These data demonstrate that DCs continue to phagocytose apoptotic cells in the
presence of macrophages. Furthermore, production of cytokines and
stimulation of T cell proliferation by DCs were modulated by macrophage
contact. These observations confirm previous reports that macrophages have
strong ability to suppress T cell proliferation (Mills 1991) and suggest that some
of these suppressor effects are in part due to inhibition of DCs. This suppressor
activity was greater if macrophages were pre-treated with apoptotic cells. Also
the data presented suggests that macrophages secrete proinflammatory
mediators and that it is the failure of macrophages that have internalised
apoptotic cells to produce proinflammatory factors that is a key contributor to
an anti-inflammatory outcome.
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Figure 7.6: Activation of bystander DCs by apoptotic celt treated
macrophages. Mouse bone marrow derived macrophages were
unstimulated or incubated with apoptotic cells and / or LPS (0.1 i^g/ml)
and IFN-y 100U/ml). DCs from C3H/HeJ mice were cultured in transwell
inserts over these macrophage cultures for 24 hours, and culture
supernatants harvested and IL12 measured by ELISA. Figures show
mean cytokine levels +/- s.d. for triplicate measurements. LPS activated
macrophages induce low levels of IL12 from bystander LPS
unresponsive DCs which can be augmented by IFN-y priming.
Macrophages that have phagocytosed apoptotic cells induce less
bystander activation .
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Despite high efficiency at internalising apoptotic cells, the ability of DCs to
cross-present apoptotic-derived antigen has proved to be a relatively inefficient
process hindering their use as source of antigen for immunotherapy. Cross-
presentation in vitro is inhibited by the presence of contaminating macrophages,
thought to 'sequester' apoptotic-derived antigen (Albert et al. 1998b). However,
the relative numbers of macrophages, DCs and apoptotic cells will vary in
different sites (Hume et al. 1983; Inaba et al. 1994; Hume et al. 2002) and
throughout the inflammatory process; resident tissue macrophages and DCs
will be present in low numbers in the early stages of inflammation whilst
recruited macrophages will arrive in large numbers in the later stages of
inflammation when they will heavily outnumber DCs. Thus, the identity of the
phagocytes engulfing apoptotic cells in vivo may vary as relative numbers of
DCs and macrophages change during the highly dynamic process of
inflammation and may be difficult to model in vitro. However, the data
presented from this static assay suggests that macrophages do indeed decrease
the number of DCs that internalise apoptotic cells. Furthermore, macrophages
internalise large numbers of dying cells efficiently and rapidly and outnumber
DCs in many tissues and suggests that, on balance, the majority of clearance of
dying cells in vivo will be performed by macrophages. Nonetheless, DCs do
internalise some apoptotic cells in the presence of macrophages and therefore
antigen sequestration alone cannot explain how macrophages prevent
crosspresentation.
The origin of activatory and inhibitory cues in vivo depends on the tissue
microenvironment, with contributions from resident tissue cells and recruited
leucocytes. Macrophages exist in many peripheral tissue with higher frequency
than DCs and macrophage derived cytokines and chemokines will make a
significant contribution to the tissue microenvironment in which DCs first
encounter antigen. It is known that macrophages inhibit bystander T cell
proliferation and these data confirm that such inhibition is in part due to
suppression of dendritic cell function. Furthermore, macrophages and
monocytes interacting with apoptotic cells are reprogrammed and upon further
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stimulus by bacterial products switch from producing inflammatory cytokines
such as TNFa to production of antinflammatory cytokines such as TGF-P and
PGE2 (Fadok et al. 1998a) (Fig 7.7). Interestingly, the anti-inflammatory action
of phagocytosing macrophages appears to 'spread' to bystander macrophages in
vitro, in part through the actions of TGF-p. An attractive possibility is that
macrophages recruited to phagocytose dying cells in the inflammatory site are
also able to 'spread' their suppressive effects to bystander immature dendritic
cells in local tissue and via release of a 'cocktail' of inhibitory cytokines.
However, macrophages may also secrete factors such as TNFa, IL1 and IL6 that
augment or at least 'license' DC maturation and a TGF-P vs. TNFa 'switch' has
been suggested as being important in bone marrow DC cultures (Yamaguchi et
al. 1997). The effects of proinflammatory stimuli (TNFa) on DCs were dominant
over the anti-inflammatory mediator (TGF-P) suggesting that the balance of the
inhibitory and activatory cytokines produced by macrophages that is a key
factor determining the phenotype of bystander DCs (Fig 7.8). Thus the
inhibitory effects appear to be accentuated in macrophages that have
internalised apoptotic cells because of decreased production of pro¬
inflammatory TNFa.
Failure of macrophages appropriately to switch off production of
proinflammatory cytokines does correlate to susceptibility to autoimmunity; for
example mice whose macrophages are deficient in inhibitory Fc receptors are
prone to autoimmunity (Takai 2002) and interestingly, macrophages in the Axl-
Mer-Tyro deficient mice produce high levels of TNFa and, unlike normal tissue
macrophages, may contribute to the autoimmune phenotype by 'licensing' DC
activation in tissue (Lu, Q. et al. 2001; Scott et al. 2001). It is interesting to
hypothesise that such high levels of TNFa are actually due to perturbations in
apoptotic cell driven 'reprogramming' of macrophages and will be of interest in
the future. In view of the potent immunosuppressive effects of macrophages,
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Figure 7.7: Macrophage reprogramming following ingestion
of apoptotic cells. Mouse bone marrow derived macrophages
were incubated with apoptotic cells for 2 hours or untreated, and
then stimulated with LPS (Vg/ml). Supernatants were collected
24 hours after LPS treatment and TNF-a and TGF-p levels
determined by ELISA. Data are shown as mean cytokine levels
+/- s.d. for triplicate measurements. The same results have been
seen in over 5 independent experiments. Macrophages that
have internalised apoptotic cells switch off production of TNFa










Figure 7.8: Model of macrophage: DC interactions in inflammatory
sites
A: Resting macrophages make small amounts of proinflammatory
mediators such as TNFa but also inhibit bystander DCs via TGFp
production and a contact dependent mechanism.
B: In a LPS activated environment macrophage production of TNFa
licenses DCs to produce large amounts of IL12
C: Macrophages that have internalised apoptotic cells do not produce
TNFa and fail to license bystander DCs to produce IL12 which then rely
solely on direct activation by LPS. Furthermore, apoptotic cell treated
macrophages may upregulate both their contact dependent and contact
independent capacity to inhibit DCs.
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that they should not be forgotten as an important target for modulation when







This thesis has considered the inhibitory consequences of cell death focusing
particularly on the dendritic cell. It has explored the role of the DC as an innate
immune player, removing dying cells and particulate matter either by
endocytosis or phagocytosis. These data presented demonstrate that
internalisation of apoptotic cells by DCs modulates their subsequent activation,
specifically inhibiting IL12 secretion and upregulation of the costimulatory
molecule CD86 and renders them relatively poor antigen presenting cells. In
addition, it has explored the possible role of cytokines and phagocytic receptors
in signalling these anti-inflammatory responses. Finally, I have attempted to
put these DCs back into context - either alongside their phagocytic partners,
macrophages, or by studying them in vivo.
8.2 Discussion
8.2.1 Apoptotic cells phagocytosis and modulation of DCs
As demonstrated here, apoptotic cells are capable of modulating DCs both
directly and via their ability to 'reprogram' macrophages. The direct effects on
DCs are closely linked with phagocytosis, implicating ligation of specific
phagocytic receptors in propagating the inhibitory signal. However,
examination of DCs generated from mice deficient in CD36 and (33/5 integrins,
the candidate DC receptors for apoptotic cells implicated in antibody blockade
experiments, (Rubartelli et al. 1997; Albert et al. 1998a) demonstrated no defects
in either phagocytosis or inhibition by apoptotic cells. It is likely therefore, that
DC phagocytosis of dying cells is a more complex and orchestrated event than
these original experiments indicated and, similar to the macrophage, further
study may identify a variety of additional receptors used by DCs.
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Complementarity studies, combining knockouts and antibody blockade, will be
required to establish the identity and exact roles of these and other receptors
that constitute the DC's 'phagocytic synapse'. Such complementarity strategies
may also be required to identify the receptor, at the surface or within the
phagolysosome, from which the inhibitory signal originates. Alternatively,
inhibition may not be generated from these proximal surface receptor and
recognition events but occur distally, emanating from conserved parts of the
phagocytic signalling pathway and machinery (eg Rac activation). Indeed, work
studying modulation of IL12 secretion by macrophages (Mosser et al. 1999)
would support both common and receptor specific inhibitory effects of
phagocytosis. A final possibility is that apoptotic cells, acting as 'Trojan horses'
for TGF-P (Chen et al. 2001) and other mediators, directly inhibit the phagocytes
that internalise them.
8.2.2 DC phagocytosis and implications for cross priming
DCs are scavengers (Austyn 1996), able to phagocytose dying cells. Such cells
are likely to be a significant source of antigen provided to DCs in vivo and have
also been shown to be highly efficient means of delivery of antigen in vitro. The
realisation that DCs can internalise apoptotic cells and present their derived
antigens to the immune system was a fascinating observation (Albert et al.
1998b) especially when considered in the context of class I presentation. It
explained a possible route by which uninfected DCs were able to present viral
antigens as well as providing a mechanism by which tumour immunity might
be initiated. However, this obviously important pathway for priming to such
unwanted cellular antigens also provided a possible mechanism by which
transplantation antigens might become visible to the recipient immune system
and autoimmunity might occur. Hence, although vital for our immune system
to function, it appeared likely that DC clearance of apoptotic cells might have a
darker side if inappropriately controlled.
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These early results encouraged the use of DC loaded with apoptotic cells to
crossprime anti-viral (Albert et al. 1998a) and anti-tumour specific T cells
(Larsson et al. 2001; Fonteneau et al. 2002). However, it appears that this
process is relatively inefficient, requiring a variety of additional factors
including strong DC maturation stimuli (such as MCM) and cognate T cell help
(to provide CD40 ligation), acting together to induce a specific maturation
programme without which tolerance ensues (Albert et al. 2001; Dhodapkar, M.
V. et al. 2001). Furthermore, demonstration of cross priming in vivo and
identification of the responsible cell has proved difficult (den Haan et al. 2000).
The difficulties in inducing cross-priming can be explained, in part, by the
existence of an inhibitory effect of apoptotic cells on DC maturation as described
here. These direct effects of apoptotic cells on DCs imply that they would be
relatively poor activators of naive T cell responses. However,my system is
limited in that it does not allow me to determine the amount of antigen that
reaches the surface of the DC for presentation to either CD4 or CD8 T cells and
this may be an important factor in the final outcome of cross-presentation in vivo
(Kurts et al. 1998). For example the high efficiency with which apoptotic cells are
able to access the endogenous pathway (Inaba et al. 1998) may partly negate
their inhibitory effects, especially in situations of 'apoptotic derived antigen
overload'. Nevertheless, by studying an externally loaded class II peptide, we
have been able to make comparisons between the activation state of ac+ and ac-
DCs that would not be possible in conventional class I restricted cross-priming
systems, where only ac+DCs would initiate a functional readout. Understanding
the mechanism by which DCs are 'modulated' by apoptotic cells should allow
us to explore more efficient ways of delivering cellular antigens for cross
priming by bypassing these inhibitory signal and favouring maturation
(Dhodapkar, K. M. et al. 2002).
8.2.3 ac+DCs in defining 'immunological self' and cross-tolerance
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The ability of our immune system to maintain self-tolerance is evidenced by the
infrequency with which autoimmunity occurs. Mechanisms maintaining central
tolerance are now well understood and beyond the scope of this discussion
(Sprent et al. 2002). However, many antigens are not expressed in the
developing thymus and additional mechanisms for peripheral tolerance must
exist. For such antigens, self-reactive T cells are not deleted centrally and must
be deleted or deactivated in the periphery. To this end, it has been realised that
regulatory T cells, capable of deactivating effector T cells, are vital (Groux et al.
1997). However, many of these regulatory populations demonstrate some
antigen specificity and a memory phenotype implying that they are expanded in
an antigen specific manner. It is likely that the initial clonal expansion of such T
cells occurs after encounter with DCs. One such candidate is the immature DC,
lacking in costimulatory molecule expression and shown in vivo to be capable of
generating such cells (Dhodapkar, M. V. et al. 2001). Another possibility is that
it is a mature but 'modulated' DC that performs this task. In work performed
by Albert et al (Albert et al. 2001) they demonstrated that DCs that had
phagocytosed apoptotic cells and matured with MCM were in many ways
mature, capable of interacting and stimulating naive T cells. However, the
outcome of the interaction was unusual; these 'modulated' DCs, unlike their
mature endogenously infected equivalents, did not fully activate influenza
specific CTLs unless provided with additional cognate help, and instead
tolerized them. The ac+DCs described in this thesis could also be considered as
'modulated' rather than immature as they demonstrate many characteristics of
mature/activated DCs, producing TNFa and expressing a variety of surface
markers found on mature DCs. However, our ac+DCs are still able to stimulate
naive T cells (albeit to a lesser extent) despite failing to express costimulatory
molecule CD86, or produce IL12. These observations would suggest that
apoptotic cells modulate DCs, maintain their ability to interact with naive T cells




In vivo evidence of the existence of such DCs is demonstrated by two
descriptions in the rat, (Liu, L. et al. 1998; Trinite et al. 2000). The OX41-/CD4-
DCs described in the latter work are relatively poor stimulators of naive T cells
and have been shown to contain inclusions derived from apoptotic intestinal
epithelial cells (Huang, F. P. et al. 2000). Such cells were found in the draining
lymph and as such were not completely naive as they had presumably received
some cue to exit the peripheral tissue. Interestingly, in an elegant in vitro model
of monocyte/DC trafficking, phagocytosis was able to provide such a stimulus,
inducing DCs to reverse transmigrate (analogous to exiting tissue into lymph)
(Randolph et al. 1998). It seems likely therefore that the OX41-/CD4- DCs have
also been modulated by internalising apoptotic cells ie are mature, migratory
but not fully activated. Such migratory subsets probably reach the secondary
lymph tissue carrying myriad peripheral tissue antigens. Here they educate T
cells, providing a constant source of self-antigen and act to maintain regulatory
T cell populations. In this way ac+DCs are a constant reference for the immune
system and, as suggested by Steinmann, define 'immunological self' and tolerize
to it (Steinman et al. 2000). The data presented would further add to these
theories a regulatory control of DC maturation by apoptotic cells, implying that
their internalisation is not simply an immunologically null event but actively
contributes to maintaining this DC population.
8.2.4 Implications for CD8a+DCs
CD8a+DCs are also thought to have an important role in the maintenance of
peripheral tolerance (Belz et al. 2002a). This role of CD8a+DCs was suggested
after the original description when these 'lymphoid' DCs were shown have the
unusual ability to induce rapid AICD in interacting lympohocytes, raising the
possibility that such deletion might remove autoreactive T cells in vivo (Suss et
al. 1996). Interestingly, apoptosis was crucial in the observed 'killer' phenotype
of CD8a+DCs and the conclusion from these observations was that CD8a+DCs
actively killed interacting T cells by expressing Fas-L upon their surface.
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However, preferential expression of Fas-L by CD8a+DCs has not been
supported by subsequent studies using different CD95 antibodies. Instead we
would suggest a reinterpretation of these observations and suggest that
apoptosis may contribute to this DC phenotype in a more complex way; ac+DCs
specifically inhibit IL12 production and costimulatory molecule CD86
expression but continue to make TNFa. Such modulation results in DCs which
are relatively poor at stimulating T cell proliferation and prime interacting T
cells for rapid AICD upon restimulation. CD8a+DCs, by virtue of their
expression of specific receptors for apoptotic cells (CD36), probably clear small
numbers of apoptotic cells during normal tissue turnover and larger numbers
when rates of apoptosis are high or upon immunisation with dying cells. One
such situation is induced during the termination phase of the adaptive immune
response when large numbers of redundant effector T cells are deleted by AICD.
In this model, internalisation of these dying T cells by the stimulating
CD8a+DCs results in down regulation of IL12 production and drives CD8a+DC
to adopt a 'killer' phenotype. These CD8a+DCs, perhaps through FasL
expression, or other members of the TNF superfamily, that are present or
induced by phagocytosis, actively 'kill' interacting T cells, increasing the
apoptotic cell load.
Currently, we have little data implicating an absolute requirement for CD36 in
this process. However, a precedent for a 'feedforward' role for CD36 function
and regulation exists; CD36 is important both in the induction and maintenance
of foam cell formation in atheroma (Febbraio et al. 2001) and studies of lipid
handling indicate that oxidised lipid, acting as a CD36 ligand, upregulates CD36
expression (Han et al. 1997). We would suggest a similar, but inhibitory,
feedforward loop may contribute to the rapid AICD seen in CD8a+DC primed T
cell cultures and occurs preferentially with these cells partly because of the
efficiency with which they phagocytose dying cells and the inhibitory
consequences that ensue. Interestingly, although ligation of CD36 has been
shown to be capable of modulating DC function our preliminary data using
CD36-/-DCs show that it is not an absolute requirement. Furthermore, CD36-/-
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DCs isolated ex vivo demonstrate only a minor defect in apoptotic cell clearance
and our preliminary data suggest compensatory mechanisms exist between
scavenger receptor family molecules in vivo. We favour the concept that it is the
ability of DCs to internalise apoptotic cells, rather than the receptor involved
that is key. Taken together these data suggest a novel mechanism by which
normal clearance of constitutively apoptotic cells might contribute to DC
function and the maintenance of the 'killer' CD8a+DC phenotype in vivo.
8.2.5 Implications for tumour immunity
Apoptosis is a characteristic of certain tumours and is also the form of cell death
induced by many anti-tumour treatments. A major goal for medical science is to
understand how we can harness natural immune responses to provoke tumour
regression. Induction of tumour specific T cells is one such strategy but is
hindered by identification of antigens specific for a particular tumour capable of
generating and maintaining tumour reactive T cells. Dying tumour cells are an
attractive source of such antigens as most of the antigenic repertoire of a tumour
will be represented within them. However, although efficient cross-priming to
tumours has been demonstrated in both model animal systems and an
increasing number of human trials it is only now apparent that certain 'tricks of
the trade', such as vigorous ex vivo stimulation of DCs, opsonisation of antigen
to increase immunogenicity and careful immunisation regimes, are essential for
a successful outcome (Steinman et al. 2001). Furthermore, generation of
autoimmunity as a consequence of such immunotherapy strategies is a genuine
concern (Ludewig et al. 2000; Gilboa 2001). These data presented partly explain
this and also imply that limited apoptosis by a tumour may well be a means of
immune evasion. Cell death recruits phagocytes and macrophages are in fact,
commonly found infiltrating tumours. Although the role of these tumour
macrophages is not fully understood, they are thought to benefit the tumour by
providing angiogenic factors. The data presented would suggest they may
further benefit the tumour by hindering cross-presentation and possibly
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expanding tumour specific Treg cells if dying tumour cells are internalised by
DCs. In addition, infiltrating macrophages may also deactivate any bystander
DCs carrying appropriate antigens preventing initiation or maintenance of a
tumour specific response. Thus, the darker side of ac+DCs and macrophage
clearance of dying cells is that it provides a potential means of immunological
'escape' for tumours.
8.2.6 Implications for autoimmunity
Autoimmune diseases are complex and multifactorial, involving, amongst
others, abnormalities in B and T cell activation thresholds, lack of regulatory
controls and genetic factors (O'Shea et al. 2002; Ohashi 2002; Walker et al. 2002).
The models outlined here demonstrate how apoptotic cells might, as a source of
self-antigen, prevent rather than initiate autoimmunity. Apoptotic cells as
presented to the immune system by DC define 'immunological self' (Steinman
et al. 2000), without which autoimmunity would be inevitable. However,
autoimmunity does occur, and, in some cases, has been shown to be associated
with perturbations in normal apoptotic cell clearance processes (Mevorach 2000;
Walport 2000; Rosen et al. 2001). Considering data presented within this thesis,
such associations could be explained by a variety of hypotheses (Fig 8.1):
1) Failure ofmacrophages to clear apoptotic cells results in excess number of dying
cells, which are cleared instead by DCs. Although this is an attractive initial
hypothesis, the observation that the DC that internalises an apoptotic
cells is in fact inhibited does not support such a theory. The data
presented in this thesis would suggest that autoimmunity would only
result if clearance of apoptotic cells became proinflammatory in these
circumstances, e.g. as a result of secondary necrosis, DC 'overload' or
stimulating tissue derived 'danger signals' able to overcome the











Figure 8.2. Possible mechanisms by which defective apoptotic cell
clearance might drive autoimmunity. A: Failure of macrophages to clear
apoptotic cells results in excess numbers of dying cells, which are cleared
by DCs. B: Failure of macrophages to clear apoptotic cells results in
macrophages that fail to inhibit bystander DCs. C: Failure of DC clearance




2) Failure of macrophages to clear apoptotic cells results in macrophages that fail to
inhibit bystander DCs. As shown, apoptotic cell internalisation
'reprogrammes' macrophages to secrete antinflammatory cytokines able
to prevent DC maturation. Failed clearance of apoptotic cells by
macrophages, by curtailing their gatekeeper role, might suffice to 'permit'
or lower the threshold for bystander DC maturation.
3) Failure in DC clearance and failure to generate/maintain regulatory T cells or
delete autoreactive T cells. ac+DCs may act primarily to maintain regulatory
T cell populations and delete self-reactive T cell clones in the periphery
and failure of these regulatory checkpoints because of failed clearance by
DC might contribute to autoimmunity.
It is possible that some or all of the mechanisms described contribute to generation or
maintenance ofself-reactive effector cells found in autoimmune disease.
8.3 Summary: Apoptotic cells, macrophages and modulation of
DCs
Together, these data would support a complex model for the role of
macrophages, apoptotic cells and DCs in control of immunity (Fig 8.2). Local
macrophages, especially in inflammed tissue, would control T cell proliferation
by modulating DC function and prevent formation of extra-lymphoid tissue. In
addition, macrophages recruited for internalisation of apoptotic cells during the
resolution phase of inflammation, would be able to dampen systemic
inflammatory responses effectively turning off recruitment of effector
lymphocytes, through secretion of factors able to act at distant sites such as TGF-
p. In this way macrophages may act as 'gate-keepers' of DC maturation in the
periphery and down regulate adaptive immune responses.
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Figure 8.2. Spectrum of outcomes that DCs internalising apoptotic
cells might have on the immune system
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Also, in normal steady state, DCs loaded with apoptotic antigen would traffic to
draining lymph nodes continuously sampling the peripheral tissue. These
ac+DCs would fail to mature and hence tolerise/anergise/delete interacting
self-reactive T cells. In inflammation, DCs escaping the periphery carrying
apoptotic cell derived antigen, because of the direct inhibitory effects of
apoptotic cells, would be prohibited from presenting auto-antigens. In contrast,
dendritic cells escaping the inflammatory site carrying pathogen-derived
antigen, upon encounter of their appropriate cognate T cell, would activate
normally. However, this network of control so important in the resolution of
inflammation and control of autoimmunity, allows 'escape' of apoptotic
tumours from efficient cross-presentation, effectively rendering them invisible
to the adaptive immune system.
8.4 Conclusion
"That the organism possess certain contrivances by means of which the
immunity reaction, so easily produced by all kinds of cells, is prevented from
acting against the organs own elements."
Paul Ehrlich
Dendritic cells are effective scavengers of their local microenvironment,
constantly internalising antigen for processing and presentation. Their
migratory capacity and unique ability at interacting with naive T cells to
generate both immunity and tolerance is increasingly being understood and has
highlighted their importance in bridging the innate and adaptive immune
systems.
Phagocytosis of apoptotic cells appears to provide DCs with a constant burden
of self-antigen for delivery to the draining lymph nodes. However, the ability of
apoptotic cells to actually inhibit the DCs that have internalised them ensures
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the safe passage of derived antigen in most cases. In fact these ac+DCs are
multifunctional - they constantly provide a source of processed and presented
tissue-derived antigens, defining 'immunological self' and are likely to maintain
regulatory T cell populations in vivo.
However, the darker side of these ac+ DCs must exist. It is likely that they are
involved, directly or indirectly, in the induction of autoimmunity and also in
transplantation rejection. In addition the ability of certain viruses and other
pathogens such as malaria to harness these mechanism for immune evasion is
possible. Finally, it is possible to envisage how apoptotic tumour cells might
use this portal to 'hijack' DCs, infiltrating the regulatory network and effectively






Aderem, A. and R. }. Ulevitch (2000). "Toll-like receptors in the induction of the innate immune
response." Nature 406(6797): 782-7.
Adler, A. J., D. W. Marsh, et al. (1998). "CD4+ T cell tolerance to parenchymal self-antigens
requires presentation by bone marrow-derived antigen-presenting cells." T Exp Med
187(10): 1555-64.
Adorini, L., S. Gregori, et al. (1996). "The role of IL-12 in the pathogenesis of Thl cell-mediated
autoimmune diseases." Ann N Y Acad Sci 795: 208-15.
Aitman, T. J., L. D. Cooper, et al. (2000). "Malaria susceptibility and CD36 mutation." Nature
405(6790): 1015-6.
Akbari, O., R. H. DeKruyff, et al. (2001). "Pulmonary dendritic cells producing IL-10 mediate
tolerance induced by respiratory exposure to antigen." Nat Immunol 2(8): 725-31.
Albert, M. L., M. Jegathesan, et al. (2001). "Dendritic cell maturation is required for the cross-
tolerization of CD8+ T cells." Nat Immunol 2(11): 1010-7.
Albert, M. L., J. I. Kim, et al. (2000). "alphavbeta5 integrin recruits the CrkII-Dockl80-racl
complex for phagocytosis of apoptotic cells." Nat Cell Biol 2(12): 899-905.
Albert, M. L., S. F. Pearce, et al. (1998a). "Immature dendritic cells phagocytose apoptotic cells
via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes." I
Exp Med 188(7): 1359-68.
Albert, M. L., B. Sauter, et al. (1998b). "Dendritic cells acquire antigen from apoptotic cells and
induce class I- restricted CTLs." Nature 392(6671): 86-9.
Anjuere, F., P. Martin, et al. (1999). "Definition of dendritic cell subpopulations present in the
spleen, Peyer's patches, lymph nodes, and skin of the mouse." Blood 93(2): 590-8.
Armant, M., M. N. Avice, et al. (1999). "CD47 ligation selectively downregulates human
interleukin 12 production." 1 Exp Med 190(8): 1175-82.
Asseman, C., S. Mauze, et al. (1999). "An essential role for interleukin 10 in the function of
regulatory T cells that inhibit intestinal inflammation." T Exp Med 190(7): 995-1004.
Austyn, J. M. (1996). "New insights into the mobilization and phagocytic activity of dendritic
cells." T Exp Med 183(4): 1287-92.
Bachmann, M. F., A. Oxenius, et al. (1995). "TAPl-independent loading of class I molecules by
exogenous viral proteins." Eur T Immunol 25(6): 1739-43.
Baker, A. J., A. Mooney, et al. (1994). "Mesangial cell apoptosis: the major mechanism for
resolution of glomerular hypercellularity in experimental mesangial proliferative
nephritis." T Clin Invest 94(5): 2105-16.




Banchereau, J. and R. M. Steinman (1998). "Dendritic cells and the control of immunity." Nature
392(6673): 245-52.
Basu, S., R. }. Binder, et al. (2001). "CD91 is a common receptor for heat shock proteins gp96,
hsp90, hsp70, and calreticulin." Immunity 14(3): 303-13.
Basu, S., R. J. Binder, et al. (2000). "Necrotic but not apoptotic cell death releases heat shock
proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-
kappa B pathway." Int Immunol 12(11): 1539-46.
Bellgrau, D., D. Gold, et al. (1995). "A role for CD95 ligand in preventing graft rejection." Nature
377(6550): 630-2.
Bellone, M., G. Iezzi, et al. (1997). "Processing of engulfed apoptotic bodies yields T cell
epitopes." 1 Immunol 159(11): 5391-9.
Belz, G. T., G. M. Behrens, et al. (2002a). "The CD8alpha(+) dendritic cell is responsible for
inducing peripheral self-tolerance to tissue-associated antigens." T Exp Med 196(8): 1099-
104.
Belz, G. T., D. Vremec, et al. (2002b). "CD36 is differentially expressed by CD8+ splenic dendritic
cells but is not required for cross-presentation in vivo." T Immunol 168(12): 6066-70.
Bevan, M. J. (1976a). "Cross-priming for a secondary cytotoxic response to minor H antigens
with H-2 congenic cells which do not cross-react in the cytotoxic assay." T Exp Med
143(5): 1283-8.
Bevan, M. J. (1976b). "Minor H antigens introduced on H-2 different stimulating cells cross-
react at the cytotoxic T cell level during in vivo priming." T Immunol 117(6): 2233-8.
Bickerstaff, M. C., M. Botto, et al. (1999). "Serum amyloid P component controls chromatin
degradation and prevents antinuclear autoimmunity." Nat Med 5(6): 694-7.
Bittencourt, M. C., S. Perruche, et al. (2001). "Intravenous injection of apoptotic leukocytes
enhances bone marrow engraftment across major histocompatibility barriers." Blood
98(1): 224-230.
Blystone, S. D., S. E. Slater, et al. (1999). "A molecular mechanism of integrin crosstalk:
alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates
alpha5betal function." I Cell Biol 145(4): 889-97.
Boettiger, D., L. Lynch, et al. (2001). "Distinct ligand-binding modes for integrin alpha(v)beta(3)-
mediated adhesion to fibronectin versus vitronectin." I Biol Chem 276(34): 31684-90.
Borkowski, T. A., J. J. Letterio, et al. (1996). "A role for endogenous transforming growth factor
beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null
mice is devoid of epidermal Langerhans cells." 1 Exp Med 184(6): 2417-22.
Botto, M., C. Dell'Agnola, et al. (1998). "Homozygous Clq deficiency causes glomerulonephritis
associated with multiple apoptotic bodies." Nat Genet 19(1): 56-9.
186
Bibliography
Braun, M. C., J. He, et al. (1999). "Cholera toxin suppresses interleukin (IL)-12 production and
IL-12 receptor betal and beta2 chain expression." I Exp Med 189(3): 541-52.
Braun, M. C. and B. L. Kelsall (2001). "Regulation of interleukin-12 production by G-protein-
coupled receptors." Microbes Infect 3(2): 99-107.
Bu, P., A. Keshavarzian, et al. (2001). "Apoptosis: one of the mechanisms that maintains
unresponsiveness of the intestinal mucosal immune system." T Immunol 166(10): 6399-
403.
Byrne, A. and D. J. Reen (2002). "Lipopolysaccharide induces rapid production of IL-10 by
monocytes in the presence of apoptotic neutrophils." I Immunol 168(4): 1968-77.
Carbone, F. R. and M. J. Bevan (1990). "Class I-restricted processing and presentation of
exogenous cell- associated antigen in vivo." T Exp Med 171(2): 377-87.
Casciola-Rosen, L. A., G. Anhalt, et al. (1994). "Autoantigens targeted in systemic lupus
erythematosus are clustered in two populations of surface structures on apoptotic
keratinocytes." T Exp Med 179(4): 1317-30.
Caux, C., B. Vanbervliet, et al. (1994). "B70/B7-2 is identical to CD86 and is the major functional
ligand for CD28 expressed on human dendritic cells." T Exp Med 180(5): 1841-7.
Cella, M., A. Engering, et al. (1997). "Inflammatory stimuli induce accumulation of MHC class II
complexes on dendritic cells." Nature 388(6644): 782-7.
Cella, M., D. Scheidegger, et al. (1996). "Ligation of CD40 on dendritic cells triggers production
of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via
APC activation." T Exp Med 184(2): 747-52.
Chen, W., M. E. Frank, et al. (2001). "TGF-beta Released by Apoptotic T Cells Contributes to an
Immunosuppressive Milieu." Immunity 14(6): 715-25.
Chung, S., T. L. Gumienny, et al. (2000). "A common set of engulfment genes mediates removal
of both apoptotic and necrotic cell corpses in C. elegans." Nat Cell Biol 2(12): 931-7.
Cohen, P. L. and R. A. Eisenberg (1991). "Lpr and gld: single gene models of systemic
autoimmunity and lymphoproliferative disease." Annu Rev Immunol 9: 243-69.
de Baey, A. and A. Lanzavecchia (2000). "The role of aquaporins in dendritic cell
macropinocytosis." T Exp Med 191(4): 743-8.
Demeure, C. E., H. Tanaka, et al. (2000). "CD47 engagement inhibits cytokine production and
maturation of human dendritic cells." T Immunol 164(4): 2193-9.
den Haan, J. M., S. M. Lehar, et al. (2000). "CD8(+) but not CD8(-) dendritic cells cross-prime
cytotoxic T cells in vivo." T Exp Med 192(12): 1685-96.
Devitt, A., O. D. Moffatt, et al. (1998). "Human CD14 mediates recognition and phagocytosis of
apoptotic cells [see comments]." Nature 392(6675): 505-9.
187
Bibliography
Dhodapkar, K. M., J. Krasovsky, et al. (2002). "Antitumor monoclonal antibodies enhance cross-
presentation ofcCellular antigens and the generation of myeloma-specific killer T cells
by dendritic cells." I Exp Med 195(1): 125-33.
Dhodapkar, M. V., R. M. Steinman, et al. (2001). "Antigen-specific inhibition of effector T cell
function in humans after injection of immature dendritic cells." T Exp Med 193(2): 233-8.
Dieu, M. C., B. Vanbervliet, et al. (1998). "Selective recruitment of immature and mature
dendritic cells by distinct chemokines expressed in different anatomic sites." I Exp Med
188(2): 373-86.
Engelmayer, J., M. Larsson, et al. (1999). "Vaccinia virus inhibits the maturation of human
dendritic cells: a novel mechanism of immune evasion." T Immunol 163(12): 6762-8.
Fadok, V. A., D. L. Bratton, et al. (2001). "Differential effects of apoptotic versus lysed cells on
macrophage production of cytokines: role of proteases." T Immunol 166(11): 6847-54.
Fadok, V. A., D. L. Bratton, et al. (1998a). "Macrophages that have ingested apoptotic cells in
vitro inhibit proinflammatory cytokine production through autocrine/paracrine
mechanisms involving TGF-beta, PGE2, and PAF." T Clin Invest 101(4): 890-8.
Fadok, V. A., D. L. Bratton, et al. (2000). "A receptor for phosphatidylserine-specific clearance of
apoptotic cells [see comments]." Nature 405(6782): 85-90.
Fadok, V. A., P. P. McDonald, et al. (1998b). "Regulation of macrophage cytokine production by
phagocytosis of apoptotic and post-apoptotic cells." Biochem Soc Trans 26(4): 653-6.
Fadok, V. A., J. S. Savill, et al. (1992a). "Different populations of macrophages use either the
vitronectin receptor or the phosphatidylserine receptor to recognize and remove
apoptotic cells." T Immunol 149(12): 4029-35.
Fadok, V. A., D. R. Voelker, et al. (1992b). "Exposure of phosphatidylserine on the surface of
apoptotic lymphocytes triggers specific recognition and removal by macrophages." J
Immunol 148(7): 2207-16.
Fadok, V. A., M. L. Warner, et al. (1998c). "CD36 is required for phagocytosis of apoptotic cells
by human macrophages that use either a phosphatidylserine receptor or the vitronectin
receptor (alpha v beta 3)." I Immunol 161(11): 6250-7.
Febbraio, M., D. P. Hajjar, et al. (2001). "CD36: a class B scavenger receptor involved in
angiogenesis, atherosclerosis, inflammation, and lipid metabolism." T Clin Invest 108(6):
785-91.
Finelli, A., K. M. Kerksiek, et al. (1999). "MHC class I restricted T cell responses to Listeria
monocytogenes, an intracellular bacterial pathogen." Immunol Res 19(2-3): 211-23.
Finnemann, S. C., V. L. Bonilha, et al. (1997). "Phagocytosis of rod outer segments by retinal
pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for
internalization." Proc Natl Acad Sci U S A 94(24): 12932-7.
188
Bibliography
Finnemann, S. C. and E. Rodriguez-Boulan (1999). "Macrophage and retinal pigment epithelium
phagocytosis: apoptotic cells and photoreceptors compete for alphavbeta3 and
alphavbeta5 integrins, and protein kinase C regulates alphavbeta5 binding and
cytoskeletal linkage." T Exp Med 190(6): 861-74.
Finnemann, S. C. and R. L. Silverstein (2001). "Differential roles of CD36 and alphavbeta5
integrin in photoreceptor phagocytosis by the retinal pigment epithelium." 1 Exp Med
194(9): 1289-98.
Fiorentino, D. F., A. Zlotnik, et al. (1991). "IL-10 acts on the antigen-presenting cell to inhibit
cytokine production by Thl cells." T Immunol 146(10): 3444-51.
Fisher, G. FI., F. J. Rosenberg, et al. (1995). "Dominant interfering Fas gene mutations impair
apoptosis in a human autoimmune lymphoproliferative syndrome." Cell 81(6): 935-46.
Fonteneau, J. F., M. Larsson, et al. (2002). "Interactions between dead cells and dendritic cells in
the induction of antiviral CTL responses." Curr Opin Immunol 14(4): 471-7.
Franc, N. C., J. L. Dimarcq, et al. (1996). "Croquemort, a novel Drosophila
hemocyte/macrophage receptor that recognizes apoptotic cells." Immunity 4(5): 431-43.
Franc, N. C., P. Heitzler, et al. (1999). "Requirement for croquemort in phagocytosis of apoptotic
cells in Drosophila." Science 284(5422): 1991-4.
Fraser, I., A. Doyle, et al. (1994). "Use of surface molecules and receptors for studying
macrophages and mononuclear phagocytes." T Immunol Methods 174(1-2): 95-102.
Fugier-Vivier, I., C. Servet-Delprat, et al. (1997). "Measles virus suppresses cell-mediated
immunity by interfering with the survival and functions of dendritic and T cells." I Exp
Med 186(6): 813-23.
Gagliardi, M. C., F. Sallusto, et al. (2000). "Cholera toxin induces maturation of human dendritic
cells and licences them for Th2 priming." Eur 1 Immunol 30(8): 2394-403.
Gallucci, S., M. Lolkema, et al. (1999). "Natural adjuvants: endogenous activators of dendritic
cells." Nat Med 5(11): 1249-55.
Garrett, W. S., L. M. Chen, et al. (2000). "Developmental control of endocytosis in dendritic cells
by Cdc42." Cell 102(3): 325-34.
Geissmann, F., P. Revy, et al. (1999). "TGF-beta 1 prevents the noncognate maturation of human
dendritic Langerhans cells." T Immunol 162(8): 4567-75.
Gerber, ]. S. and D. M. Mosser (2001a). "Reversing lipopolysaccharide toxicity by ligating the
macrophage Fc gamma receptors." I Immunol 166(11): 6861-8.
Gerber, J. S. and D. M. Mosser (2001b). "Stimulatory and inhibitory signals originating from the
macrophage Fcgamma receptors." Microbes Infect 3(2): 131-9.
Gershov, D., S. Kim, et al. (2000). "C-Reactive protein binds to apoptotic cells, protects the cells
from assembly of the terminal complement components, and sustains an
189
Bibliography
antiinflammatory innate immune response: implications for systemic autoimmunity." J
Exp Med 192(9): 1353-64.
Gilboa, E. (2001). "The risk of autoimmunity associated with tumor immunotherapy." Nat
Immunol 2(9): 789-92.
Giles, K. M., K. Ross, et al. (2001). "Glucocorticoid augmentation of macrophage capacity for
phagocytosis of apoptotic cells is associated with reduced pl30Cas expression, loss of
paxillin/pyk2 phosphorylation, and high levels of active Rac." T Immunol 167(2): 976-86.
Gordon, S. (1999). "Macrophage-restricted molecules: role in differentiation and activation."
Immunol Lett 65(1-2): 5-8.
Grazia Cappiello, M., F. S. Sutterwala, et al. (2001). "Suppression of 11-12 transcription in
macrophages following Fc gamma receptor ligation." T Immunol 166(7): 4498-506.
Green, J. M., A. Zhelesnyak, et al. (1999). "Role of cholesterol in formation and function of a
signaling complex involving alphavbeta3, integrin-associated protein (CD47), and
heterotrimeric G proteins." I Cell Biol 146(3): 673-82.
Griffith, T. S., T. Brunner, et al. (1995). "Fas ligand-induced apoptosis as a mechanism of
immune privilege." Science 270(5239): 1189-92.
Griffith, T. S., X. Yu, et al. (1996). "CD95-induced apoptosis of lymphocytes in an immune
privileged site induces immunological tolerance." Immunity 5(1): 7-16.
Groux, H., A. O'Garra, et al. (1997). "A CD4+ T-cell subset inhibits antigen-specific T-cell
responses and prevents colitis." Nature 389(6652): 737-42.
Han, J., D. P. Hajjar, et al. (1997). "Native and modified low density lipoproteins increase the
functional expression of the macrophage class B scavenger receptor, CD36." I Biol Chem
272(34): 21654-9.
Hanayama, R., M. Tanaka, et al. (2002). "Identification of a factor that links apoptotic cells to
phagocytes." Nature 417(6885): 182-7.
Hara, M., C. I. Kingsley, et al. (2001). "IL-10 is required for regulatory T cells to mediate
tolerance to alloantigens in vivo." T Immunol 166(6): 3789-96.
Harshyne, L. A., S. C. Watkins, et al. (2001). "Dendritic cells acquire antigens from live cells for
cross-presentation to CTL." T Immunol 166(6): 3717-23.
Hawiger, D., K. Inaba, et al. (2001). "Dendritic cells induce peripheral t cell unresponsiveness
under steady state conditions in vivo." T Exp Med 194(6): 769-80.
He, J., S. Gurunathan, et al. (2000). "Primary role for Gi protein signaling in the regulation of
interleukin 12 production and the induction of T helper cell type 1 responses." 1 Exp
Med 191(9): 1605-10.
Heath, W. R. and F. R. Carbone (2001a). "Cross-presentation, dendritic cells, tolerance and
immunity." Annu Rev Immunol 19: 47-64.
190
Bibliography
Heath, W. R. and F. R. Carbone (2001b). "Cross-presentation in viral immunity and self-
tolerance." Nat Rev Immunol 1(2): 126-34.
Hochrein, H., K. Shortman, et al. (2001). "Differential production of IL-12, IFN-alpha, and IFN-
gamma by mouse dendritic cell subsets." T Immunol 166(9): 5448-55.
Horng, T. and R. Medzhitov (2001). "Drosophila MyD88 is an adapter in the Toll signaling
pathway." Proc Natl Acad Sci U S A 98(22): 12654-8.
Hoshino, K., O. Takeuchi, et al. (1999). "Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice
are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product."
1 Immunol 162(7): 3749-52.
Huang, A. Y., A. T. Bruce, et al. (1996). "In vivo cross-priming of MHC class I-restricted antigens
requires the TAP transporter." Immunity 4(4): 349-55.
Huang, F. P., N. Piatt, et al. (2000). "A discrete subpopulation of dendritic cells transports
apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes." T Exp
Med 191(3): 435-44.
Huang, L. Y., C. Reis e Sousa, et al. (2001). "IL-12 induction by a THl-inducing adjuvant in vivo:
dendritic cell subsets and regulation by IL-10." I Immunol 167(3): 1423-30.
Hugues, S., E. Mougneau, et al. (2002). "Tolerance to islet antigens and prevention from diabetes
induced by limited apoptosis of pancreatic beta cells." Immunity 16(2): 169-81.
Hume, D. A., A. P. Robinson, et al. (1983). "The mononuclear phagocyte system of the mouse
defined by immunohistochemical localization of antigen F4/80. Relationship between
macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and
hematopoietic organs." T Exp Med 158(5): 1522-36.
Hume, D. A., I. L. Ross, et al. (2002). "The mononuclear phagocyte system revisited." T Leukoc
Biol 72(4): 621-7.
Imachi, H., K. Murao, et al. (2000). "Human scavenger receptor B1 is involved in recognition of
apoptotic thymocytes by thymic nurse cells." Lab Invest 80(2): 263-70.
Inaba, K., M. Inaba, et al. (1992a). "Generation of large numbers of dendritic cells from mouse
bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating
factor." I Exp Med 176(6): 1693-702.
Inaba, K., R. M. Steinman, et al. (1992b). "Identification of proliferating dendritic cell precursors
in mouse blood." T Exp Med 175(5): 1157-67.
Inaba, K., S. Turley, et al. (2000). "The formation of immunogenic major histocompatibility
complex class II- peptide ligands in lysosomal compartments of dendritic cells is
regulated by inflammatory stimuli." T Exp Med 191(6): 927-36.
Inaba, K., S. Turley, et al. (1998). "Efficient presentation of phagocytosed cellular fragments on




Inaba, K., M. Witmer-Pack, et al. (1994). "The tissue distribution of the B7-2 costimulator in mice:
abundant expression on dendritic cells in situ and during maturation in vitro." 1 Exp
Med 180(5): 1849-60.
Iwasaki, A. and B. L. Kelsall (1999). "Freshly isolated Peyer's patch, but not spleen, dendritic
cells produce interleukin 10 and induce the differentiation of T helper type 2 cells." I
Exp Med 190(2): 229-39.
Iyoda, T., S. Shimoyama, et al. (2002). "The CD8+ dendritic cell subset selectively endocytoses
dying cells in culture and in vivo." 1 Exp Med 195(10): 1289-302.
janetzki, S., N. E. Blachere, et al. (1998). "Generation of tumor-specific cytotoxic T lymphocytes
and memory T cells by immunization with tumor-derived heat shock protein gp96." J
Immunother 21(4): 269-76.
Janeway, C. (1989a). "Immunogenicity signals 1,2,3 ... and 0." Immunol Today 10(9): 283-6.
Janeway, C. A., Jr. (1989b). "Approaching the asymptote? Evolution and revolution in
immunology." Cold Spring Harb Svmp Quant Biol 54(Pt 1): 1-13.
Janeway, C. A., Jr. (1992). "The immune system evolved to discriminate infectious nonself from
noninfectious self." Immunol Today 13(1): 11-6.
Kaisho, T. and S. Akira (2000). "Critical roles of Toll-like receptors in host defense." Crit Rev
Immunol 20(5): 393-405.
Kato, K., Y. Takaue, et al. (2001). "T-cell-conditioned medium efficiently induces the maturation
, and function of human dendritic cells." T Leukoc Biol 70(6): 941-9.
Kerr, J. F., A. H. Wyllie, et al. (1972). "Apoptosis: a basic biological phenomenon with wide-
ranging implications in tissue kinetics." Br I Cancer 26(4): 239-57.
Kodaira, Y., S. K. Nair, et al. (2000). "Phenotypic and functional maturation of dendritic cells
mediated by heparan sulfate." I Immunol 165(3): 1599-604.
Kulkarni, A. B., C. G. Huh, et al. (1993). "Transforming growth factor beta 1 null mutation in
mice causes excessive inflammatory response and early death." Proc Natl Acad Sci U S
A 90(2): 770-4.
Kurts, C., F. R. Carbone, et al. (1997a). "CD4+ T cell help impairs CD8+ T cell deletion induced
by cross- presentation of self-antigens and favors autoimmunity." I Exp Med 186(12):
2057-62.
Kurts, C., W. R. Heath, et al. (1996). "Constitutive class I-restricted exogenous presentation of
self antigens in vivo." I Exp Med 184(3): 923-30.
Kurts, C., H. Kosaka, et al. (1997b). "Class I-restricted cross-presentation of exogenous self-
antigens leads to deletion of autoreactive CD8(+) T cells." 1 Exp Med 186(2): 239-45.
Kurts, C., J. F. Miller, et al. (1998). "Major histocompatibility complex class I-restricted cross-
presentation is biased towards high dose antigens and those released during cellular
destruction." 1 Exp Med 188(2): 409-14.
192
Bibliography
Lamont, A. G. and L. Adorini (1996). "IL-12: a key cytokine in immune regulation." Immunol
Today 17(5): 214-7.
Langenkamp, A., M. Messi, et al. (2000). "Kinetics of dendritic cell activation: impact on priming
of TH1, TH2 and nonpolarized T cells." Nat Immunol 1(4): 311-6.
Larsson, M., J. F. Fonteneau, et al. (2001). "Dendritic cells resurrect antigens from dead cells."
Trends Immunol 22(3): 141-8.
Lesage, S. and C. C. Goodnow (2001). "Organ-specific autoimmune disease: a deficiency of
tolerogenic stimulation." I Exp Med 194(5): F31-6.
- Letterio, J. J. and A. B. Roberts (1998). "Regulation of immune responses by TGF-beta." Annu
Rev Immunol 16:137-61.
Liu, K., T. Iyoda, et al. (2002). "Immune tolerance after delivery of dying cells to dendritic cells
in situ." T Exp Med 196(8): 1091-7.
Liu, L., M. Zhang, et al. (1998). "Dendritic cell heterogeneity in vivo: two functionally different
dendritic cell populations in rat intestinal lymph can be distinguished by CD4
expression." T Immunol 161(3): 1146-55.
Liu, S., Y. Yu, et al. (2001a). "The involvement of TNF-alpha-related apoptosis-inducing ligand
in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor
cells." I Immunol 166(9): 5407-15.
Liu, Y. J. (2001). "Dendritic cell subsets and lineages, and their functions in innate and adaptive
immunity." Cell 106(3): 259-62.
Liu, Y. J., H. Kanzler, et al. (2001b). "Dendritic cell lineage, plasticity and cross-regulation." Nat
Immunol 2(7): 585-9.
Lu, Q. and G. Lemke (2001). "Homeostatic regulation of the immune system by receptor tyrosine
kinases of the Tyro 3 family." Science 293(5528): 306-11.
Lu, Z., L. Yuan, et al. (2000). "CD40-independent pathways of T cell help for priming of CD8(+)
cytotoxic T lymphocytes." T Exp Med 191(3): 541-50.
Ludewig, B., A. F. Ochsenbein, et al. (2000). "Immunotherapy with dendritic cells directed
against tumor antigens shared with normal host cells results in severe autoimmune
disease." T Exp Med 191(5): 795-804.
Lutz, M. B., N. Kukutsch, et al. (1999). "An advanced culture method for generating large
quantities of highly pure dendritic cells from mouse bone marrow." I Immunol Methods
223(1): 77-92.
Magram, J., S. E. Connaughton, et al. (1996). "IL-12-deficient mice are defective in IFN gamma
production and type 1 cytokine responses." Immunity 4(5): 471-81.
Maldonado-Lopez, R., T. De Smedt, et al. (1999). "CD8alpha+ and CD8alpha- subclasses of




Marrack, P., J. Kappler, et al. (2001). "Autoimmune disease: why and where it occurs." Nat Med
7(8): 899-905.
Martin, D. A., L. Zheng, et al. (1999). "Defective CD95/APO-l/Fas signal complex formation in
the human autoimmune lymphoproliferative syndrome, type la." Proc Natl Acad Sci U
S A 96(8): 4552-7.
Martinez-Pomares, L., N. Piatt, et al. (1996). "Macrophage membrane molecules: markers of
tissue differentiation and heterogeneity." Immunobiology 195(4-5): 407-16.
Massague, J. (1998). "TGF-beta signal transduction." Arrnu Rev Biochem 67: 753-91.
Massague, J., S. W. Blain, et al. (2000). "TGFbeta signaling in growth control, cancer, and
heritable disorders." Cell 103(2): 295-309.
Matzinger, P. (1994). "Tolerance, danger, and the extended family." Annu Rev Immunol 12: 991-
1045.
Meagher, L. C., J. S. Savill, et al. (1992). "Phagocytosis of apoptotic neutrophils does not induce
macrophage release of thromboxane B2." T Leukoc Biol 52(3): 269-73.
Mellman, I. and R. M. Steinman (2001). "Dendritic cells: specialized and regulated antigen
processing machines." Cell 106(3): 255-8.
Mevorach, D. (2000). "Opsonization of apoptotic cells. Implications for uptake and
autoimmunity." Ann N Y Acad Sci 926: 226-35.
Mevorach, D., J. O. Mascarenhas, et al. (1998a). "Complement-dependent clearance of apoptotic
cells by human macrophages." I Exp Med 188(12): 2313-20.
Mevorach, D., J. L. Zhou, et al. (1998b). "Systemic exposure to irradiated apoptotic cells induces
autoantibody production." I Exp Med 188(2): 387-92.
Mills, C. D. (1991). "Molecular basis of "suppressor" macrophages. Arginine metabolism via the
nitric oxide synthetase pathway." T Immunol 146(8): 2719-23.
Mills, C. D., K. Kincaid, et al. (2000). "M-l/M-2 macrophages and the Thl/Th2 paradigm." I
Immunol 164(12): 6166-73.
Mitchell, D. A., M. C. Pickering, et al. (2002). "Clq Deficiency and Autoimmunity: The Effects of
Genetic Background on Disease Expression." Tournal of Immunology 168 (in press).
Morgan, D. J., H. T. Kreuwel, et al. (1999). "Antigen concentration and precursor frequency
determine the rate of CD8+ T cell tolerance to peripherally expressed antigens." J
Immunol 163(2): 723-7.
Moser, M. and K. M. Murphy (2000). "Dendritic cell regulation of TH1-TH2 development." Nat
Immunol 1(3): 199-205.
Mosser, D. M. and C. L. Karp (1999). "Receptor mediated subversion of macrophage cytokine
production by intracellular pathogens." Curr Opin Immunol 11(4): 406-11.
194
Bibliography
Moynault, A., M. F. Luciani, et al. (1998). "ABC1, the mammalian homologue of the engulfment
gene ced-7, is required during phagocytosis of both necrotic and apoptotic cells."
Biochem Soc Trans 26(4): 629-35.
Murphy-Ullrich, J. E., S. Schultz-Cherry, et al. (1992). "Transforming growth factor-beta
complexes with thrombospondin." Mol Biol Cell 3(2): 181-8.
Nagata, S. (1996). "Fas-induced apoptosis, and diseases caused by its abnormality." Genes Cells
1(10): 873-9.
Nagata, S. (1998). "Fiuman autoimmune lymphoproliferative syndrome, a defect in the
apoptosis-inducing Fas receptor: a lesson from the mouse model." 1 Hum Genet 43(1): 2-
8.
Napirei, M., H. Karsunky, et al. (2000). "Features of systemic lupus erythematosus in Dnasel-
deficient mice." Nat Genet 25(2): 177-81.
Nishimura, Y., Y. Hirabayashi, et al. (1997). "In vivo analysis of Fas antigen-mediated apoptosis:
effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver." Int Immunol 9(2):
307-16.
Norbury, C. C., B. J. Chambers, et al. (1997). "Constitutive macropinocytosis allows TAP-
dependent major histocompatibility complex class I presentation of exogenous soluble
antigen by bone marrow-derived dendritic cells." Eur T Immunol 27(1): 280-8.
O'Keeffe, M., H. Hochrein, et al. (2002a). "Mouse Plasmacytoid Cells: Long-lived Cells,
Heterogeneous in Surface Phenotype and Function, that Differentiate Into CD8(+)
Dendritic Cells Only after Microbial Stimulus." T Exp Med 196(10): 1307-1319.
O'Keeffe, M., H. Hochrein, et al. (2002b). "Dendritic cell precursor populations of mouse blood:
identification of the murine homologues of human blood plasmacytoid pre-DC2 and
CDllc+ DC1 precursors." Blood 10: 10.
O'Shea, J. J., A. Ma, et al. (2002). "Cytokines and autoimmunity." Nat Rev Immunol 2(1): 37-45.
Ogden, C. A., A. deCathelineau, et al. (2001). "Clq and mannose binding lectin engagement of
cell surface calreticulin and cd91 initiates macropinocytosis and uptake of apoptotic
cells." I Exp Med 194(6): 781-96.
Ohashi, P. S. (2002). "T-cell signalling and autoimmunity: molecular mechanisms of disease."
Nat Rev Immunol 2(6): 427-38.
Oka, K., T. Sawamura, et al. (1998). "Lectin-like oxidized low-density lipoprotein receptor 1
mediates phagocytosis of aged/apoptotic cells in endothelial cells." Proc Natl Acad Sci
USA 95(16): 9535-40.
Pickering, M. C., M. Botto, et al. (2000a). "Systemic lupus erythematosus, complement
deficiency, and apoptosis." Adv Immunol 76: 227-324.
Pickering, M. C. and M. J. Walport (2000b). "Links between complement abnormalities and
systemic lupus erythematosus." Rheumatology (Oxford-) 39(2): 133-41.
195
Bibliography
Pierre, P., S. J. Turley, et al. (1997). "Developmental regulation of MHC class II transport in
mouse dendritic cells." Nature 388(6644): 787-92.
Piatt, N., H. Suzuki, et al. (1996). "Role for the class A macrophage scavenger receptor in the
phagocytosis of apoptotic thymocytes in vitro." Proc Natl Acad Sci U S A 93(22): 12456-
60.
- Pooley, J. L., W. R. Heath, et al. (2001). "Cutting edge: intravenous soluble antigen is presented
to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+
dendritic cells." 1 Immunol 166(9): 5327-30.
"Pulendran, B., J. Banchereau, et al. (2001). "Modulating the immune response with dendritic
cells and their growth factors." Trends Immunol 22(1): 41-7.
Qureshi, S. T., L. Lariviere, et al. (1999). "Endotoxin-tolerant mice have mutations in Toll-like
receptor 4 (Tlr4)." 1 Exp Med 189(4): 615-25.
Randolph, G. J. (2002). "Is maturation required for Langerhans cell migration?" T Exp Med
196(4): 413-6.
Randolph, G. J., S. Beaulieu, et al. (1998). "Differentiation of monocytes into dendritic cells in a
model of transendothelial trafficking." Science 282(5388): 480-3.
Reddy, A., M. Sapp, et al. (1997). "A monocyte conditioned medium is more effective than
defined cytokines in mediating the terminal maturation of human dendritic cells." Blood
90(9): 3640-6.
Reis e Sousa, C. (2001). "Dendritic cells as sensors of infection." Immunity 14(5): 495-8.
Reis e Sousa, C., S. Hieny, et al. (1997). "In vivo microbial stimulation induces rapid CD40
ligand-independent production of interleukin 12 by dendritic cells and their
redistribution to T cell areas." 1 Exp Med 186(11): 1819-29.
Ren, Y., L. Stuart, et al. (2001). "Nonphlogistic clearance of late apoptotic neutrophils by
macrophages: efficient phagocytosis independent of beta 2 integrins." T Immunol 166(7):
4743-50.
Rescigno, M. and P. Borrow (2001). "The host-pathogen interaction: new themes from dendritic
cell biology." Cell 106(3): 267-70.
Reynolds, L. E., L. Wyder, et al. (2002). "Enhanced pathological angiogenesis in mice lacking
beta3 integrin or beta3 and beta5 integrins." Nat Med 8(1): 27-34.
Rodriguez, A., A. Regnault, et al. (1999a). "Selective transport of internalized antigens to the
cytosol for MHC class I presentation in dendritic cells." Nat Cell Biol 1(6): 362-8.
Rodriguez, A., A. Regnault, et al. (1999b). "Selective transport of internalized antigens to the
cytosol for MHC class I presentation in dendritic cells [see comments]." Nat Cell Biol
1(6): 362-8.
Ronchetti, A., P. Rovere, et al. (1999). "Immunogenicity of apoptotic cells in vivo: role of antigen
load, antigen-presenting cells, and cytokines." T Immunol 163(1): 130-6.
196
Bibliography
Rosen, A. and L. Casciola-Rosen (1999). "Autoantigens as substrates for apoptotic proteases:
implications for the pathogenesis of systemic autoimmune disease." Cell Death Differ
6(1): 6-12.
Rosen, A. and L. Casciola-Rosen (2001). "Clearing the way to mechanisms of autoimmunity."
Nat Med 7(6): 664-5.
Rossi, A. G., J. C. McCutcheon, et al. (1998). "Regulation of macrophage phagocytosis of
apoptotic cells by cAMP." I Immunol 160(7): 3562-8.
Rovere, P., G. Peri, et al. (2000). "The long pentraxin PTX3 binds to apoptotic cells and regulates
their clearance by antigen-presenting dendritic cells." Blood 96(13): 4300-6.
Rovere, P., C. Vallinoto, et al. (1998). "Bystander apoptosis triggers dendritic cell maturation and
antigen- presenting function." T Immunol 161(9): 4467-71.
Rubartelli, A., A. Poggi, et al. (1997). "The selective engulfment of apoptotic bodies by dendritic
cells is mediated by the alpha(v)beta3 integrin and requires intracellular and
extracellular calcium." Eur T Immunol 27(8): 1893-900.
Ryeom, S. W., J. R. Sparrow, et al. (1996). "CD36 participates in the phagocytosis of rod outer
segments by retinal pigment epithelium." T Cell Sci 109(Pt 2): 387-95.
Sauter, B., M. L. Albert, et al. (2000). "Consequences of cell death: exposure to necrotic tumor
cells, but not primary tissue cells or apoptotic cells, induces the maturation of
immunostimulatory dendritic cells." T Exp Med 191(3): 423-34.
Savill, J., I. Dransfield, et al. (1990). "Vitronectin receptor-mediated phagocytosis of cells
undergoing apoptosis." Nature 343(6254): 170-3.
Savill, J. and V. Fadok (2000a). "Corpse clearance defines the meaning of cell death." Nature
407(6805): 784-8.
Savill, J. and V. Fadok (2000b). "Corpse clearance defines the meaning of cell death [In Process
Citation]." Nature 407(6805): 784-8.
Savill, J., V. Fadok, et al. (1993). "Phagocyte recognition of cells undergoing apoptosis."
Immunol Today 14(3): 131-6.
Savill, J., N. Hogg, et al. (1992). "Thrombospondin cooperates with CD36 and the vitronectin
receptor in macrophage recognition of neutrophils undergoing apoptosis." T Clin Invest
90(4): 1513-22.
Schirmbeck, R., K. Melber, et al. (1995). "Hepatitis B virus small surface antigen particles are
processed in a novel endosomal pathway for major histocompatibility complex class I-
restricted epitope presentation." Eur T Immunol 25(4): 1063-70.
Schultz-Cherry, S. and J. E. Murphy-Ullrich (1993). "Thrombospondin causes activation of latent
transforming growth factor- beta secreted by endothelial cells by a novel mechanism." I
Cell Biol 122(4): 923-32.
197
Bibliography
Schulz, O., D. A. Edwards, et al. (2000). "CD40 triggering of heterodimeric IL-12 p70 production
by dendritic cells in vivo requires a microbial priming signal." Immunity 13(4): 453-62.
Schulz, O., D. J. Pennington, et al. (2002a). "CD36 or alphavbeta3 and alphavbeta5 integrins are
not essential for MHC class I cross-presentation of cell-associated antigen by CD8
alpha+ murine dendritic cells." I Immunol 168(12): 6057-65.
Schulz, O. and C. Reis e Sousa (2002b). "Cross-presentation of cell-associated antigens by
CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells."
Immunology 107(2): 183-9.
'
Scott, R. S., E. J. McMahon, et al. (2001). "Phagocytosis and clearance of apoptotic cells is
mediated by MER." Nature 411(6834): 207-11.
Shortman, K. (2000). "Burnet oration: dendritic cells: multiple subtypes, multiple origins,
multiple functions." Immunol Cell Biol 78(2): 161-5.
Shortman, K. and W. R. Heath (2001). "Immunity or tolerance? That is the question for dendritic
cells." Nat Immunol 2(11): 988-9.
Shortman, K. and Y. J. Liu (2002). "Mouse and human dendritic cell subtypes." Nat Rev
Immunol 2(3): 151-61.
Shull, M. M., I. Ormsby, et al. (1992). "Targeted disruption of the mouse transforming growth
factor-beta 1 gene results in multifocal inflammatory disease." Nature 359(6397): 693-9.
Silverstein, R. L., M. Baird, et al. (1992). "Sense and antisense cDNA transfection of CD36
(glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor." T Biol
Chem 267(23): 16607-12.
Singer, G. G. and A. K. Abbas (1994a). "The fas antigen is involved in peripheral but not thymic
deletion of T lymphocytes in T cell receptor transgenic mice." Immunity 1(5): 365-71.
Singer, G. G., A. C. Carrera, et al. (1994b). "Apoptosis, Fas and systemic autoimmunity: the
MRL-lpr/lpr model." Curr Opin Immunol 6(6): 913-20.
Sprent, J. and H. Kishimoto (2002). "The thymus and negative selection." Immunol Rev 185: 126-
35.
Srivastava, P. (2002a). "Interaction of heat shock proteins with peptides and antigen presenting
cells: chaperoning of the innate and adaptive immune responses." Annu Rev Immunol
20: 395-425.
Srivastava, P. (2002b). "Roles of heat-shock proteins in innate and adaptive immunity." Nat Rev
Immunol 2(3): 185-94.
Steinbrink, K., M. Wolfl, et al. (1997). "Induction of tolerance by IL-10-treated dendritic cells." I
Immunol 159(10): 4772-80.
Steinman, R. M. and M. Dhodapkar (2001). "Active immunization against cancer with dendritic
cells: the near future." Int T Cancer 94(4): 459-73.
198
Bibliography
Steinman, R. M., S. Turley, et al. (2000). "The induction of tolerance by dendritic cells that have
captured apoptotic cells." T Exp Med 191(3): 411-6.
Stuart, L., M. Lucas, et al. (2002). "Inhibitory effects of apoptotic cell ingestion upon endotoxin
driven myeloid dendritic cell maturation." T Immunol (in press) 168(4): 1627-35.
Suss, G. and K. Shortman (1996). "A subclass of dendritic cells kills CD4 T cells via Fas/Fas-
ligand- induced apoptosis." T Exp Med 183(4): 1789-96.
Sutterwala, F. S. and D. M. Mosser (1999). "The taming of IL-12: suppressing the production of
proinflammatory cytokines." T Leukoc Biol 65(5): 543-51.
Sutterwala, F. S., G. J. Noel, et al. (1998). "Reversal of proinflammatory responses by ligating the
macrophage Fcgamma receptor type I." I Exp Med 188(1): 217-22.
Sytwu, H. K., R. S. Liblau, et al. (1996). "The roles of Fas/APO-1 (CD95) and TNF in antigen-
induced programmed cell death in T cell receptor transgenic mice." Immunity 5(1): 17-
30.
Takai, T. (2002). "Roles of Fc receptors in autoimmunity." Nat Rev Immunol 2(8): 580-92.
Taylor, P. R., A. Carugati, et al. (2000). "A hierarchical role for classical pathway complement
proteins in the clearance of apoptotic cells in vivo." T Exp Med 192(3): 359-66.
Termeer, C., F. Benedix, et al. (2002). "Oligosaccharides of Hyaluronan activate dendritic cells
via toll-like receptor 4." I Exp Med 195(1): 99-111.
Thery, C., A. Regnault, et al. (1999). "Molecular characterization of dendritic cell-derived
. exosomes. Selective accumulation of the heat shock protein hsc73." T Cell Biol 147(3):
599-610.
Thery, C., L. Zitvogel, et al. (2002). "Exosomes: composition, biogenesis and function." Nat Rev
Immunol 2(8): 569-79.
Thornberry, N. A. (1997). "The caspase family of cysteine proteases." Br Med Bull 53(3): 478-90.
Trinchieri, G. (2003). "Interleukin-12 and the regulation of innate resistance and adaptive
immunity." Nat Rev Immunol 3(2): 133-46.
Trinite, B., C. Voisine, et al. (2000). "A subset of cytolytic dendritic cells in rat." T Immunol
165(8): 4202-8.
Turley, S. J., K. Inaba, et al. (2000). "Transport of peptide-MHC class II complexes in developing
dendritic cells." Science 288(5465): 522-7.
Urban, B. C., D. J. Ferguson, et al. (1999). "Plasmodium falciparum-infected erythrocytes
modulate the maturation of dendritic cells." Nature 400(6739): 73-7.
Urban, B. C., N. Willcox, et al. (2001). "A role for CD36 in the regulation of dendritic cell
function." Proc Natl Acad Sci U S A 98(15): 8750-5.
Vidalain, P. O., O. Azocar, et al. (2001). "Cytotoxic activity of human dendritic cells is




Voll, R. E., M. Herrmann, et al. (1997a). "Immunosuppressive effects of apoptotic cells." Nature
390(6658): 350-1.
Voll, R. E., M. Herrmann, et al. (1997b). "Immunosuppressive effects of apoptotic cells [letter]."
Nature 390(6658): 350-1.
Vremec, D., J. Pooley, et al. (2000). "CD4 and CD8 expression by dendritic cell subtypes in
mouse thymus and spleen." 1 Immunol 164(6): 2978-86.
Walker, L. S. and A. K. Abbas (2002). "The enemy within: keeping self-reactive T cells at bay in
the periphery." Nat Rev Immunol 2(1): 11-9.
Walport, M. J. (2000). "Lupus, DNase and defective disposal of cellular debris." Nat Genet 25(2):
135-6.
West, M. A., A. R. Prescott, et al. (2000). "Rac is required for constitutive macropinocytosis by
dendritic cells but does not control its downregulation." Curr Biol 10(14): 839-48.
Wintergerst, E. S., J. Jelk, et al. (2000). "Apoptosis induced by oxidized low density lipoprotein in
human monocyte- derived macrophages involves CD36 and activation of caspase-3."
Eur I Biochem 267(19): 6050-9.
Winzler, C., P. Rovere, et al. (1997). "Maturation stages of mouse dendritic cells in growth factor-
dependent long-term cultures." 1 Exp Med 185(2): 317-28.
Wolfers, J., A. Lozier, et al. (2001). "Tumor-derived exosomes are a source of shared tumor
rejection antigens for CTL cross-priming." Nat Med 7(3): 297-303.
Yamaguchi, Y., H. Tsumura, et al. (1997). "Contrasting effects of TGF-beta 1 and TNF-alpha on
the development of dendritic cells from progenitors in mouse bone marrow." Stem Cells
15(2): 144-53.
Yanagihara, S., E. Komura, et al. (1998). "EBI1/CCR7 is a new member of dendritic cell
chemokine receptor that is up-regulated upon maturation." 1 Immunol 161(6): 3096-102.
Yokota, K., K. Ariizumi, et al. (1996). "Cytokine-mediated communication between dendritic
epidermal T cells and Langerhans cells. In vitro studies using cell lines." 1 Immunol
157(4): 1529-37.
Yoshida, Y., K. Kang, et al. (1998). "Monocyte induction of IL-10 and down-regulation of IL-12
by iC3b deposited in ultraviolet-exposed human skin." 1 Immunol 161(11): 5873-9.
Yu, Y., S. Liu, et al. (2002). "Involvement of tumour necrosis factor-alpha-related apoptosis-
inducing ligand in enhanced cytotoxicity of lipopolysaccharide-stimulated dendritic
cells to activated T cells." Immunology 106(3): 308-15.
Zal, T., A. Volkmann, et al. (1994). "Mechanisms of tolerance induction in major
histocompatibility complex class Il-restricted T cells specific for a blood-borne self-
antigen." I Exp Med 180(6): 2089-99.
Zitvogel, L., A. Regnault, et al. (1998). "Eradication of established murine tumors using a novel
cell-free vaccine: dendritic cell-derived exosomes." Nat Med 4(5): 594-600.
200
Publications arising from this thesis
Stuart, L., M. Lucas, et al. (2002). "Inhibitory effects of apoptotic cell ingestion
upon endotoxin driven myeloid dendritic cell maturation." I Immunol 168(4):
1627-35.
Ren, Y., L. Stuart, et al. (2001). "Nonphlogistic clearance of late apoptotic
neutrophils by macrophages: efficient phagocytosis independent of beta 2
integrins." I Immunol 166(7): 4743-50.
Inhibitory Effects of Apoptotic Cell Ingestion upon
Endotoxin-Driven Myeloid Dendritic Cell Maturation1
Lynda M. Stuart,2 Mark Lucas, Cathy Simpson, Jonathan Lamb, John Savill, and
Adam Lacy-Hulbert
Dendritic cells (DCs) are the sentinels of the immune system, able to interact with both naive and memory T cells. The recent
observation that DCs can ingest cells dying by apoptosis has raised the possibility that DCs may, in fact, present self-derived Ags,
initiating both autoimmunity and tumor-specific responses, especially if associated with appropriate danger signals. Although the
process of ingestion of apoptotic cells has not been shown to induce DC maturation, the exact fate of these phagocytosing DCs
remains unclear. In this paper we demonstrate that DCs that ingest apoptotic cells are able to produce TNF-a but have a
diminished ability to produce IL-12 in response to external stimuli, a property that corresponds to a failure to up-regulate CD86.
By single-cell analysis we demonstrate that these inhibitory effects are restricted to those DCs that have engulfed apoptotic cells,
with bystander DCs remaining unaffected. These changes were independent of the production of anti-inflammatory cytokines
TGF-/31 and IL-10 and corresponded with a diminished capacity to stimulate naive T cells. Thus, the ingestion of apoptotic cells
is not an immunologically null event but is capable of modulating DC maturation. These results have important implications for
our understanding of the role of clearance of dying cells by DCs not only in the normal resolution of inflammation but also in
control of subsequent immune responses to apoptotic cell-derived Ags. The Journal of Immunology, 2002, 168: 1627-1635.
Dendritic cells (DCs)3 are the sentinels of the adaptiveimmune system and have an important role not only ininduction of immunity but also in maintenance of toler¬
ance (1). Immature DCs exist in the periphery, where they capture
and process exogenous Ag. Upon receipt of maturation stimuli
they migrate to draining lymph nodes, a process associated with
phenotypic changes, including down-regulation of their Ag-cap-
turing machinery, up-regulation of MHC and costimulatory mol¬
ecules, and production of IL-12, becoming fully functional APC
(2). This maturation process is affected by a variety of endogenous
or exogenous factors and can be modeled in vitro by LPS and other
bacterial products (3).
Immature DCs acquire Ag by many pathways including uptake
of soluble Ag or protein complexes by endocytosis and macropi-
nocytosis and ingestion of entire cells by phagocytosis. Ingestion
of certain necrotic cells is capable of inducing DC maturation,
while ingesting apoptotic cells fails to activate DCs, appearing to
be an immunologically null event (4, 5). However, such DCs are
capable of responding to strong external stimuli, such as mono-
cyte-conditioned medium or IFN-y, to mature and present Ag de¬
rived from the ingested apoptotic cells to T cells (6-9). Apoptotic
cells are a preferential source of many autoantigens (10), often
found localized to apoptotic blebs, and the ability of DCs to
Medical Research Council Center for Inflammation Research, University of Edin¬
burgh, Edinburgh, Scotland, United Kingdom
Received for publication September 6, 2001. Accepted for publication December
12, 2001.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1 L.M.S. was supported by Wellcome Trust Clinical Training Fellowship 34842, and
J.S. was supported by Wellcome Program Grant 34561.
2 Address correspondence and reprint requests to Dr. Lynda M. Stuart, Medical Re¬
search Council Center for Inflammation Research, University of Edinburgh, Teviot
Place, Edinburgh, Scotland, U.K. EH8 9AG. E-mail address: lynda.stuart@ed.ac.uk
3 Abbreviations used in this paper: DC, dendritic cell; ac, apoptotic cell; SAC, Staph¬
ylococcus aureus (Cowan strain).
present such Ags unchecked might initiate autoimmunity. In sup¬
port of this, perturbations in apoptotic cell death and clearance of
these cells have been shown to contribute to the induction of au¬
toimmunity (11, 12).
However, a growing body of evidence implicates DCs that in¬
gest dying cells in maintaining self-tolerance, by constantly sam¬
pling peripheral self Ags and presenting them in a tolerogenic way
to the adaptive immune system. Thus, a dichotomy exists in re¬
sponses of DCs that may be either "friend or foe" (13). The ability
of a DC to deliver "signal 2," either as costimulation or IL-12,
singly or in combination, appears key in determining subsequent
immune responses and is likely to be tightly controlled. Interest¬
ingly, the ingestion of apoptotic cells by macrophages generates an
active anti-inflammatory response through the production of
TGF-/31 and other anti-inflammatory molecules and down-regu¬
lates subsequent release of proinflammatory cytokines (14-16).
Because of the close lineage relationship of macrophages and my¬
eloid DCs, we postulated that apoptotic cell ingestion by DCs
might similarly modulate their effector functions.
In this paper we confirm that immature murine bone marrow-
derived DCs ingest apoptotic cells and, after phagocytosis, become
functionally distinct. We demonstrate that endotoxin-induced pro¬
duction of IL-12, but not TNF-a, is selectively diminished in DCs
that have ingested apoptotic cells. In addition, endotoxin-driven
up-regulation of the costimulatory molecule CD86 is inhibited in
those DCs that had phagocytosed apoptotic cells, but not in neigh¬
boring DCs. We show the functional consequences of these
changes by demonstrating that these DCs have a reduced capacity
to stimulate T cell proliferation. Thus, phagocytosis of apoptotic
cells affects subsequent maturation of DCs in a manner analogous
to the anti-inflammatory effects in macrophages, generating ma¬
ture, CD86low cells that produce less IL-12. These data confirm
that the apoptotic cell is not immunologically null, but, by inhib¬
iting DC activation, may contribute to down-regulation of the re¬
sponse to apoptotic cell-derived self Ag and maintenance of self
tolerance.
Copyright © 2002 by The American Association of Immunologists 0022-1767/02/$02.00
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Materials and Methods
Mice
BALB/c mice were purchased from B & K Universal (Hull, U.K.) and were
used at 8 wk for bone marrow-derived DC and macrophage preparation. T
cells were isolated from the DO 11.10 transgenic mice expressing TCR
specific for the chicken OVA peptide, OVA323_339, in association with
1-Ad. The mice were typed for the presence of the transgene using Abs
against CD4 (BD PharMingen, San Diego, CA) and biotin peak 2 (KJ1 -26;
Scottish Antibody Production Unit, Lanarkshire, U.K.) and streptavidin-PE
(BD PharMingen) on PBL.
DC and macrophage culture
Murine cells were cultured in RPMI 1640 supplemented with 2 mM l-
glutamine, 100 U/ml penicillin, 100 /xg/ml streptomycin, 5 X 10-5 M
2-ME, and 15% heat-inactivated FBS unless otherwise stated. DC com¬
plete medium also contained 10-15% conditioned supernatant from a hy-
bridoma (gift from Prof. D. Gray, Edinburgh, U.K.) expressing rGM-CSF,
resulting in a final GM-CSF concentration of 20-30 ng/ml. This hybrid-
oma also produces IL-10, at a final concentration of ~2 ng/ml, but no
TNF-a or IL-12. All culture reagents were obtained from Life Technolo¬
gies (Grand Island, NY) unless otherwise stated.
DCs were cultured as described previously (17). Briefly, femurs from
BALB/c mice were removed, dipped in 70% ethanol for 10 s, and then
placed in DC complete medium. Bone marrow was flushed from femurs,
and 10 ml of a single-cell suspension of bone marrow cells at 2 X 105/ml
was plated in non-tissue culture grade petri dishes. On day 3 an additional
10 ml of fresh medium was added to the cultures. On day 6 half the me¬
dium was removed, and the cells were pelleted, resuspended in fresh me¬
dium, and added back to the petri dishes. On day 7 nonadherent cells were
removed, leaving strongly adherent macrophages on the plate. These cells
were pelleted, resuspended at 2 X 105 cells/ml, and replated before use. On
day 7 these were a heterogeneous population, 65-80% of the cells having
surface phenotype and morphology of immature DCs (Fig. 1A), with gran¬
ulocytes being the main contaminant. Maturation was initiated on day 7
with 0.1-1 /xg/ml LPS (Escherichia coli serotype 026:B6; Sigma-Aldrich,
St. Louis, MO) or 0.02% (w/v) Staphylococcus aureus (Cowan strain)
(SAC; Calbiochem, La Jolla, CA) (3), and cells were assessed on day 8.
Bone marrow-derived macrophages were cultured in DMEM supple¬
mented with 2 mM L-glutamine, 100 U/ml penicillin, 100 /xg/ml strepto¬
mycin, 10% heat-inactivated FBS, and 10% conditioned supernatant from
L929 cells, which was changed on day 2 of culture. Macrophages were
used for experiments on day 7 of culture.
Generation ofapoptotic cells
Neutrophils were extracted from peripheral blood of healthy volunteers as
described previously (18). Briefly, blood was separated using dextran sed¬
imentation and a Percoll gradient. This yielded highly pure human neutro¬
phils (>90%), which were allowed to undergo constitutive apoptosis by
aging overnight in Iscove's medium supplemented with 100 U/ml penicil¬
lin, 100 /xg/ml streptomycin, and 10% autologous serum. After this period
the cells were 40-80% apoptotic by cytospin morphology. This method of
generating apoptotic bodies was preferred because there was no significant
necrosis (<1%) by trypan blue exclusion, as confirmed by annexin-pro-
pidium iodide staining and flow cytometry. Apoptotic murine thymocytes
were also generated for use in some experiments by treating single-cell
suspensions of thymocytes with dexamethasone for 4-6 h. This method
yielded apoptotic cells, but these preparations often contained contaminat¬
ing postapoptotic cells and other nonapoptotic thymic cells. For most ex¬
periments cells were stained using a green cell tracker dye (Molecular
Probes, Eugene, OR) before overnight culture.
DC-apoptotic cell coculture
Fluorescently labeled apoptotic cells were cocultured with day 7 DCs at a
ratio of 2-5:1, apoptotic cells:DC. Interaction of DCs with apoptotic cells
was assessed by removing cells after 2 h and staining with allophycocya-
nin-CDllc for FACS analysis. All FACS analyses were conducted on a
FACSCalibur flow cytometer (BD Biosciences, Mountain View, CA).
Maximum interaction was seen at ratios of 5:1 apoptotic cells/DCs, but the
large numbers of uningested apoptotic cells reduced the efficiency of cell
sorting, so ratios of 2:1 were used in most experiments. For fluorescent
microscopy DCs were grown on chamber well slides, allowed to interact
with red fluorescent apoptotic cells, then fixed with 4% paraformaldehyde.
Slides were stained in PBS with 0.5% BSA and 0.2% sodium azide with
I-Ad-FITC (BD PharMingen) in the presence of 10% normal mouse serum.
Slides were mounted and examined under X63 oil lens using an inverted
microscope (Zeiss, New York, NY), and images were captured using Open
Lab software (Improvision, Coventry, U.K.) and CoolSnap digital camera
(Media Cybernetics, Silver Spring, MD).
T cell proliferation assays
CD4 T cells were isolated from spleens of DO11.10 transgenic mice. In
brief, spleens were made into a single-cell suspension by passing through
a 53-/xm pore size filter in PBS, and debris and red cells were removed by
density gradient sedimentation through Lympholyte-M (Cedarlane Labo¬
ratories, Ontario, Canada) according to the manufacturer's instructions.
Cells were then isolated using L3T4 (CD4) microbeads and the MACS
purification system (Miltenyi Biotec, Auburn, CA). Day 7 DCs were cocul¬
tured with apoptotic cells for 4 h, stimulated with LPS overnight, and then
pulsed with 5 /xg/ml OVA peptide (OVA323_339; Albachem Laboratories,
Edinburgh University, Edinburgh, U.K.) for 2 h. They were then washed
thoroughly, and cells were sorted into DCs containing apoptotic cells and
those not, using a FACSVantage cell sorter (BD Biosciences). Contami¬
nating apoptotic cells could be excluded from the sort by their smaller size
and bright fluorescence. OVA-TCR-transgenic T cells (3 X 105) were
cocultured in 24-well tissue culture dishes with varying doses of DCs for
5 days in a final volume of 2 ml. Proliferation was assessed by removing
triplicate 100-/xl samples pulsed with 1 /xCi/well [3H]thymidine (Sigma-
Aldrich) for 16 h. Cells were harvested, and thymidine incorporation was
measured using a scintillation counter. Interactions were performed in
duplicate.
FACS analysis of costimulatory molecules
DCs were cocultured with apoptotic cells for 4 h before overnight stimu¬
lation with LPS. Nonadherent cells were then removed from plates and
resuspended in PBS with 0.5% BSA and 0.2% sodium azide. Blocking was
performed using 10% mouse serum for 15 min, then cells were stained with
relevant Abs at 4°C in the dark for 30 min. Cells were then washed and
resuspended in 200 /xl of FACS wash and analyzed using FACSCalibur
and FlowJo software. The following Abs were used (all from BD Phar¬
Mingen unless otherwise stated): FITC-I-Ad/I-Ed, PE-CD40, PE-CD86,
PE-CD54, PE-CD1 lc, allophycocyanin-CDl lc, and FITC-F4/80 (Serotec,
Oxford, U.K.). All samples were compared with appropriate isotype con¬
trols. The geometric mean fluorescence of cells positive to isotype control
was used in analysis unless stated otherwise.
Cytokine detection
For intracellular cytokine staining, cells were cocultured with apoptotic
cells for 4 h and stimulated with LPS for 5 h in the presence of GolgiPlug
(BD PharMingen) according to the manufacturer's instructions. Cells were
harvested and stained for cell surface markers as described above. Cells
were then fixed using 4% paraformaldehyde and permeabilized with 2%
saponin in PBS with 0.5% BSA, 0.2% sodium azide, and 10% mouse
serum while staining with allophycocyanin-TNF-o:, IL-10, and IL-12p40/
p70 (BD PharMingen). IL-10 could not be reliably detected above back¬
ground by intracellular staining and so was also measured in the superna¬
tant after 24-48 h of interaction with apoptotic cells and LPS using a
Quantakine ELISA kit (R&D Systems, Minneapolis, MN). Interactions
were performed in duplicate wells, and triplicate readings of each super¬
natant were made. Soluble forms of IL-10 and TGF-/3R were obtained from
R&D Systems and used at the recommended concentrations (1.25 and 0.5
/xg/ml, respectively).
Results
Immature murine myeloid DCs ingest apoptotic cells
Day 7 murine myeloid DCs cultured as described above were im¬
mature by cell surface phenotype (CDllc+MHC class
II+CD40~CD80'OWCD86'OW) and could be matured (as evidenced
by up-regulation of costimulatory molecules and MHC class II)
over 24 h by the addition of LPS in a dose-dependent manner (Fig.
1/4). Similar results were seen by stimulation with SAC (data not
shown). Apoptotic cells stained with a fluorescent cell-tracker dye
were cultured with DCs at a ratio of 5:1, and interactions with DCs
were quantified by flow cytometry. In a typical experiment, 2 h
after coincubation —50% of CDllc+ cells had interacted with
apoptotic cells. Such interaction was exhibited by <5% of DCs at
4°C, demonstrating that the interaction assay used predominantly
detected phagocytosis rather than binding (Fig. IB). Ingestion was
further confirmed by fluorescence microscopy (Fig. 1C). Similar





FIGURE 1. Immature murine myeloid DCs ingest apoptotic cells. A, DCs cultured as described are immature on day 7, as assessed by levels of
expression of costimulatory molecules and MHC class II. Stimulation by LPS for 24 h induced a mature phenotype in a dose-dependent manner. DCs were
prepared as described in Materials and Methods and stimulated with 0 (thin lines), 0.1 (dashed lines), or 0.5 /xg/ml (thick lines) LPS for 24 h and assessed
by flow cytometry. Isotype controls are omitted for clarity but sit in the first log order of fluorescence. Data shown are from one experiment, representative
of at least five similar experiments. B, Immature DCs were incubated with fluorescently labeled apoptotic neutrophils at a ratio of 1:5. Flow cytometric assay
of interaction between DCs and apoptotic cells demonstrating at 37°C green fluorescence of phagocytic DC, which was almost completely inhibited at 4°C.
Events were gated for CD1 lc-positive cells and were representative of at least three experiments. C, DC were incubated with fluorescent apoptotic cells
and counterstained with FITC-conjugated I-Ad/I-Ed (MHC II). By fluorescence microscopy, red fluorescent apoptotic bodies interact with MHC II-positive
DCs (green) and, after internalization by a DC, change their fluorescent properties (arrow). Original magnification, X63 oil. Scale bar represents 10 /xm.
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rates of phagocytosis were seen when dexamethasone-treated mu¬
rine thymocytes were used as an alternative source of apoptotic
cells (data not shown). Thus, immature murine DCs exhibited a
capacity for phagocytosis of apoptotic cells similar in magnitude to
that reported in studies of immature human DC (7, 8).
Ingestion of apoptotic cells specifically inhibits the ability of
DCs to up-regulate CD86
To ascertain whether ingestion of apoptotic cells alters DC phe-
notype, cell surface expression of activation markers was studied
by flow cytometry after phagocytosis. No significant dilference in
cell surface expression of the costimulatory molecules CD40,
CD80, and CD86 was seen between immature DCs that had in¬
gested apoptotic cells (ac+) and those that had not (ac~) either
immediately (2 h, data not shown) or 24 h (Fig. 2) after phagocy¬
tosis, confirming that ingestion of apoptotic cells did not activate
DCs. However, on DC maturation with LPS a marked difference in
surface expression of CD86 was detected between ac+ DCs and
ac~ DCs. Immature DCs were predominantly CD86'ow, with a
small population of CD86hlgh cells. Upon maturation driven by
LPS the proportion of CD86h,gh cells increased in a dose-depen¬
dent manner (Fig. 1 A). However, fewer ac+ DCs became CD86h,gh
compared with ac~ DCs; in a typical experiment at 0.1 /eg/ml LPS
only 13.2% of ac+ DCs became CD86h,Eh vs 42% ac~ DCs, and
this difference was maintained at the highest LPS dose of 0.5 yxg/
ml, with only 24% of ac+ DCs becoming CD86h,gh compared with
46% of ac~ DCs (Fig. 2). Similar results were seen when DCs
were matured with SAC (data not shown). Mature DCs were het¬
erogeneous for CD54 with distinct populations of CD54low and
CD54hlgh cells, becoming most apparent at the highest dose of LPS
(0.5 /rg/ml). Despite the general increase in fluorescent intensity of
the ac+ DCs after phagocytosis, it is apparent that the percentage
of CD54hlgh cells was lower in ac+ than ac~ populations (Fig. 2).
CD40 expression was unaffected by apoptotic cells, with matura¬
tion in response to 0.5 /xg/ml generating a single CD40+ popula¬
tion (Fig. 2), and no statistically significant difference was seen in
MHC class II or CD80 expression (data not shown). Hence, the
failure to up-regulate CD86 in the ac+ DCs was not due to general
unresponsiveness to LPS but appeared to affect a subset of co-
stimulatory molecules.
Failure to up-regulate CD86 expression in ac+ DCs could reflect
preferential ingestion of apoptotic cells by a subpopulation of DCs
destined not to become CD86hlgh in response to maturation stimuli.
However, when the mean CD86 fluorescence for the whole DC
population was compared between DCs matured in the presence or
the absence of apoptotic cells (Fig. 3, A and B), the presence of
apoptotic cells resulted in significantly lower CD86 fluorescence
for the whole DC population compared with the control. No such
difference would have been detectable had the capacity to ingest
apoptotic cells merely marked a subpopulation of DCs destined not
to up-regulate CD86 in response to LPS. This and the observation
that no significant difference in costimulatory molecule expression
was detected between the ac+ DCs and ac~ DC population im¬
mediately after ingestion (data not shown) support the fact that
phagocytosis had not preferentially occurred in a subpopulation
destined to be CD86low. Also, this inhibitory effect was not merely
a result of particle ingestion, as immature DCs, when cocultured
with latex beads and oxidized lipid, showed remarkably high levels
(>85%) of phagocytosis and endocytosis, respectively, and exhib¬
ited no defect in LPS-driven up-regulation of CD86 expression,
exhibiting, instead, apparently enhanced expression (Fig. 3C).
Taken together these data support the hypothesis that apoptotic cell
Control
FIGURE 2. DCs that have internalized ap¬
optotic cells, but not control particles, fail to
up-regulate CD86 normally in response to
LPS or SAC, but up-regulate other markers,
such as CD40 and CD54. DCs were incu¬
bated with green fluorescent apoptotic cells,
matured with LPS, and stained for surface co¬
stimulatory molecules. DCs were gated into
ac+ (filled histogram) and ac (open histo¬
gram) by incorporation of green fluorescence.
Isotype control Abs are not shown for clarity
but sat in the first log order of fluorescence
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FIGURE 3. Surface CD86 expression of bulk DC cultures containing
both ac+ DCs and ac~ DCs was inhibited by apoptotic cells. DCs were
incubated with apoptotic cells and subsequently matured with SAC
(0.02%, w/v; A) or LPS (0.1 fig/ml; B). Surface CD86 expression was
measured by FACS and is expressed as mean fluorescence relative to con¬
trol unstimulated DCs. Relative fluorescence of DCs cocultured with ap¬
optotic cells (□) or medium alone (■) is shown, demonstrating that apo¬
ptotic cells can suppress both LPS- and SAC-driven DC maturation.
Apoptotic cells were excluded from FACS analysis on the basis of small
size and bright green fluorescence. The mean fluorescence ± SD for trip¬
licate measurements from one culture is shown. Similar results were seen
in three (SAC) or five (LPS) independent experiments. *, p < 0.05 (by
ANOVA). C, DCs were cultured with latex beads (□) or oxidized LDL
(HI); compared with incubation with no particles (■), these control particles
augmented, rather than decreased, CD86 expression. The mean fluores¬
cence of duplicate cultures is shown, and similar results were seen in two
independent experiments.
ingestion alters the subsequent response of DCs to maturation
stimuli.
Ingestion of apoptotic cells modulates proinflammatory cytokine
expression by DCs
Cytokines produced by DCs are especially important in determin¬
ing subsequent T cell responses. We therefore examined the effect
of ingestion of apoptotic cells on cytokine production by DCs by
combining the fluorescent phagocytosis assay and intracellular cy¬
tokine staining of cells, allowing us to study the production of
cytokines by individual DCs (Fig. 4). The autocrine response to
TNF-a produced after LPS stimulation is an important factor in
terminal maturation and activation of DCs as well as recruitment
and activation of neighboring effector cells. Interestingly, virtually
all the DCs containing apoptotic cells expressed TNF-a after stim¬
ulation with LPS for 5 h, demonstrating their functional viability
and continuing responsiveness to LPS stimulation. A small popu¬
lation of the ac~ DCs failed to produce TNF-a and probably rep¬
resented a population of fully matured or "exhausted" DCs (19)
(Fig. 4). IL-12 is produced predominately by DCs and orchestrates
both the innate and adaptive immune responses. DCs express a
functional IL-12R, ligation of which by bioactive IL-12p70 aug¬
ments LPS maturation. In contrast to TNF-a, ac+ DCs failed to
express IL-12 even when stimulated with 0.5 jiig/ml LPS (Fig. 4).
Similar results were seen when DCs were stimulated with SAC
(data not shown).
Inhibitory effects of apoptotic cells on DCs are not mediated by
autocrine/paracrine effects of IL-10 or TGF-fil
IL-10 is an important anti-inflammatory cytokine associated with
induction of tolerance, resolution of inflammation, inhibition of
production of proinflammatory cytokines, and DC maturation (20).
IL-10 has been shown to inhibit DC maturation, acting in both a
paracrine and an autocrine manner (21). Interaction of apoptotic
cells with monocytes (22), but not macrophages (14), has been
shown to induce the production of IL-10. To investigate whether
changes in IL-10 expression by DCs ingesting apoptotic cells
might contribute to the different phenotype, intracellular IL-10
production and release into the supernatant were studied. IL-10
was detectable in DC culture supernatant but was unaffected by
interaction with apoptotic cells or the addition of LPS (Fig. 5x4).
Intracellular IL-10 was difficult to detect reliably over background
staining, and no differences in levels of IL-10 staining between ac+
and ac~ DCs were detectable (data not shown). Furthermore,
blockade of functional IL-10 by soluble IL-10R did not differen¬
tially affect costimulatory molecule expression in the two DC sub-
populations (data not shown). Finally, LPS activation of DCs de¬
rived from bone marrow of IL-10-deficient mice was also inhibited
by the ingestion of apoptotic cells. Interestingly, these DCs dem¬
onstrated a heightened responsiveness to LPS, confirming an au¬
tocrine feedback role for IL-10 in DC maturation (Fig. 5B).
TGF/3-1 is another important inhibitory cytokine implicated in
anti-inflammatory effects of apoptotic cells. TGF-j3 is found in
apoptotic cells, preferentially localized to the mitochondria (23), as
well as being secreted by macrophages ingesting apoptotic cells
(14-16). Although TGF-/31 could be found in our culture super-
natants, levels of serum contamination made determining its origin
difficult (data not shown). However, when a soluble TGF-/3R was
used to neutralize active TGF-/31 released by DCs they were still
inhibited after ingesting apoptotic cells (Fig. 5C). In contrast, sol¬
uble TGF-J3R was capable of blocking inhibition of TNF-a pro¬
duction by macrophages that had ingested apoptotic cells in a par¬
allel system (Fig. 5D). Taken together these data mitigate against
a role for autocrine IL-10 or TGF-/31 in inhibiting the DC response
to LPS while confirming the previously reported role forTGF-/3 in
the inhibition of macrophages that have ingested apoptotic cells.
Ingestion of apoptotic cells generates DCs with diminished
capacity to sustain Ag-dependent unprimed T cell proliferation
despite LPS maturation
To determine whether these cytokine and surface CD86 differences
reflected a distinct functional phenotype of DCs, we chose to ex¬
amine the capacity of ac_ DCs and ac+ DCs to sustain Ag-de¬
pendent naive T cell proliferation, a process critically dependent
on IL-12 production and expression of costimulatory molecules.
The use of unprimed T cells from DOl 1.10 TCR-transgenic mice
allowed us directly to compare T cell proliferation in response
to mature ac+ DCs vs ac~ DCs, pulsed in both cases with
OVA323_339 peptide after LPS maturation. Interestingly, ac+ DCs
retained the ability to sustain naive T cell proliferation but were
only —30% as effective as stimulators compared with ac~ DCs or
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FIGURE 4. Apoptotic cells inhibit IL-12 production, but not TNF-a production, by LPS-stimulated DCs. DCs were incubated with green fluorescent
apoptotic cells and stimulated with LPS. Intracellular cytokine production was measured after 4 h by FACS analysis gated on CD1 lc-positive cells (DCs).
DCs that have ingested apoptotic cells can be distinguished by the incorporation of green fluorescence. The quadrant markers are set on isotype control
Abs (cytokine) or DCs prepared without apoptotic cells (phagocytosis), and figures give the percentage of cells in each quadrant. The data are representative
of three independent experiments.
DCs matured without apoptotic cells when cultured at a ratio of
10:1, Tcells:DCs (Fig. 6).
Discussion
The data presented demonstrate that DC ingestion of apoptotic
cells, but not control particles, results in subsequent down-regula¬
tion of LPS-driven IL-12 production and CD86 expression. Fur¬
thermore, this correlated with impaired Ag-dependent T cell acti¬
vation in vitro. Interestingly, these effects were restricted to those
DCs that had ingested apoptotic cells and were not due to anti¬
inflammatory cytokine production, implicating ligation of specific
phagocytic receptors in this process.
Bone marrow-derived DCs and macrophages arise from com¬
mon myeloid precursors and share many characteristics while
maintaining subtle differences in responses and effector functions.
Ingestion of apoptotic cells stimulates macrophages to adopt an
anti-inflammatory phenotype, inhibiting LPS-induced release of
TNF-a and up-regulating release of TGF-/31 and other anti¬
inflammatory mediators (24, 25). Furthermore, previous reports
and our unpublished data emphasize that this phenotypic change in
macrophages ingesting apoptotic cells is spread to surrounding
cells through the paracrine action of cytokine release triggered by
the ingestion of apoptotic cells. This is in contrast to the response
of DCs ingesting apoptotic cells, which, in this current study, did
not affect the ability of neighboring DCs that had not ingested
apoptotic cells to mature or stimulate T cells. This would implicate
a direct and cell-specific effect of apoptotic cell ingestion on DC
expression of CD86 and cytokine production, rather than a para¬
crine effect of secreted anti-inflammatory cytokines. Our data lend
weight to the possibility that the different recognition mechanisms
employed for ingestion of apoptotic cells by monocyte-derived
phagocytes might determine the different responses seen between
macrophages and DCs (7, 26), although we have not set out to
define the receptors for apoptotic cells implicated in the inhibition
of DC maturation in this study. The preferential inhibition of IL-12
has been demonstrated by ligation of a large number of phagocytic
receptors used by macrophages, including some that are also ex¬
pressed on DCs (27, 28). The CD36/integrin av05/thrombospondin
complex has been implicated as the major receptor for apoptotic
cells in DC phagocytosis, and recently binding of both malaria-
infected erythrocytes (29) or apoptotic cells (30) to this complex
has been shown to inhibit human DC maturation. Although these
studies did not address whether apoptotic cell internalization must
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FIGURE 5. The secretion of anti-inflammatory cytokines, IL-10 and
TGF-/3, is not responsible for the observed changes in DC function. A,
Apoptotic cells do not induce the release of IL-10 from DCs. Twenty-four-
hour supernatants from control DCs (■) and DCs cocultured with apoptotic
cells (□) stimulated with varying doses of LPS were assayed for IL-10 by
ELISA. The mean ± SD of triplicate measurements from one culture su¬
pernatant is shown. Constitutive amounts of IL-10 detected in fresh me¬
dium containing hybridoma supernatant is shown (media) as baseline. Sim¬
ilar results were seen in three independent experiments. B, DCs derived
from bone marrow of IL-10_/~ mice were also inhibited by apoptotic cells.
WT DCs with (□) and without (■) apoptotic cells demonstrate inhibition
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FIGURE 6. Ag-driven T cell stimulation was diminished in DCs that
ingested apoptotic cells despite LPS stimulation. Mature DCs were pulsed
with OVA323_339 peptide, sorted into ac" (■) and ac+ (•) cells, and in¬
cubated with T cells from DO11.10 mice. DCs that had not been incubated
with apoptotic cells are included as a control (□). T cell proliferation was
measured by [3H]thymidine incorporation. A, Proliferation in response to
different T cell:DC ratios, measured after 3 days of interaction. B, Time
course of T cell/DC interaction demonstrated inhibition at all time points.
Background proliferation in the absence of OVA peptide was <2000 cpm
in all experiments. The mean ± SD from triplicate measurements in one
experiment, representative of three independent experiments, are shown.
occur, our data imply that a direct interaction is necessary for these
effects to be seen.
Apoptotic cells are poorly immunogenic and, unless they over¬
load normal clearance mechanisms (probably becoming second¬
arily necrotic) or are associated with danger signals, rarely incite
an immune response (31). Furthermore, UV irradiation, character¬
ized by widespread apoptosis, is associated with generalized im¬
munological hyporesponsiveness, demonstrating a potential im¬
munosuppressive effect of apoptotic cells on the adaptive immune
system. In an interesting recent report, injection of apoptotic cells
was able to promote bone marrow engraftment even across MHC
barriers in a species-independent manner (32). Although the exact
mechanisms of immunosuppression in such systems are not fully
understood, a bone marrow-derived cell, likely to be the DC, has
been implicated. Exactly how this occurs is controversial, but an
increasingly accepted view is that the immature DC, with low lev¬
els of costimulatory molecule expression, would fail to deliver
incubated with or without apoptotic cells. Note the generally higher levels
of expression of CD86 in IL-10-deficient DCs. Data are the mean ± SD
from triplicate wells from one knockout or wild-type mouse representative
of four similar mice. The presence of TGF-/3 soluble receptor (C) does not
affect the inhibitory capacity of apoptotic cells. DCs were cultured with
apoptotic cells as described in Materials and Methods in the presence or
the absence of TGF-/3 soluble receptor. Data are the mean ± SD from
triplicate wells from one culture. Similar results were seen in two inde¬
pendent experiments. D, TGF-/3 soluble receptor does inhibit the effect of
apoptotic cell ingestion on TNF-a production by LPS-stimulated mouse
bone marrow-derived macrophages. Macrophages were incubated with
LPS (1 /xg/ml) and/or apoptotic cells, and TNF-a production was measured
by ELISA after 24 h.
1634 INHIBITORY EFFECTS OF APOPTOTIC CELLS ON DCs
signal 2 and induce anergy or deletion of an interacting T cell. In
support of this, repeated immunization with immature DCs does
appear to induce Treg/Trl cells. In contrast, mature DCs, which
are able to secrete a potent stimulatory cytokine, IL-12, and ex¬
press high levels of costimulatory molecule expression, induce
strong adaptive immunity. IL-12 has been shown to have a myriad
of functions, including modulating Thl vs Th2 switching, activa¬
tion of NK cells, and production of IFN-y. Furthermore, the au¬
tocrine effects of IL-12 have been shown to augment DC responses
to exogenous stimuli, underscoring the importance of this cytokine
in DC effector functions and the subsequent adaptive immune re¬
sponse. Although failure of ac+ DCs to produce high levels of
IL-12 might contribute to some of the subsequent phenotypic
changes, including diminished T cell stimulation, we have no di¬
rect evidence of whether this is indeed the case and is the subject
of ongoing investigation. Nevertheless, failure to produce IL-12
after apoptotic cell ingestion appears to correlate closely with these
changes.
The importance of ingestion of apoptotic cells by DCs is un¬
derscored by circumstantial evidence implicating such DCs in
maintaining tolerance. For example, a specific population of rat
lymph DCs, characterized by being OX41~CD4~, has been de¬
scribed. These cells represent a major population found in the
lymph draining the intestinal epithelium and have blunt pseudo-
podia and coarse granular inclusions, identified as being derived
from apoptotic intestinal epithelial cells. Functionally, these
OX41 ~CD4~ rat lymph DCs also demonstrate an impaired ability
to stimulate T cells in vitro and have been implicated in the ability
of the gut to handle large amounts of foreign Ags in a tolerogenic
fashion (33-35). Interestingly, our in vitro cultured ac+ DCs also
share some of these physical characteristics with the OX41 ~CD4~
rat lymph DCs (our personal observations). While comparisons
between in vivo/ex vivo studies of rat DCs and our in vitro work
on murine DCs need to be made with caution, taken together these
data lend strong support to the concept that ingestion of apoptotic
cells by DCs modulates their function.
In conclusion, it is essential for DCs to mature before they can
activate naive T cells, and our data and two recent studies (4, 5)
confirm that ingestion of apoptotic cells alone did not provide suf¬
ficient maturation stimulus. However, some necrotic cells or vi-
rally infected apoptotic cells are effective stimulators of DC mat¬
uration. Therefore, DCs ingesting apoptotic cells must be exposed
to additional agents, such as necrotic cells, monocyte-conditioned
medium, or viral products, before they become capable of stimu¬
lating T cells. Many of these agents will be present in inflamed
sites alongside apoptotic cells in vivo, and the potential for DCs
both to acquire apoptotic cell-derived self-Ags and receive matu¬
ration signals is high. However autoimmunity is uncommon, and
the response of the DC is likely to be tightly regulated. We suggest
that ingestion of apoptotic cells is not immunologically null, but is
capable of regulating DC maturation, providing a counterbalance
for inflammatory stimuli. A failure to see these inhibitory effects of
apoptotic cells in other studies may reflect the percentage of DCs
ingesting apoptotic cells and the strength of the maturation stim¬
ulus used. In the future, defining whether apoptotic cells them¬
selves are sufficient to alter DCs effector functions in vivo will be
of great interest. Further investigating this process will increase
our understanding of the mechanisms controlling peripheral self-
tolerance while giving us new insights into strategies for Ag de¬
livery that might generate tolerance rather than immunity. In con¬
trast, understanding how apoptotic tumor cells or pathogens might
also use this phenomenon for immune evasion will increase our
understanding of tumor immunology and infectious disease.
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Nonphlogistic Clearance of Late Apoptotic Neutrophils by
Macrophages: Efficient Phagocytosis Independent of /32
Integrins1
Yi Ren,* Lynda Stuart,* Frederik P. Lindberg,+ Alexander R. Rosenkranz,* Yongmei Chen,f
Tanya N. Mayadas,* and John Savill2*
Neutrophils undergo constitutive death by apoptosis, leading to safe nonphlogistic phagocytosis and clearance by macrophages.
Recent work has shown that before secondary necrosis, neutrophils exhibiting classical features of apoptosis can progress to a
morphologically defined late apoptotic state. However, whether such neutrophils could be safely cleared was unknown. We now
report that human late apoptotic neutrophils could be purified from cultured neutrophil populations undergoing constitutive death
and were subsequently ingested by human monocyte-derived macrophages by serum-independent mechanisms that did not trigger
the release of IL-8 or TNF-a. Such ingestion was specifically inhibited by Abs to thrombospondin-1 and the «V/T, vitronectin
receptor. Murine bone marrow-derived macrophage phagocytosis of late and early apoptotic neutrophils occurred by similar
mechanisms, proceeding with the same efficiency as that observed for wild-type controls when macrophages from am~'~ or fi2
mice were used. We conclude that specific nonphlogistic, /32 integrin-independent mechanisms involving thrombospondin-1 and
ayfi3 allow macrophages to ingest late apoptotic neutrophils without eliciting inflammatory cytokine secretion. The Journal of
Immunology, 2001, 166: 4743-4750.
Neutrophils and their toxic contents are vital for host de¬fense, but may also mediate undesirable tissue injury ina wide range of inflammatory diseases (1,2). However,
a growing body of evidence indicates that neutrophils can be safely
eliminated from inflamed tissues, promoting resolution of the in¬
flammatory response, by constitutively undergoing apoptosis (3-
9). This is a programmed form of cell death that leads to swift
phagocyte recognition, uptake, and degradation of intact senescent
neutrophils, preventing leakage of noxious contents from the dying
cells and failing to elicit proinflammatory responses from the in¬
gesting phagocyte (10-13). Consequently, safe phagocytic clear¬
ance of neutrophils undergoing constitutive apoptosis is viewed as
a key control point in the inflammatory response.
However, the molecular mechanisms mediating safe phagocytic
clearance of apoptotic cells remain poorly understood; an increas¬
ing number of phagocyte receptors (see Refs. 14-16 for reviews)
have been implicated in vitro. This complexity may reflect the fact
that studies have frequently involved administration to phagocytes
of "meals" consisting of heterogeneous populations containing
cells at various stages of the death program, including secondary
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necrosis (17). By contrast, human neutrophils undergoing consti¬
tutive apoptosis during overnight culture contain a mixture of his¬
tologically normal neutrophils (not ingested by phagocytes) and
intact cells that exclude trypan blue and propidium iodide (PI)3 and
exhibit classical morphologic features of early apoptosis (3). These
include nuclear coalescence and chromatin condensation accom¬
panied by well-defined surface changes such as the capacity to
bind annexin V (18-20). By separating intact apoptotic neutro¬
phils from histologically normal neutrophils within the same pop¬
ulation of aging cells, we confirmed that phagocytes recognized
only the apoptotic neutrophils (3). Nevertheless, even this appar¬
ently "clean" model system has proved more complex than was
first thought. Beyond 18 h in culture, a steadily increasing propor¬
tion of senescent neutrophils exhibit a characteristic late apoptotic
morphology in which nuclear degradation or so-called evanes¬
cence is accompanied by electron microscopic evidence of limited
granule fusion with the plasma membrane (21, 22). To avoid con¬
fusion, we propose that neutrophils with classical features of ap¬
optosis (3) should be regarded as early apoptotic cells.
We have become interested in whether late apoptotic neutro¬
phils are recognized by macrophages (M$s) and, if so, the molec¬
ular mechanisms and consequences of this event. A number of
different types of phagocytes can deploy the phagocyte surface
ayfi3 vitronectin receptor integrin to present bridging throm-
bospondin 1 (TSP1) to apoptotic cells and promote phagocytosis
without inciting proinflammatory secretory responses (10, 11, 23,
24). This mechanism was a strong candidate for M</> recognition of
late apoptotic neutrophils, because 1) these cells exhibit limited
fusion with the plasma membrane of granules containing proteins
3 Abbreviations used in this paper: PI, propidium iodide; TSP1, thrombospondin 1;
CR3/4, complement receptor type 3/type 4: M</>, macrophage; MPO, myeloperoxi¬
dase; PMN, polymorphonuclear neutrophil granulocyte; PPP, platelet-poor plasma;
PRPDS, platelet-rich plasma-derived serum; RGDS, Arg-Gly-Asp-Ser; RGES,
Arg-Gly-Glu-Ser.
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capable of binding TSP1 (21, 22, 25); 2) a very recent report in¬
dicates that late apoptotic neutrophils bind TSP1 with such effi¬
ciency that this can be demonstrated with soluble biotinylated
TSP1 (19); and 3) myeloid dendritic cells bind late apoptotic cells
via an av-mediated mechanism (26). However, equally strong can¬
didate phagocyte receptors were those of the fj2 integrin family
that bind opsonic complement fragments, type 3 complement re¬
ceptor (CR3; ctmp2 or CDllb/CD18) and CR4 (ax/32 or CDllc/
CD 18). Not only does ligation of these receptors fail to stimulate
the release of inflammatory mediators from M$s (27, 28), but
there is also evidence that they can bind, via opsonic complement
fragments, populations of dying cells (17, 29). Furthermore, )32
integrins can also bind denatured proteins (30), which might be
exposed by late apoptotic cells.
Therefore, in this study we set out to determine whether it was
possible to purify late apoptotic neutrophils from cultured neutro¬
phil populations undergoing constitutive death, whether such cells
were nonphlogistically ingested by Mc/>s, and whether either M</>




All chemicals were purchased from Sigma (St. Louis, MO) unless other¬
wise indicated. Culture media (HBSS, IMEM, and DMEM) and supple¬
ments (100 U/ml penicillin, 100 /xg/ml streptomycin, 2 mM glutamine, and
10% FCS) were obtained from Life Technologies (Grand Island, NY).
Sterile tissue culture plasticware was purchased from Falcon Plastics
(Cockeysville, MD).
Abs and peptides
mAb to the human vitronectin receptor integrin (31) was the av/33-specific
mAb 23C6 (IgGl; provided by Prof. M. Horton, St. Bartholomew's Med¬
ical School, London, U.K.). V. Dixit (University of Michigan, Ann Arbor,
MI) provided mTSPl, a rabbit affinity-purified polyclonal Ab specific for
mouse TSP1 (32), and A6.1, an IgGl murine mAb for human TSP1 (33).
H9.2B8, a hamster mAb specific for the mouse integrin av chain (34) was
obtained from PharMingen (San Diego, CA). The control mAb was mAb
OX-7 (from Serotec, Banbury, Oxon, U.K.), an IgGl that recognized Thy
1.1. The tetrapeptides Arg-Gly-Asp-Ser (RGDS) and Arg-Gly-Glu-Ser
(RGES) were obtained from Sigma.
Human leukocytes
Neutrophils were isolated from fresh citrated normal human blood by dex-
tran sedimentation and plasma-Percoll discontinuous density gradient cen-
trifugation and were "aged" in tissue culture in IMEM with 10% autolo¬
gous platelet-rich plasma-derived serum (PRPDS) so as to undergo
apoptosis, exactly as previously described (3). Late apoptotic neutrophils
were purified from 22-h aged polymorphonuclear neutrophil granulocyte
(PMN) by discontinuous plasma-Percoll density gradient centrifugation; as
described later in this report, >95% pure late apoptotic cells were isolated
at the interface between platelet-poor plasma (PPP) and 31% Percoll in
PPP, whereas a mixed population of late apoptotic and early apoptotic cells
was found at the interface of 31 and 42% Percoll in PPP; the latter was not
used in phagocytosis assays. A mixed population of early apoptotic and
nonapoptotic neutrophils free of late apoptotic cells was retrieved at the
42-51% Percoll in PPP interface; this last population was used as early
apoptotic neutrophils in studies of recognition by M$ (see below), as all
our previous studies have used similar mixed populations that routinely
arise after overnight aging in culture, because such cells are >99% viable
by trypan blue exclusion (3, 6, 23, 24). Gradients were centrifuged at
610 X g for 24 min at 4°C. Human monocytes (>90% pure) were prepared
by counterflow centrifugation as described previously (35) and cultured for
5 days in IMEM with 10% autologous prpds to mature into M<£ as previ¬
ously described (35).
Isolation and culture ofmouse M(j)
Bone marrow was harvested from BALB/c mice and plated in 96-well
plates in DMEM containing 10% FCS and 10% L929 cell-conditioned
medium as a source of M-CSF. Bone marrow M(/> were used in phagocy¬
tosis assays after 7 days of growth in culture as previously described (34).
In some experiments M<£ were prepared as described above from gene-
targeted mice and wild-type strain controls as follows: am (CDllb)~/_
BALB/c mice and BALB/c controls were used as previously described
(36); /32 (CD 18) null mice were crossed from 129sv/eg onto the C57BL/6J
background, and F2 CD18_/_ animals were used as founders for the
CD18-/~ mice used in the current experiments, with control mice bred
from 129sv/eg and C57BL/6J in parallel (37).
Assessment of PMN morphology and flow cytometric analysis
Early apoptotic and late apoptotic PMN were assessed by microscopic
examination of cytocentrifuge preparations fixed in methanol and stained
with May-Giemsa or by transmission electron microscopy as previously
described (3). Binding of FITC-conjugated annexin V in ice-cold PBS
containing calcium and magnesium as previously described (18, 20) was
used to assess exposure of phosphatidylserine exposure. PI was used to
assess plasma membrane permeability. Cells were exposed to PI at 1 /xg/ml
for 120 s immediately before flow cytometric analysis; a positive control
was provided by brief heating of 22-h aged neutrophil populations to
100°C. Labeled cells were applied to a Becton Dickinson FACScan flow
cytometer (Mountain View, CA) that automatically and simultaneously
measured the fluorescence of individual cells identified by their size-de-
pendent light-scattering properties.
Interaction assay
A coded, observer-blind, microscopically quantified phagocytic assay of
M4> ingestion of apoptotic PMNs, which has been extensively described,
illustrated, and validated (3, 23, 24, 38), was used in these studies. Apo¬
ptotic and late apoptotic PMNs prepared as described above from a single
population of 22-h aged PMNs were washed once in HBSS and suspended
in IMEM, and 0.5 X 106 PMN in 50 /il of medium were added to each
washed well ofM$ cultured in 96-well plates. After interaction for 30 min
at 37°C in 5% C02, the wells were washed in cold (4°C) 0.9% saline to
remove noningested PMNs, and then the M$ monolayer was fixed in 2%
glutaraldehyde in saline for 2 min and stained for myeloperoxidase (MPO),
and the proportion of M</>-ingesting PMNs was counted by inverted light
microscopy, exactly as previously described (3, 23, 24, 38). Because of a
tendency of nonapoptotic neutrophils to adhere to mouse bone marrow Mc/>
after 30-min interaction, mouse M<£ were then trypsinized, and a separate
cytocentrifuge preparation was prepared for each well as previously de¬
scribed (11, 35). These were fixed with 2% glutaraldehyde, stained for
MPO, and finally counterstained with Hemalum (BDH, Poole, U.K.). The
proportion of mouse M</>-containing, brown-staining, MPO-positive PMNs
was then counted.
Effects of serum
To determine whether there were effects of serum on the phagocytosis of
early apoptotic and late apoptotic PMN, such PMNs were interacted with
human monocyte-derived M<£ in the presence of 15% normal nonheated
autologous human PRPDS or serum prepared in glass and 15% normal
heated (56°C for 30 min) autologous human PRPDS or serum from glass.
Effects ofAbs
These were determined as previously described (23, 24, 34, 38). Mcp in
96-well plates were washed, and 50 /xl of Ab at the desired concentration
in IMEM was added to each well. The plates were incubated for 15 min at
4°C, followed by addition of 0.5 X 106 PMN in 10 /xl of IMEM at 37°C,
and then interacted for 30 min under standard conditions.
Effects of soluble inhibitors
Various inhibitors were included in the interaction medium. The tetrapep-
tide RGDS and the control peptide RGES were made up in IMEM before
being added to the interaction medium to achieve the desired concentration
(1 mM).
Assessment of M<fr response to ingestion of late apoptotic cells
Human M(f) were washed with HBSS, then incubated with apoptotic PMN,
late apoptotic PMN, and control particles in IMEM for 30 min. The non-
ingested apoptotic PMN and control particles were washed away, and
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FIGURE 1. Heterogeneity of neutrophils aged in culture. Light micro¬
scopy (X1000) of cytoprep of 22-h aged neutrophils showing nonapoptotic
neutrophils (examples marked by A), early apoptotic neutrophils (exam¬
ples marked by open arrows), and a late apoptotic neutrophil (closed ar¬
row). Note the lack of chromatin in the latter.
IMEM was added for 16 h. Supernatants were collected at this time point
because cytokine secretion stimulated by opsonized zymosan was maximal
(13). Supernatants were centrifuged at 6000 rpm for 3 min to remove
particulate debris. Cytokine concentrations in the culture supematants were
assayed by ELISA for TNF-a and IL-8 using specific assays as previously
described (11).
Results
Purification of late apoptotic neutrophils
In keeping with the studies by Hebert et al. (21), we observed
increasing proportions of apparently anucleate late apoptotic neu¬
trophils after 18 h of culture of normal human peripheral blood
neutrophils (Figs. 1 and 2). We reasoned that it might be possible
to purify late apoptotic neutrophils by density centrifugation on
discontinuous Percoll-plasma gradients. From neutrophil popula¬
tions aged in vitro for 22 h, we were able to obtain a fraction from
the 0/31% Percoll interface containing >95% pure late apoptotic
cells (Fig. 3A) with typical nuclear evanescence (21) and other
characteristic features confirmed by electron microscopy (Fig. 3B)
and a distinct fraction of aged neutrophils from the 42/51% Percoll
interface displaying a mix of morphologically normal and early
apoptotic neutrophils (Fig. 3C) closely similar to the overnight-
aged neutrophil populations used in our previous studies of phago¬
cyte recognition of early apoptotic neutrophils (23, 24, 34, 38).
Typically around 50% of cells in this fraction displayed early ap¬
optotic morphology (Fig. 3C; see also Fig. 4B).
When the phenotype of purified late apoptotic neutrophils from
the 0/31% Percoll interface was further examined by flow cytom¬
etry, nonfixed cells stained with FITC-labeled annexin V, indicat¬
ing exposure of phosphatidylserine (Fig. 4A) to a degree similar to
that exhibited by the 50% of early apoptotic cells in the fraction
from the 42/51% Percoll interface (Fig. 4B, lower right quadrant).
The late apoptotic neutrophil population exhibited slightly greater
permeability to PI than early apoptotic cells (compare Fig. 4, A and
B), although much less than that exhibited by heat-permeabilized
22-h aged neutrophils (Fig. 4C). These data indicated that late
apoptotic neutrophils exhibited some increase in plasma mem¬
brane permeability despite being morphologically intact. However,
the late apoptotic neutrophil fraction isolated from 22-h aged neu¬
trophil populations did not begin to undergo secondary necrosis, as
evidenced by detectable spontaneous release of the granule con¬
stituent MPO, until recultured under standard conditions for at
least 4 h (data not shown).
Human monocyte-derived M(f> phagocytosis of late apoptotic
cells is nonphlogistic
Previously we (10, 11, 39) and others (13) reported that uptake of
apoptotic cells did not trigger release of proinflammatory cytokines
from M<(>s and other phagocytes. However, M<£ did release such
cytokines when ingesting debris from granulocytes that had under¬
gone secondary necrosis after constitutive apoptosis (39). Conse¬
quently, it was important to determine the response made by M<£
taking up late apoptotic neutrophils. Following a 30-min interaction
with late apoptotic neutrophils as described in Materials and Methods,
40.2 ± 1.8% (mean ± SE; n — 6) of human monocyte-derived M$
ingested late apoptotic neutrophils. However, by contrast with uptake
of opsonized zymosan, there was no release of the proinflammatory
cytokines, IL-8 or TNF-a, indicating that uptake of late apoptotic
neutrophils was also nonphlogistic (Table I).
Human Mtp phagocytosis of late apoptotic cells is not
modulated by serum, but is inhibited by Abs to TSP1 and a,,/33
Although our previous studies have routinely used human neutro¬
phils and M<(> cultured in autologous serum obtained by recalci-
fying platelet-rich plasma (PRPDS), we have routinely washed
both cell types before interaction in the absence of added serum (3,
23, 24, 35, 38). A recent report, using an assay of aged neutrophil
interaction with human in which much of the interaction sig¬
nal appeared to be tethering of apoptotic cells rather than phago¬
cytosis, suggested that interaction could be markedly enhanced by
the presence of up to 15% serum as a source of complement (29).
Nevertheless, the inclusion of 15% autologous serum prepared in
glass did not enhance human monocyte-derived phagocytosis of
either late apoptotic or early apoptotic neutrophil fractions in our
assay (Fig. 5). Furthermore, the use of 15% PRPDS also failed to
120
FIGURE 2. Time course of appear¬
ance of late apoptotic neutrophils during
prolonged culture of purified neutro¬
phils. With increasing time in culture
note the successive appearance of early
apoptotic cells (♦), late apoptotic cells
(■), and intact cells admitting trypan
blue dye (A). Data are the mean ± SE
(n = 4).
- % early apoptotic PMN
- % late apoptotic PMN
- % trypan blue positive PMN
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FIGURE 3. Purification of late apoplotic neutrophils. Human PMNs
aged for 22 h in culture were separated on a discontinuous Percoll-plasma
gradient and examined by light microscopy of May-Griemsa-stained cy-
topreps. A, Cells from the 0/31% Percoll interface; note that these senes¬
cent neutrophils have late apoptotic morphology. B, Transmission electron
microscopy of a late apoptotic neutrophil (X 10,000) prepared by plasma-
Percoll density gradient centrifugation of 28-h aged cell population; note
intact plasma membrane and retained granules. C, Cells from the 42/51%
interface; note that this is a mixed population of nonapoptotic neutrophils
and apoptotic neutrophils (examples; open arrows).
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FIGURE 4. Permeability to PI and expression of phosphatidylserine by
late apoptotic, early apoptotic, and heat-permeabilized aged neutrophils.
Typical flow cytometric profiles for staining with FITC-annexin V (hori¬
zontal axis) and PI (vertical axis), comparing late apoptotic neutrophils (A)
isolated from the 0/31% Percoll interface of discontinuous plasma-Percoll
density gradient centrifugation of 22-h aged neutrophils, early apoptotic
neutrophils (right quadrants of B) and normal neutrophils (left quadrants
of B) isolated from the 42/51% Percoll interface, and heat-permeabilized
22-h aged neutrophils (C). Numbers in upper left, upper right, and lower
right quadrants are the percentage of total cells in each quadrant. Note that
>95% of late apoptotic neutrophils bind annexin V, and that such cells
exhibit slightly increased PI staining compared with early apoptotic
neutrophils.
enhance phagocytosis of each cell type (data not shown). By con¬
trast, mAbs (but control mAb) to TSP1 and av/33 significantly
inhibited human monocyte-derived Mc/> phagocytosis of both late
and early apoptotic neutrophil fractions (Fig. 6), but not uptake of
opsonized RBC used as controls (data not shown for clarity).
Murine bone marrow-derived Mf> phagocytosis of late apoptotic
neutrophils is also inhibited by Abs to TSP1 and av
Our previous work suggested that murine bone marrow-derived
M</> use mechanisms similar to those of human monocyte-derived
Mcj) in uptake of human early apoptotic neutrophils; inhibition by
Table I. Proinflammatory cytokine release by human monocyte-derived
M(f> phagocytosing aged PMN"
Stimulus TNF-a (ng/ml) IL-8 (ng/ml)
Control 2.60 ± 0.36 8.33 ± 1.35
Opsonised zymosan 589.29 ± 1.32* 62.75 ± 9.42*
Early apoptotic PMN 2.81 ± 1.49 4.81 ± 0.99
Late apoptotic PMN 1.61 ± 0.61 5.90 ± 1.45
" Note that phagocytosis of neither early apoptotic PMN by 38.3 ± 3.0% of M<£
nor phagocytosis of late apoptotic PMN by 48.4 ± 1.9% of M<£ stimulated cytokine
release, by contrast with positive control stimulus of opsonised zymosan. Date are
mean ± SE, n = 4; the only significant differences from control observed were in
cytokine release after opsonized zymosan (*, p < 0.001).
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FIGURE 5. Serum does not potentiate phagocy¬
tosis of early or late apoptotic neutrophils. The pres¬
ence of 15% autologous serum prepared by clotting
blood in glass (bars in center) or decomplemented
serum (heated at 56°C for 30 min; bars on right) did
not potentiate phagocytosis of early apoptotic (■) or
late apoptotic (□) by human monocyte-derived M<£s
compared with control conditions in which no serum
was added to washed cells (bars on left). Values are
the mean ± SE (n = 6). p > 0.05 in all cases.
□ late apoptotic PMN
■ early apoptotic PMN
control heated serum
RGDS peptide and anti-murine av mAb is demonstrable (34). Not
only did these reagents inhibit uptake of late apoptotic neutrophils
by murine bone marrow-derived M<f> (but not control RGES pep¬
tide or control mAb; Fig. 7), but inhibition was observed with an
affinity-purified rabbit Ab to TSP1 (but not by control rabbit IgG).
No reagent used inhibited uptake of opsonized erythrocytes (data
not shown for clarity).
/32 integrins are not necessary for efficient Mc/> uptake of early
and late apoptotic neutrophils
Because ligation of M<f> CR3 and CR3-mediated uptake of parti¬
cles have been reported not to activate proinflammatory responses
from M(£> (27, 28), we considered it important to examine the role
of a2 integrins in Mc/> uptake of early and late apoptotic neutro¬
phils, particularly the am/32/CDllb CD18 CR3 integrin. Conse¬
quently, we sought definitive evidence of a requirement for amj32
or other /32 integrins by studying M<f> from gene-targeted mice. In
experiments using bone marrow-derived M<f> from am-/~ mice
and wild-type controls, no difference was observed in the propor¬
tion of M<(> ingesting late apoptotic neutrophils; these were highly
efficiently ingested by 71.8 ± 5.3% of am~'~ and 66.7 ±
5.9% of wild-type M<£ (mean ± SE; n = 3; i.e., three mice in
eachgroup; experiments were also performed in triplicate in M<£>
from each mouse). These findings were confirmed in a more ex¬
tensive series of experiments using bone marrow-derived M(f> from
j32~/- and wild-type control mice; there was no difference in the
proportion of M$ ingesting either apoptotic or late apoptotic neu¬
trophils (Fig. 8). Indeed, although recognition of late apoptotic
neutrophils was generally slightly greater in absolute degree than
uptake of early apoptotic cells in each set of experiments, perhaps
reflecting unavoidable dilution of early apoptotic cells by copuri-
fied nonapoptotic neutrophils, the mechanism of recognition by
bone marrow-derived M</> from wild-type or /32~/_ mice appeared
very similar despite variation in the baseline degree of phagocy¬
tosis between sets of experiments consistent with previous expe¬
rience (11, 34). Thus, specific inhibition of bone marrow-derived
M<(> uptake of late apoptotic neutrophils was observed with RGDS
peptide at 1 mM, but not control RGES peptide, and was seen also
with Ab to murine vitronectin receptor (av), but not control Ab
(Fig. 8).
Discussion
Although previous work (21) has demonstrated that neutrophils
undergoing constitutive death by apoptosis can pass from the early
apoptotic state (as defined in our earlier studies (3)) to a late ap¬
optotic state for some hours before finally undergoing secondary
necrosis, it has been unknown whether late apoptotic neutrophils
can be safely cleared by M$s. In this report we have demonstrated
that fractions ofmorphologically defined late apoptotic neutrophils
can be purified from populations of senescent human neutrophils.
Furthermore, in keeping with previous data obtained with popula¬
tions of 'early' apoptotic neutrophils (10, 11), late apoptotic neu¬
trophils were efficiently ingested by human monocyte-derived M<^>
without triggering release of the pro-inflammatory mediators IL-8
and TNF-a. By contrast with a previous report (29), the proportion
of human monocyte-derived ingesting early apoptotic neutro¬
phils was not increased by the presence of serum and no increase
in uptake of late apoptotic neutrophils was observed. These data
argued against a role for M<^> ji2 integrins in uptake of dying neu¬
trophils. Flowever, the uptake of late apoptotic neutrophils by both
human monocyte-derived M<f> and murine bone marrow-derived
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FIGURE 6. Human monocyte-derived M(/> phagocyto¬
sis of aged PMN. Comparison of phagocytosis of late ap¬
optotic PMNs (□) and early apoptotic PMNs (■) pre¬
pared from the same 22-h aged human PMN populations.
Note that RGDS peptide, av/33 mAb 23C6, and TSP1
mAb A6.1 all inhibited phagocytosis of both types of aged
PMN. Values are the mean ± SE (n = 6). =, p < 0.05;
**, p < 0.001.
23C6 Ml
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FIGURE 7. BALB/c murine bone marrow-derived
M</< phagocytosis of aged PMN. Comparison of phago¬
cytosis of late apoptotic PMNs (□) and early apoptotic
PMNs (■) prepared from the same 22-h aged human
PMN populations. Note that phagocytosis of both apo¬
ptotic and late apoptotic PMN was inhibited by rabbit
polyclonal Ab to murine TSP1 (mTSPl), H9.2B8 mAb
to murine av, and RGDS peptide, but not by respective
controls, rabbit IgG (RIgG), 0X7 mAb, and RGES
peptide. Values are the mean ± SE (n = 6). *,p < 0.05;
**, p < 0.001.
RIgG mTSP1 RGDS RGES OX7 H9.2B6
was ingestion of early apoptotic neutrophils. Furthermore, strong
evidence against a requirement for /32 integrins in efficient M<j>
phagocytosis of either early or late apoptotic neutrophils was pro¬
vided by the failure of M$s from and /32~'~ knockout mice
to exhibit any defect in phagocytosis of either target.
Our first major conclusion from these data is that progression
beyond the (early) apoptotic state originally defined in our studies
of the constitutive death of cultured neutrophils (3) does not deny
senescent neutrophils the opportunity for safe clearance while in
the late apoptotic state before potentially deleterious secondary
necrosis. Although our assessment of the proinflammatory secre¬
tory response from M$s taking up late apoptotic neutrophils was
limited to assay of Mcft release of the key chemokine IL-8 and the
master inflammatory mediator TNF-a, previous studies (11-13)
indicate that other classes of inflammatory mediator are unlikely to
be released by M<j> under these circumstances. The current data
re-emphasize the tissue-protective potential of neutrophil clear¬
ance by apoptosis, demonstrating that even cells reaching what
might be termed the "last chapter" of constitutive death can be
cleared safely.
However, our data also indicate that it may prove difficult to
selectively define the potential for tissue protection afforded by
OX7 H92B8
; □ late apoptotic PMN j
■ early apoptotic PMN I
FIGURE 8. Effect of CD 18 deficiency on murine bone
marrow-derived M</> phagocytosis of aged PMN. Com¬
parison of phagocytosis of late apoptotic PMNs (□) and
early apoptotic PMNs (■) prepared from the same 22-h
aged human PMN populations. A, Wild-type control; B,
M(f> from CD18-/~ knockout mice. Data are the mean ±
SE (n = 3). *, p < 0.05. Note that in both cases there was
inhibition of uptake of both types of aged PMNs by 100
/xg/ml mAb H9.2B8 and 1 mM RGDS peptide, but not by
identical concentrations of controls, mAb OX-7 and
RGES peptide.
OX7 H9.2B8 RGDS RGES
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specific clearance of late apoptotic neutrophils in vivo. This is
because phagocytosis of both early and late apoptotic neutro¬
phils appears likely to involve similar mechanisms in which TSP1
and the vitronectin receptor play a major role. Thus, it may prove
difficult to inhibit uptake of early apoptotic cells selectively, be¬
cause this would be necessary for a formal assessment of the ca¬
pacity ofMtf. phagocytosis of late apoptotic neutrophils to serve as
a last line of tissue defense in inflammation. Nevertheless, despite
a growing understanding of molecular mechanisms mediating
phagocytic clearance, we still know very little of those mecha¬
nisms that predominate in the clearance of apoptotic cells from
various sites in the living mammal. Future work should take into
account the possibility that clearance mechanisms dedicated to re¬
moval of late apoptotic cells could exist. Some support for this
possibility can be drawn from the observation by Rubartelli et al.
that myeloid dendritic cells may use av integrins in selective in¬
gestion of late apoptotic cells (26).
The second major finding of our study also emphasizes that
much remains to be learned about mechanisms mediating M(j> in¬
gestion of cells dying by apoptosis. The data clearly demonstrate
that expression of /32 integrins is not necessary for efficient phago¬
cytosis of either early or late human apoptotic neutrophils by mu¬
rine bone marrow-derived M<j)s (which, nevertheless, appear to use
TSPl/vitronectin receptor-mediated mechanisms similar to those
exhibited by human monocyte-derived Mc/>). The current data are
in keeping with our earlier work (3, 38) in an assay system in
which neutrophils underwent apoptosis in the presence of autolo¬
gous PRPDS, a source of complement that, according to a recent
report, apoptotic cells may activate so that they become coated
with opsonic complement fragments (29). Nevertheless, when
such cells were interacted in the absence of added serum with
human monocyte-derived M<j>, no defect in phagocytosis of apo¬
ptotic neutrophils was observed despite functionally validated Ab
blockade of M<j>, CR1, CR3, and CR4 receptors (38), nor was any
obvious defect in phagocytosis exhibited by monocyte-derived
M<j> prepared from a patient with severe congenital /32 deficiency
(40). However, our findings must be set against 1) growing evi¬
dence that the first component of complement, Clq, could bridge
apoptotic cells to phagocytes in a manner similar to that proposed
for TSP1 (41, 42), and 2) compelling data suggesting that M<j>
receptors for opsonic complement fragments could be important in
amplifying efficient phagocytosis of dying cells (17, 29). Never¬
theless, it is notable that these latter reports have either used mixed
populations of dying cells, including cells in secondary necrosis
(17), or have used assays of interaction with M<p that include a
large tethering element (29) rather than our own extensively val¬
idated assay of completed phagocytosis. Further studies will be
needed to resolve the importance of complement components in
removal of neutrophils at various stages of the apoptotic death
program.
To conclude, our studies demonstrate that late apoptotic neutro¬
phils can be ingested by M<j>s via specific mechanisms uncoupled
from secretory proinflammatory responses. Such mechanisms can
operate efficiently in the absence of M<j> /32 integrins, however,
emphasizing the need for further characterization of the role of
complement components in the safe clearance of cells dying by
apoptosis.
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Introduction
During normal tissue homeostasis, the rate of cell
death is perfectly balanced by the rate of production
of new cells, resulting in a constant cell number.
Apoptosis is a critically important mechanism that
facilitates deletion of unwanted or damaged cells
in various circumstances, including embryogenesis,
inflammation and tissue healing. The purpose of this
article is to outline a 'darker side' of apoptosis since
defects in the apoptotic cell death programme and
subsequent clearance of cellular corpses are implicated
in the pathogenesis of clinically important autoim¬
mune diseases such as systemic lupus erythematosus
(SLE).
What is apoptosis?
Apoptosis is characterized by stereotypical morpho¬
logical and biochemical changes including the activa¬
tion of specific intracellular proteolytic enzymes
(caspases) that cleave myriad nuclear and cytoplasmic
substrates [1,2]. Apoptosis may result from an
insufficient supply of survival signals or may be
actively induced by various injurious stimuli such as
hypoxia, reactive oxygen species, complement attack,
nitric oxide, cytokines such as tumour necrosis factor-a
or ligation of the Fas (CD95) cell surface death
receptor. Apoptosis elicits specific cell surface changes,
such as the exposure of phosphatidylserine, normally
found on the intracellular aspect of the cell membrane,
resulting in the swift uptake and degradation of
apoptotic cells either by local resident cells or
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infiltrating phagocytes. This process is very rapid
such that apoptotic cells are conspicuously absent in
normal tissues. Furthermore, cell deletion by apoptosis
leading to clearance by 'professional' phagocytes such
as macrophages is not associated with proinflamma¬
tory mediator release but rather causes release of anti¬
inflammatory agents such as transforming growth
factor beta 1 (TGF/tl) [3,5]. The mechanisms whereby
macrophages and 'semi-professional' phagocytes
(including mesangial cells) recognise and ingest apop¬
totic cells are complicated and may involve numerous
molecules including the vitronectin receptor (av//3
integrin), CD36, thrombospondin, the phosphatidyl-
serine receptor, the first component of complement
Clq, /J2 thrombomodulin, class A scavenger receptors,
etc. [4] (Table 1).
The role of apoptosis in the maintenance of self
tolerance and the regulation of T cell populations
Self tolerance requires the removal or deactivation of
autoreactive T cells with specificity to both central
(i.e. T cells reacting to self antigen present in the
thymus) and peripheral antigens. Within the develop¬
ing thymus, engagement of autoreactive T cells by
self antigen induces apoptosis and deletion of these
potentially injurious T cells. Consequently, defects
in this process will facilitate the persistence of
T cells capable of recognising self and inducing
autoimmunity.
However, the entire repertoire of self antigens is
not represented within the thymus and therefore addi¬
tional mechanisms are needed to maintain adequate
peripheral self tolerance. Although this process is
incompletely understood apoptosis may also be
involved. It has been recognised for some time
that certain organs such as the eye and the testes
exhibit "immunological privilege'. It is now apparent
that this is at least partly due to the expression of Fas
ligand by resident tissue cells at these sites. This
tissue 'self defense' mechanism results in the induction
of apoptosis in infiltrating Fas-bearing lymphocytes
following Fas ligation.
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Table 1. Receptors and molecules involved in the recognition and
ingestion of apoptotic cells
Phagocyte cell surface Bridging molecules Apoptotic cell surface
Phosphatidylserine Thrombospondin Phosphatidylserine
receptor Clq ICAM-3
CD36 iC3b Sugar moieties
Integrins (fo/ft//b/ft) B2GP1 Thrombospondin
CD14 binding site





Note that the receptors utilized may differ between various
phagocytic cells and that some of the proposed receptors and
molecules involved have not been well characterized (e.g. cell surface
lectins that binding sugar moieties on the apoptotic cell surface).
Adapted from [4],
Apoptosis also plays a role in the regulation of
T cell populations. Clonally expanded populations of
activated T cells that have served their functional
purpose are rapidly deleted by 'activation induced
cell death' (AICD), a process dependent upon ligation
of the cell surface Fas death receptor. It is therefore
very pertinent that mice with mutations in the
genes encoding either Fas or Fas ligand develop
autoimmune disease. Depending upon the genetic
background, such mice exhibit lymphadenopathy,
splenomegaly, autoantibody formation, joint inflam¬
mation and glomerulonephritis with features of SLE
[6]. Interestingly, early treatment of gld/gld mice,
deficient in functional Fas ligand, with an agonistic
anti-Fas antibody protected mice from the subsequent
development of autoimmune disease by a mechanism
which presumably involves Fas-dependent deletion of
autoreactive lymphocytes [7], Furthermore, treatment
of established autoimmune disease with the same
agonistic anti-Fas antibody resulted in a significant
improvement in disease pathology [7].
A small number of human patients have been
described with mutations in the genes encoding either
Fas or Fas ligand. These patients exhibit an auto¬
immune lymphoproliferative syndrome (ALPS or
Canale-Smith syndrome) characterized by lymphade¬
nopathy, splenomegaly and autoantibodies directed
at blood components such as erythrocytes and plate¬
lets [8]. Affected individuals do not typically develop
joint or renal disease, and therefore defects in the Fas
death receptor or its ligand do not appear vital to the
pathology in these organs but can contribute to
autoimmune disease.
Apoptotic cells express potential autoantigens on
their cell surface
The origin of the autoantibodies typically present in
the sera of patients with autoimmune conditions such
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as SLE (often directed towards intracellular antigens
such as DNA, ribonucleoproteins and nucleosomes)
has been perplexing as these autoantigens are normally
'invisible' to the immune system because of their
localization within the cell. However, seminal work by
Casciola-Rosen et al. [9] has indicated that keratino-
cytes undergoing apoptosis display potential auto¬
antigens upon their cell surface where they are
available for interaction with immunologically compe¬
tent cells. These potential autoantigens on apoptotic
cells are likely to have undergone proteolysis by
caspases, resulting in the production of immunogenic
'altered self' motifs. Indeed, cleavage of intracellular
substrates by the enzyme granzyme B can result in
unique modification of potential intracellular auto¬
antigens and raises the possibility that cytotoxic
lymphocyte-mediated death of target cells may play a
specific role in the development of autoimmunity [10].
Defective clearance of apoptotic cells may induce
autoimmunity
Although the surface of apoptotic cells may express
potential autoantigens, it is obvious that the majority
of the population do not develop autoimmune
pathology and therefore apoptosis itself is insufficient
to induce autoimmune disease. It is believed that,
in normal circumstances, apoptotic cells are rapidly
ingested and degraded by phagocytes. Indeed, in vivo
studies of both renal development and glomerulone¬
phritis indicate that the vast majority of apoptotic cells
evident in tissue sections actually lie within other cells
[11,17]. This suggests that autoimmunity may be more
likely to arise if there is a defect in the clearance of
apoptotic cells, and accumulating evidence suggests
that this is indeed the case.
For example, experiments involving the injection
of normal mice with irradiated syngeneic apoptotic
thymocytes resulted in the transient development of
antinuclear autoantibodies and anticardiolipin, and
anti-ssDNA antibodies, albeit at relatively low levels
[13]. Furthermore, these mice also exhibited mild
glomerular immunoglobulin deposition. These data
indicate that exposure to large numbers of apoptotic
cells, which may exceed the phagocytic capacity of
the reticuloendothelial system, is able to elicit an
autoantibody response.
As indicated previously, multiple macrophage cell
surface receptors and bridging molecules may be
involved in the recognition and ingestion of apoptotic
cells (Table 1). However, the involvement of Clq,
the first component of the classical complement
pathway, is of particular interest since Clq deficiency
is strongly associated with the development of SLE
[14]. It is therefore extremely important that mice
targeted for the deletion of the Clq gene spon¬
taneously develop both autoantibodies and glomerulo¬
nephritis [15]. Indeed, the glomerular inflammation in
the Clq-deficient mice is characterized by an impressive
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accumulation of apoptotic cells within glomeruli,
implying that defective clearance of apoptotic cells is
an important aetiological factor in the development
of disease [15]. In addition, as in human disease, the
genetic background of the Clq-knockout mice plays
an important role in modulating disease suscept¬
ibility and phenotype. A pathogenetic role of defective
apoptotic cell clearance in the development of auto¬
immunity may also explain why exposure to UV light
or intercurrent infections are associated with increased
disease activity since they would be predicted to
increase the burden of apoptotic keratinocytes or
leukocytes requiring phagocytic clearance. Lastly, it
is pertinent that monocyte-derived macrophages iso¬
lated from patients with SLE exhibit reduced ingestion
of apoptotic cells in a quantifiable in vitro assay of
phagocytosis, suggesting that a defect in apoptotic
cell clearance may be relevant to the pathogenesis of
SLE in Clq-replete human patients [16].
Biological systems have evolved to ensure that
apoptotic cells do not normally undergo secondary
necrosis, which would be predicted to increase the
likelihood of autoimmune responses. For example,
C reactive protein, a teleologically ancient acute phase
reactant protein, can bind to the apoptotic cell surface.
Bound CRP stimulates activation of the classical
pathway of complement, resulting in opsonization of
the cell with complement components that can aug¬
ment apoptotic cell clearance [17], and also assists
the maintenance of cell viability by inhibiting the
activation of the cytolytic C5b-9 terminal membrane
attack complex. In addition, the pentraxin PTX3
is an acute phase protein generated locally within
inflamed tissues that acts to inhibit uptake of apoptotic
cells by dendritic cells, which are capable of present¬
ing apoptotic cell-derived antigen to T cells [18,19].
Finally, the acute phase protein serum amyloid P
component (SAP) binds chromatin on apoptotic cell
surfaces as well as binding, solubilizing and regu¬
lating the degradation of free chromatin that results
from cell breakdown. The importance of this
chromatin scavenging system is underscored by the
phenotype of mice targeted for the deletion of the
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SAP gene, which exhibit antinuclear autoantibodies
and glomerulonephritis [20],
Immunological presentation of antigens derived
from apoptotic cells
Unlike macrophages, dendritic cells are unique in
their ability to stimulate primary immune responses.
Immature dendritic cells exist in the periphery and
constantly sample their antigenic milieu. In order to
become fully functional antigen-presenting cells they
must mature and migrate to draining lymph nodes
where they can interact with nai've T cells. Dendritic
cell maturation is normally provoked by inflammatory
stimuli such as TNF-a or bacterial products. Recent
data indicate that dendritic cells not only ingest
apoptotic cells but are capable of presenting apoptotic
cell-derived antigen to both CD4 and CD8 T cells
if they receive appropriate activation signals [18,19].
Since apoptotic cells are a source of potential auto-
antigens it is conceivable that the phagocytic imma¬
ture dendritic cell can induce a primary autoimmune
response if it encounters apoptotic cells concurrently
with appropriate 'danger' signals. Indeed, it has been
suggested that a large load of apoptotic cell material,
perhaps due to secondary necrosis following failed
clearance, may predispose to the development of
autoimmune responses by increasing the potential
for dendritic cells to phagocytose apoptotic cell
material and subsequently present autoantigens [21].
However, this is a controversial area of research as
conflicting data suggests that dendritic cells that have
ingested apoptotic cells may play a role in the
maintenance of peripheral tolerance [22].
Resolution of inflammation and scarring
Defective clearance of apoptotic cells in patients
with SLE may actually represent a 'double whammy',



















Fig. 1. Simplified schema indicating the role of apoptosis in autoimmunity.
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as well as blunt the macrophage 'deactivating' effects
of apoptotic cell ingestion at inflamed sites [5]. In
theory, this failure to 'switch off' activated pro¬
inflammatory macrophages may impair the resolution
of inflammation in the kidney and other tissues,
with the consequent promotion of scarring and loss
of organ function.
Conclusion
Apoptosis and the clearance of apoptotic cells are
essential for normal tissue homeostasis, embryogenesis
and tissue remodelling. Apoptotic deletion of poten¬
tially autoreactive T cells is involved in the main¬
tenance of self tolerance. Furthermore, apoptotic cells
are an important and preferential source of many
potential autoantigens. Defective apoptotic cell clear¬
ance may facilitate the inappropriate presentation
of potential autoantigens by dendritic cells, thereby
initiating autoimmune responses. These observations
confirm an important role for defects in apoptosis
and the clearance of apoptotic cells in the develop¬
ment of autoimmunity (Figure 1). Future research
will shed further light upon the involvement of
apoptosis in autoimmunity and hopefully highlight
new targets for potential therapeutic intervention.
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